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Chapter I 
 
Introduction 
 
Force generation in living systems 
Force generation is a fundamental property of life, from the microscopic to the 
macroscopic levels. Nowhere is this more readily apparent than the force dependent 
phenomenon of movement. The ability to move affects every living organism. Obvious 
examples include the thrilling chase of hunter and prey, and the powerful but graceful 
movements of a ballerina. Less obvious, but no less important is the subtle, determined 
growth of a plants intricate network of life-provide roots, and the digestive processes of 
a stationary, filter feeding sponge. Beneath the level of detection of the human eye, 
these desperate movements are just as prevalent, where “molecular motors” drive 
movement required for life sustaining processes. Whip-like cilia powered by kinesin and 
dynein motors allow single cell eukaryotes to swim and hunt prey, and eukaryotic cells 
in complex tissues to establish left-right asymmetry. The muscles of the hunter and 
ballerina are power by the contraction of myosin and actin. These macroscale and 
molecular movements have fascinated humanity from the beginning, as ancient cave 
paintings of hunting scenes by our ancestors can confirm. More recently, a series of 
elegant experiments by Italian scientists Caldani and Galvani in the late 1700s and early 
1800s highlights our fascination with force generation and movement. These 
experiments demonstrated electricity could excite and cause the movement of muscle 
of a cadaver, experiments which inspired aspects of Mary Shelley’s Frankenstein (Hill, 
14 
 
2012). Over 200 years later, how force generation occurs still fascinates scientists and 
non-scientists alike.  
 
Actin and Myosin II Based Force Generation 
Force generation at the cellular level is critical for eukaryotic development, 
homeostasis, and the progression of force dependent diseases such as cancer (Babbin 
et al., 2009; Ma and Adelstein, 2014b; Samuel et al., 2011; Tullio et al., 1997; Xia et al., 
2012). Molecular motors coordinate with cytoskeletal elements, such as actin filaments, 
to drive force dependent processes such as cell migration, cell division, and muscle 
contraction (Even-Ram et al., 2007; Gupton and Waterman-Storer, 2006; Huxley, 1969; 
Mabuchi and Okuno, 1977; Sandquist et al., 2006; Spudich, 2014; Straight et al., 2003). 
These seemingly diverse processes are all driven by forces generated by the same 
contractile machinery: actin and myosin II (Fenix and Burnette, 2018; Hartman and 
Spudich, 2012; Vicente-Manzanares et al., 2009b).  
Actin and myosin II represent two of the longest studied proteins in modern 
science. German scientist, Willy Kuhne, discovered the first myosin II complex in 1864 
(Hartman and Spudich, 2012; Kuhne, 1864). Almost a century later, the great Hungarian 
scientist, Albert Szent-Gyorgyi (who shared the 1937 Nobel Prize for the discovery of 
Vitamin C) in a series of elegant papers, isolated actin and myosin (separately) from 
skeletal muscle and demonstrated the contractile ability of the isolated proteins (Szent-
Gyorgyi, 1943a; Szent-Gyorgyi, 1943b). Dr. Szent-Gyorgyi described the contraction of 
actin and myosin threads as, “perhaps the most exciting experience of my research 
career.” (Szent-Gyorgyi, 1963) Building upon these critical early observations, advances 
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in technology have exponentially increased our understanding of these proteins at the 
genetic, structural, and functional level, though there remains much to discover. 
Specifically, how cells build the complex and highly ordered actin and myosin II 
machinery required to generate the observed force generation Dr. Szent-Gyorgi so 
passionately described. 
 
Myosin II 
Myosins represent a superfamily of proteins which hydrolyze ATP and bind to 
actin (Hartman and Spudich, 2012). Myosin motors are directly involved in a diversity of 
process including muscle contraction, molecular transport, endocytosis, stress fiber 
assembly, and cell differentiation (Vicente-Manzanares et al., 2009b). For the purposes 
of this work, we will focus on “conventional” myosin molecules, referred to as myosin II. 
Myosin II was the first discovered myosin, isolated from skeletal muscle samples 
(Hartman and Spudich, 2012; Szent-Gyorgyi, 1943a; Szent-Gyorgyi, 1943b). 
Subsequently, multiple myosin IIs, encoded by separate genes have been discovered 
(Hartman and Spudich, 2012). While these myosin II genes show high sequence 
homology and protein structure, they have diverse tissue localizations and biological 
roles. Cardiac myosin IIs and skeletal myosin IIs drive the heart beat and skeletal 
muscle contraction, respectively (Resnicow et al., 2010; Yamauchi-Takihara et al., 
1989). Smooth muscle myosin II is involved in involuntary contraction such as 
esophageal contraction (Eddinger and Meer, 2007). So called, “non-muscle myosin IIs” 
(NMII) localize to most tissues and are involved in a number of developmental, 
homeostatic, and disease associated process (Fenix and Burnette, 2018; Vicente-
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Manzanares et al., 2009b).  Here, we will focus on NMIIs, as they are the most relevant 
for this work, and the most thorough characterization has been performed using these 
myosins.  
NMII is the major molecular motor responsible for generating contractile forces 
within non-muscle cells (Vicente-Manzanares et al., 2009b). To carry out its wide variety 
of cellular functions, NMII assembles into filaments capable of generating force. A single 
NMII molecule is a hetero-hexamer composed of 2 heavy chains, 2 essential light 
chains, and 2 regulatory light chains (Figure 1-1) (Vicente-Manzanares et al., 2009b). 
The N-terminal motor domains of the myosin II heavy chains contain both the actin 
binding and ATPase activity (Adelstein et al., 1971; Vicente-Manzanares et al., 2009b). 
C-terminal electrostatic interactions of the rod domains from multiple NMII molecules 
creates a bipolar filament, positioning the N-terminal motor domains on opposite sides 
of the filament (Figure 1-1) (Fenix and Burnette, 2018; Vicente-Manzanares et al., 
2009b). The motor domains of each NMII molecule in a filament can bind and contract 
actin filaments, but the number of NMII molecules added to a NMII filament is limited 
(Billington et al., 2013; Pollard, 1975). Thus, the actin binding and force generating 
capabilities of a single NMII filament is limited. 
At the genetic level, there are three paralogs of NMII, each encoded by their own 
gene; NMIIA (MYH9), NMIIB (MYH10), and NMIIC (MYH14) (Fenix and Burnette, 2018; 
Vicente-Manzanares et al., 2009b). These proteins are strikingly similar, with over > 90 
percent sequence homology. Despite this similarity however, these proteins have been 
shown to show diverse and non-redundant roles in both development and homeostasis 
(Vicente-Manzanares et al., 2009b). In addition, the small areas of divergence have 
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recently been shown to be crucial for regulation (Juanes-Garcia et al., 2015). At the 
structural level, these proteins are also very similar. Rigorous in vitro characterization 
has shown all NMII molecules form bipolar filaments of similar size and number of 
molecules (Billington et al., 2013). Fascinatingly, recent work has shown the existence 
of NMII “co-filaments”, which contain multiple paralogs of NMII (Beach et al., 2014; 
Shutova et al., 2014). For the purposes of this work, we will focus on NMIIA and NMIIB, 
as they are highest expressed paralogs in our model systems discussed below. 
The importance of NMIIA and NMIIB can be visualized by their dramatic effects 
when perturbed in model organisms, and their contribution to human disease. Germline 
NMIIA KO mice fail to gastrulate (Conti et al., 2004). Germline NMIIB KO mice die in 
utero due to heart failure (Tullio et al., 1997). Patients containing mutations in NMIIA 
present with a class of disorders referred to as May-Hegglin disorders (Costa et al., 
2000; Hussein et al., 2013). These patients display a platelet disorder resulting in 
excessive bleeding which can cause headaches, muscle weakness, intracranial 
bleeding, blindness, and deafness. A mutation in NMIIB was also recently discovered in 
a patient who was non-ambulatory, non-verbal, and required a gastrostomy tube 
(Tuzovic et al., 2013). Collectively, these in vivo studies highlight the need to 
understand how NMII filaments coordinate with actin filaments to generate force within 
cells. 
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Figure 1-1: Myosin II filament formation 
A) Schematic of a single NMII molecule and a NMII filament. Heavy and light chains are 
colored red and gray, respectively. Motor and rod domains are denoted by arrows. B) 
Bipolar filaments arise from non-covalent electrostatic rod domain binding. 
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Actin 
 Actin is a protein found throughout eukaryotes, and contains three paralogs, 
which are structurally and genetically very similar, but contain distinct tissue 
localizations and functions (Dominguez and Holmes, 2011). Actin subunits (G-actin) 
polymerize to form the larger F-actin structure (Dominguez and Holmes, 2011) (Figure 
1-2). For this work, unless stated, when actin is mentioned we are referring to the F-
actin structure. Actin filaments are polar, containing a “plus” end and “minus” end 
(Figure 1-2) (Pollard, 2016; Pollard and Borisy, 2003). Myosin II filaments bind to F-actin 
and “walk” towards the plus ends (Pollard, 2016). This allows the bipolar myosin II 
filaments (Figure 1-1) to contract and pull on actin filaments resulting in force 
generation. In addition to myosin II, there are hundreds of actin binding proteins which 
affect the structure, dynamics, and function of actin inside cells (Breitsprecher and 
Goode, 2013; Pollard, 2016; Pollard and Borisy, 2003). One class of proteins, actin 
polymerizing factors, nucleates distinct actin filament populations. 
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Figure 1-2: Actin filament assembly 
(A) G-actin (single dots) can be added to both the minus end and plus end of actin 
filaments. Addition (and subtraction) of g-actin is favored at the plus end and the f-actin 
filament (chain of dots), will grow in the direction of the plus end. (B) Two major 
organization of f-actin. Crisscrossed or branched actin (top) is often found at the leading 
edge of cells and nucleated by the Arp2/3 complex. Bundled (bottome) actin is often 
found in structures such as ventral stress fibers, and is nucleated by formins. 
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In general, actin polymerizing factors are represented by the Arp2/3 complex, 
and formin proteins (Breitsprecher and Goode, 2013; Pollard, 2007). The Arp2/3 
complex nucleates branched actin filaments (f-actin filaments growing off the side of 
existing f-actin filaments) and is often found at the leading edge of crawling cells (Figure 
1-2) (Breitsprecher and Goode, 2013; Pollard, 2007). Despite this known role, the 
Arp2/3 complex likely has more diverse and as of yet undiscovered roles inside cells. 
While the Arp2/3 complex leads to branched actin, formins nucleate unbranched actin 
filaments (Figure 1-2) (Breitsprecher and Goode, 2013; Pollard, 2007). Formin-mediated 
actin filaments can be found in structures such as filopodia and actin emanating from 
focal adhesions. In addition to other actin binding proteins, the Arp2/3 complex and 
formins are instrumental in creating the diverse actin structures found within crawling 
cells (see below). 
 Actin, along with microtubules and intermediate filaments, is considered a major 
component of the “cytoskeleton”. Given this nickname, it is not surprising actin is 
required for cell shape and structure. Diverse actin structures contribute to the 
wonderful diversity of cell shapes honed for specific tasks. Below, we will focus on one 
of these specific tasks, cell migration, which has been instrumental in understanding the 
actin cytoskeleton. 
 
Cell migration as a model system  
 Cell migration, the process of a cell moving from one place to another has 
fascinated scientists for generations, and is absolutely required for development, 
homeostasis, and the progression of devastating disease states such as cancer 
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metastasis (Vicente-Manzanares et al., 2009b). Cells can move as single units (i.e., 
during the immune cell response to a wound), or collectively with many cells (i.e., during 
gastrulation, the process which establishes the basic body plan) (De Pascalis and 
Etienne-Manneville, 2017; Mayor and Etienne-Manneville, 2016). Cells can also move 
in both 2 dimensions on a relatively flat surface, or in more complex 3 dimensional 
environments (De Pascalis and Etienne-Manneville, 2017). For the purposes of this 
work, we will focus on 2 dimensional (2D) cell migration of single cells as a model 
system to study contractile unit assembly (Figure 1-3). 
 For decades, scientists have been plating cells on 2D substrates to observe how 
cells crawl, and more recently with the advent of immunofluorescence, how subcellular 
structures are regulated during cell migration. Though a 2D substrate mimics certain 
topologies found in vivo, such as an epithelial wound, extracellular matrix fibrils, and 
bone, they have recently come under criticism for not representing an in vivo like, or 3D 
environment (Petrie and Yamada, 2012). Despite this criticism, work on 2D crawling 
cells has revealed a plethora of structures, such as focal adhesions and actin stress 
fibers, which the latest and highest resolution in vivo microscopy techniques are now 
confirming to exist in vivo (Figure 1-3) (Harunaga and Yamada, 2011; Liu et al., 2018). 
 One structure which 2D studies on crawling cells have been particularly 
rewarding to study has been the actin cytoskeleton (Figure 1-3). Crawling cells contain 
a number of actin based structures which each have their own molecular composition 
and modes of regulation (Tojkander et al., 2012). The lamellipodium is a thin, protrusive 
region at the leading edge of crawling cells, containing both branched and unbranched 
actin filaments. Actin polymerization coupled with focal adhesions drive the membrane 
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protrusion (Krause and Gautreau, 2014; Swaminathan and Waterman, 2016). Behind 
the lamellipodium is the lamella, which contains transverse actin arcs and dorsal stress 
fibers (Figure 1-3) (Tojkander et al., 2012). Dorsal stress fibers extend from focal 
adhesions on the bottom of the cell, to the actin arcs on top of the cell and are devoid of 
NMII (Figure 1-3) (Burnette et al., 2014a; Hotulainen and Lappalainen, 2006; Tojkander 
et al., 2012). Actin arcs, found on top of the cell, contain NMII, and are required for 
efficient cell migration and the shape of migrating cells (Figure 1-3) (Burnette et al., 
2014a; Hotulainen and Lappalainen, 2006; Tojkander et al., 2012). Ventral stress fibers 
are large actin structures containing NMII and adhesions at either end (Figure 1-3) 
(Tojkander et al., 2012).  
While these structures have been well characterized in a variety of cell types and 
culture systems, much remains to be understood concerning their diverse modes of 
regulation and function in cells. While readily apparent in cultured cells, recent work 
utilizing rapidly advancing microscopy techniques has confirmed the existence of these 
actin stress fiber populations in a variety of in vivo contexts (e.g., during wound healing 
and immune response), and functional assays (e.g., T-cell target engulfment) (Chen et 
al., 2014; Liu et al., 2018; Small, 1998). At the moment, it appears “simple” crawling 
cells will continue to be an informative model system for cell motility and the regulation 
of actin structures. For the purpose of this discussion, we will focus on actin arcs as a 
model to study NMII filament stack assembly, and later, as a model to inform our 
studies investigating sarcomere assembly in cardiac myocytes. 
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Figure 1-3: Cartoon Schematic depicting major actin structures in migrating cells 
(A) Bottom (left) and Top (right) views of a crawling cell. Lamellipodia (yellow puncta) 
contains both branched and f-actin filaments. Dorsal stress fibers arise from adhesions 
(gray structures), and ventral stress fibers are in the middle of the cell and contain 
myosin II and are anchored at each end by adhesions. On top of the cell, actin arcs 
containing myosin II are connected to dorsal stress fibers which couple actin arcs to the 
adhesions. (B) Side-view of the typical shape of a crawling cell. Contractile actin arcs 
pull on dorsal stress fibers resulting in a relatively flat leading edge. 
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Actin Arcs 
 
 Actin arcs were first discovered in 1983 by Julian Heath (Heath, 1983). These 
structures were characterized as being parallel to the leading edge of cells and 
undergoing retrograde flow from the leading edge towards the cell body (Heath, 1983). 
Though first discovered in chick fibroblasts, these structures were subsequently 
described in a number of diverse cell types (Burnette et al., 2011; Henson et al., 2015; 
Medeiros et al., 2006; Murugesan et al., 2016; Tojkander et al., 2012). Decades of 
subsequent work has revealed the intricate mechanisms regulating actin arc dynamics 
and regulation (Tojkander et al., 2012). Actin arcs undergo retrograde flow towards the 
cell body at ~200nm/s in most non-muscle cell types (Ponti et al., 2004). Actin arc 
formation requires NMIIA, the Arp2/3 complex, the formins dia1 and dia2, and 
tropomyosin 4 (Burnette et al., 2014a; Hotulainen and Lappalainen, 2006; Murugesan et 
al., 2016; Shutova et al., 2017; Tojkander et al., 2012; Tojkander et al., 2011). Despite a 
wealth of knowledge, the function of actin arcs remained elusive until relatively recently. 
 In 2011, (Burnette et al., 2011) used live-cell microscopy to show actin arcs 
couple to focal adhesions at the leading edge of cells. The coupling between focal 
adhesions and actin arcs ensured a net protrusion of the leading edge of cells and 
efficient cell migration (Burnette et al., 2011). Subsequent work from this group used a 
recently developed super-resolution microscopy technique (structured illumination 
microscopy), to show actin arcs are on the dorsal surface (top) of the cell (Burnette et 
al., 2014a). Loss of actin arcs via NMIIA KD and NMII inhibition (via the inhibitory 
molecule blebbistatin) resulted in a loss of actin arcs, and interestingly, loss of the 
stereotypical “flat” shape of cells at the leading edge (Burnette et al., 2014a). Thus, 
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actin arcs are required for shaping crawling cells. In addition, this work showed that 
NMIIA stack assembly occurred via the growth of small bundles of NMIIA filaments on 
actin arc structures (Burnette et al., 2014a). This observation was in direct contrast to 
the major model of NMIIA stack formation, known as the Network Contraction Model 
(Burnette et al., 2014a; Verkhovsky et al., 1999a).  
 
Non-muscle myosin II filament and stack assembly 
The organization of NMII filament stacks was first reported in a series of elegant 
papers by Gary Borisy and colleagues in the 1990’s (Svitkina et al., 1997; Verkhovsky 
and Borisy, 1993; Verkhovsky et al., 1995). Borisy’s group adapted an electron 
microscopy (EM) technique termed platinum replica EM to facilitate the exquisite 
visualization of the cytoskeleton’s architecture within motile rat fibroblasts and fish 
keratocytes (Svitkina et al., 1997; Verkhovsky and Borisy, 1993; Verkhovsky et al., 1995). 
Key findings from these studies revealed a ‘non-sarcomeric” organization of NMII 
filaments at the protruding edge of cells in which NMII filaments were arranged in splayed 
out arrays apparently connected by their motor domains, and NMII filament stacks toward 
the cell center (Figure 1-4) (Verkhovsky and Borisy, 1993; Verkhovsky et al., 1995). 
These observations led to the “Network Contraction” Model (Figure 1-4) to explain how 
the actin and NMII architecture in cells was formed (Verkhovsky et al., 1999a). The 
Network Contraction Model posits that tension generated by NMII organizes the 
unaligned actin architecture found at the leading edge, into the more organized and 
aligned actin filaments found further back in the lamella (Figure 1-4) (Verkhovsky et al., 
1999a). One of the key predictions of the Network Contraction model is that NMII 
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filaments in the splayed configuration would come together as they pull on actin filaments 
(Figure 1-4). For ~20 years, the Network Contraction Model has become the textbook 
model for actin stress fiber assembly and myosin II stack assembly. Indeed, the Network 
Contraction Model is still being promoted as the major model of NMII stack formation 
(Svitkina, 2018). In Chapter III of this work, we investigate the discrepancy noted by 
(Burnette et al., 2014a) with the Network Contraction Model using a combination of super-
resolution microscopy, live-cell imaging, and crawling cells as a model system. We 
provide evidence for a new model of NMIIA stack assembly we refer to as the “Expansion” 
model of NMIIA stack assembly which directly contradicts the Network Contraction Model 
(see Chapter III).  
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Figure 1-4: Network Contraction Model 
A) Network contraction model redrawn from Figure 5 of Verkhovsky et al. 1999. Myosin 
II filaments and actin filaments are red and blue, respectively. Arrow indicates the 
transition between splayed myosin and actin filament arrays and aligned arrays. B) A 
key prediction of the Network Contraction model is that spread myosin II filaments in 
small clusters move together (curved arrows). 
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Observations on the similarities between non-muscle and muscle contractile 
systems 
 
 Our studies investigating NMIIA filament stack assembly revealed detailed 
physical and molecular regulatory mechanisms. Despite this, no study is exhaustive and 
much work remains to elucidate the mechanisms by which cells assemble NMIIA 
stacks. These include, but are not limited to the roles of actin bundling proteins (e.g., α-
actinin), and post-translational modifications (e.g., phosphorylation). While these studies 
are on-going in the Burnette lab, a major observation led us to investigate the 
mechanisms of muscle myosin II stack assembly in cardiac myocytes. 
 Structurally, both NMII and cardiac myosin II (CMII) form bipolar structures with 
their motor domains on opposite sides of the filament (Figure 1-5). Similar to NMII in 
non-muscle crawling cells, CMII forms filaments and filament stacks in cardiac 
myocytes (Figure 1-5). Indeed, initial descriptions of NMII filaments in crawling cells 
referred to their organizations as “non-sarcomeric” at the leading edge, and 
“sarcomeric” in the cell body (Verkhovsky and Borisy, 1993; Verkhovsky et al., 1999a). 
Furthermore, both NMII and CMII share a fundamental function, to contract actin 
filaments in order to generate force. These similarities led us to test the mechanisms of 
CMII stack assembly in cardiac myocytes. Furthermore, we drew upon our results from 
studies investigating NMIIA stack assembly to establish a conceptual frame work, and 
to guide our initial experiments in order to test the mechanisms leading to CMII stack 
assembly. 
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Figure 1-5: NMII filament stacks resemble Cardiac Myosin II Stacks 
(A) Motor and rod domains of NMIIA filaments (black arrows) and a NMIIA filament 
stack (red arrow). (B) Motor domains of cardiac myosin II filaments (black arrows) and 
filament stack (red arrow).  
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Sarcomere structure and assembly in cardiac myocytes 
 
Cardiac myocytes represent a major cell type within the heart, comprising ~50% 
of the cells within the heart. Cardiac myocytes “beat” (i.e., contract) in response to 
electrical signals passed through specialized gap junctions (e.g., intercalated discs). 
The coordinated contraction of cardiac myocytes results in the beating of the heart, and 
blood flow throughout the body (Hill, 2012). The complex mechanisms of cardiac 
myocyte contraction – while fascinating – are highly dependent on a variety of stimuli, 
and not directly relevant to this work. Detailed reviews of these mechanisms are 
reviewed elsewhere (Hill, 2012). Instead, here we focus on how the structures leading 
to the coordinated contraction of cardiac myocytes are assembled in live cells. 
The fundamental unit of force generation within cardiac myocytes is the 
sarcomere. At its core, a sarcomere is composed of “thick” myosin II filaments, and 
“thin” actin filaments (Figure 1-6) (Au, 2004). One sarcomere is measured from Z-line to 
Z-line, which contain -actinin 2 (Figure 1-6).  The thick myosin II filaments “walk” 
towards the plus ends of actin filaments embedded in the Z-lines, resulting in a 
contraction of the sarcomere (Z-lines coming closer together, “sarcomere shortening”) 
and force generation (Huxley and Niedergerke, 1954a; Huxley and Niedergerke, 
1954b). Multiple sarcomeres aligned adjacently with one another form a larger structure 
referred to as a myofibril. The proper establishment of cardiac sarcomeres and 
myofibrils during development and their subsequent maintenance is critical for heart 
function. Indeed, disorganized sarcomeres are a hallmark of both dilated and 
hypertrophic cardiomyopathies in humans (Harvey and Leinwand, 2011; Ho, 2010; 
Hughes, 2004; Hughes and McKenna, 2005; Ribeiro et al., 2015; Watkins et al., 2011). 
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While the sarcomere has been well characterized using static high-resolution 
microscopy (e.g., snapshots from electron microscopy) as well as molecular and 
biochemical techniques, we do not know how the molecular components of the 
sarcomere are dynamically assembled/disassembled or how this changes during 
disease. 
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Figure 1-6: Structure of the Sarcomere 
Electron microscopy (EM) of adult mouse heart (above) and cartoon representation of 
sarcomere (below). One sarcomere is measured from Z-line to Z-line (white Zs in EM 
image). Bipolar myosin II filaments (red) pull on actin filaments (green) causing 
sarcomere shortening and force generation. Note highly ordered structure of sarcomere 
in EM image. 
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Previous studies in cultured myocytes have shown the presence of actin bundles 
called “stress fiber-like structures” similar in appearance to classic stress fibers (Dlugosz 
et al., 1984). These stress fibers were often found to be close to the edge of the myocyte 
with sarcomeres existing further from the edge (Rhee et al., 1994). These studies 
proposed that the stress fibers served as a template for the formation of sarcomeres 
(Figure 1-7) (Dlugosz et al., 1984; Rhee et al., 1994; Sanger et al., 2005). The original 
model that proposed this was called the Templating Model (Dlugosz et al., 1984), and 
was proposed before it was known these stress fibers contained both non-muscle and 
sarcomeric proteins (Figure 1-7) (Rhee et al., 1994). Beyond non-muscle myosin IIB 
(NMIIB), which is present in non-muscle cells, stress fibers in muscle cells contain muscle 
specific proteins, such as -actinin, tropomyosin, troponins, and tropomodulin (Almenar-
Queralt et al., 1999; Rhee et al., 1994; Sanger et al., 2005). Each of these proteins have 
non-muscle paralogs, which likely serve similar functions (Bryce et al., 2003; Colpan et 
al., 2013; Cote, 1983; Gunning et al., 2015; Lim et al., 1986; Sjoblom et al., 2008). Partly 
in response to the presence of muscle specific proteins in stress fibers, the Templating 
Model was modified to the “Pre-Myofibril Model” (Figure 1-7) (Rhee et al., 1994; Sanger 
et al., 2005).  Even though these models have different names and are often presented 
as mutually exclusive, they are very similar in their predictions (Figure 1-7). Specifically, 
both models posit an actin bundle that appears structurally similar to a stress fiber will 
acquire a row of sarcomeres over time to become a “myofibril” (Dlugosz et al., 1984; Rhee 
et al., 1994; Sanger et al., 2005) (Figure 1-7). There is a vast amount of localization data 
in fixed cardiomyocytes to support these models. However, there is very little dynamic 
data in live cells that suggests stress fibers give rise to sarcomeres.  The strongest 
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dynamic support comes from imaging fluorescently tagged -actinin 2 in myocytes. Time 
montages from chick skeletal myotubes showed small puncta of -actinin 2 adding to pre-
existing Z lines (McKenna et al., 1986). Subsequently, a time montage was used to show 
a similar phenomenon occurring in chick cardiomyocytes (Dabiri et al., 1997).  
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Figure 1-7 
(A) Template Model of sarcomere assembly. This model predicts that stress fiber 
like structures, staining continuously for actin will, over time, transition to a 
nascent myofibril and eventually a myofibril. Key predictions include the ideas 
that the stress fiber like structures will acquire muscle specific proteins as the 
mature, and the stress fiber template will disappear as the myofibril is 
assembled. Cartoon is a reproduction of the original Template Model. (B) 
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Premyofibril Model of sarcomere assembly. Similar to the Template Model, 
the Premyofibril envisions a precursor structure (premyofibril) transitioning to 
a myofibril over time. The premyofibril contains muscle and non-muscle 
paralogs of proteins, the latter of which is lost over time. This model, while 
very similar to the Template Model, disputes the idea that the premyofibril is a 
template, as it doesn’t “disappear” over time. Cartoon is a reproduction from 
the original Premyofibril Model.  
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Some in vivo data support the Template/Pre-Myofibril Model, while others do not. 
In strong support of the Template/Pre-Myofibril Model, static images of chick heart tissue 
have essentially revealed every structure described in primary cultured chick 
cardiomyocytes (Du et al., 2008). The presence of NMIIB-containing stress fibers in the 
cardiomyocytes was particularly clear (Du et al., 2008). NMIIB germline knockout (KO) 
mice were also reported to have fewer and disorganized sarcomeres via EM (Tullio et al., 
1997). On the other hand, several studies have called into question the role of stress 
fibers in sarcomere assembly. First, several studies examining cardiomyocytes within 
mouse or chick heart tissue did not find stress fibers containing NMIIB (Ehler et al., 1999; 
Kan et al., 2012; Ma et al., 2009). In addition, a conditional KO mouse that removes NMIIB 
genetically at P9 apparently still had striated sarcomere structures (Ma et al., 2009). 
Finally, a conditional heart KO of the other major paralog of NMII, NMIIA, was also 
reported to have no apparent defects in heart formation (Conti et al., 2004; Conti et al., 
2015). Taken together, the lack of clear data showing stress fibers in cardiomyocytes and 
inconsistencies for a role of NMII in sarcomere assembly calls into question whether the 
Template/Pre-Myofibril Model is a viable construct for understanding sarcomere 
assembly (Sanger et al., 2005; Sparrow and Schock, 2009).  
There is further data to suggest that a mechanism other than that described in the 
Template/Pre-Myofibril model could be driving sarcomere assembly. This alternative 
model—called the “Stitching Model”—is based on the idea that parts of a sarcomere are 
assembled independently and then brought together (i.e., stitched) (Holtzer et al., 1997; 
Lu et al., 1992; Sanger et al., 2005). In support of the Stitching Model, studies in 
Drosophila have shown the presence of small myosin filaments following knockdown (KD) 
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of separate Z-line components (Rui et al., 2010). This data suggests that myosin filaments 
can assemble independently of Z-lines. Indeed, there are also electron micrographs that 
appear to show stacks of myosin II filaments (i.e., A-bands) without detectable actin 
filaments in skeletal muscle (Holtzer et al., 1997; Lu et al., 1992; Sanger et al., 2005). 
Examination of electron micrographs also supports the idea that bodies containing Z-line 
components and actin filaments—called “I-Z-I” bodies—could also exist in skeletal muscle 
without apparent myosin II filaments (Holtzer et al., 1997; Lu et al., 1992; Sanger et al., 
2005). Based on this data, it was proposed that stitching could occur through sequential 
assembly by adding new I-Z-I bodies and myosin II filaments (Holtzer et al., 1997; Lu et 
al., 1992; Sanger et al., 2005). 
Despite these proposed models, dynamic and mechanistic data surrounding 
sarcomere assembly is severely lacking (Sparrow and Schock, 2009). This is mainly due 
to the lack of a tractable model system to study this process. An ideal model system would 
be amenable to live-cell imaging, protein transfection, and siRNA mediated knockdown. 
Fortunately, due to recent advances in stem cell technologies, such a system is now 
theoretically available. In Chapters III and IV of this work, we develop and utilize a model 
system to study the mechanisms and dynamics of sarcomere assembly.  
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Chapter II 
 
Non-muscle myosin IIA filament stack assembly 
Fenix, AM., Taneja, N., Butter, CA., Lewis, J., Van Engelenburg SB., Ohi, R., Burnette, 
DT. (2016). Mol Biol Cell, 27(9) 
 
Introduction 
Forces generated by the molecular motor non-muscle myosin II (NMII) are 
essential for cell migration and cytokinesis (Gardel et al., 2010; Ma et al., 2012; Straight 
et al., 2003; Vicente-Manzanares et al., 2009a). Mutations in NMII isoforms lead to an 
array of human diseases, and changes in NMII activity during processes relying on 
precise regulation of cell migration and cytokinesis lead to developmental defects and 
disease progression (Beach et al., 2011; Hamdan et al., 2014; Hu et al., 2002; Kelley et 
al., 2000; Ma and Adelstein, 2014a; Seri et al., 2000; Tullio et al., 1997; Tuzovic et al., 
2013; Vasquez et al., 2014; Vicente-Manzanares et al., 2009a). Furthermore, increased 
cellular contractility – which is primarily driven by NMII – is increasingly being recognized 
as an emergent property of tumor cells (Samuel et al., 2011). Highlighting this, 
overexpression of the NMIIA isoform is correlated with increased metastasis and poor 
patient prognosis in a variety of cancers (Ma et al., 2003; Xia et al., 2012). Despite the 
biological importance of, and wealth of genetic data surrounding NMIIA associated 
diseases, how NMIIA based contractile units form inside of cells is a surprisingly poorly 
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understood process. This lack of understanding precludes a thorough understanding of 
NMIIA related disease states, and prevents potential therapeutic strategies. 
 A single NMII molecule is a hetero-hexamer composed of 2 heavy chains, 2 
essential light chains, and 2 regulatory light chains (Vicente-Manzanares et al., 2009a). 
The N-terminal motor domains of the heavy chains contain both the actin binding and 
ATPase activity (Adelstein et al., 1971; Vicente-Manzanares et al., 2009a). In vitro 
biochemical and structural studies have elegantly shown that C-terminal electrostatic 
interactions of the heavy chains create bipolar filaments, positioning the N-terminal motor 
domains on opposite sides of the filament (Figure 2-1) (Pollard, 1975; Ricketson et al., 
2010). In this orientation, the motor domains of NMII bipolar filaments can grab onto and 
contract actin filaments to generate force. Importantly, a single NMII bipolar filament 
contains multiple NMII molecules, each of which can bind to and contract actin filaments 
(Billington et al., 2013). The number of NMII molecules added to a NMII filament (NMII-
F) is limited by steric hindrance however, and thus actin binding and force generating 
capabilities of a single NMII-F are limited (Billington et al., 2013; Pollard, 1975). Thus, in 
order to increase the scale of force generation, cells organize NMII-Fs into larger arrays 
referred to as “stacks” (Figure 2-1) (Svitkina et al., 1997; Verkhovsky and Borisy, 1993; 
Verkhovsky et al., 1995). The mechanism of NMII stack formation has eluded previous 
efforts. This is in part due to the relatively small size (~300nm in width) of NMII-Fs, 
resulting in structurally dynamic information being difficult to achieve utilizing conventional 
imaging modalities (i.e., diffraction limited microscopy), and because they do not readily 
form in vitro. Thus, current models surrounding NMII stack formation are based on fixed 
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snapshots utilizing electron microscopy, which lack dynamic information (Verkhovsky et 
al., 1999b). 
 To address these issues, we have taken advantage of recently developed live-cell 
‘super-resolution’ imaging techniques to investigate the dynamic mechanism of NMII 
stack formation. Interestingly, we found that at the leading edge of crawling cells, NMII 
stacks predominantly form via an expansion and concatenation of smaller NMII filaments, 
which is in contrast to the current models of NMII stack formation (Verkhovsky et al., 
1999b). This expansion was dependent on NMII motor activity, and actin filament 
availability. Intriguingly, NMII expansion and concatenation also underlies the formation 
of the contractile ring in dividing cells. Thus, we present a new model of NMIIA stack 
formation that underlies the formation of contractile units in distinct cellular processes and 
cell types.  
 
Results 
 We used the flat, leading edge of motile U2-OS cells (human osteosarcoma) as a 
model system to define the structural dynamics underlying NMII-F stack formation. NMII-
Fs comprised of the NMII isoform, NMIIA, are formed at the leading edge of cells and 
then move away from the edge in a process called retrograde flow, making room for new 
NMIIA-Fs to form (Hotulainen and Lappalainen, 2006; Vallenius, 2013; Verkhovsky et al., 
1995). This continuous treadmill allowed us to monitor NMIIA-F formation using high-
resolution, wide-field fluorescence time-lapse microscopy (Figure 2-1). Examination of 
this data revealed that newly formed NMIIA-Fs increased in intensity over time (Figure 2-
1). This was consistent with NMIIA molecules being added to the NMIIA-F. The increase 
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in intensity was followed by a growth in size of the NMIIA-F (Figure 2-1). Conventional 
fluorescence imaging was not able to resolve the underlying structural changes during 
the expansion of NMIIA-Fs however. Thus, we turned to structured illumination 
microscopy (SIM) (Gustafsson et al., 2008), which has a resolution (~110 nm) can 
separate the motor and rod domains in a NMIIA-F (Burnette et al., 2014b). 
To study the structure of NMIIA-Fs during expansion, we visualized motor and rod 
domains with SIM using two different localization methods. First, we exogenously 
expressed NMIIA heavy chain fused to mEmerald on the N-terminus and mApple on the 
C-terminus (Burnette et al., 2014b). This construct allowed us to image the motor and rod 
domains, respectively (Figure 2-1). We also localized endogenous NMII-Fs with 
antibodies specific to the NMIIA rod domain and myosin regulatory light chain (RLC) 
(Figure 2-S1). RLC is positioned in the neck region of NMIIA and was not distinguishable 
from a fluorescent protein tag on the N-terminus of the heavy chain using SIM (Figure 2-
S1). Importantly, our data revealed similar NMIIA-F organizations as previously described 
by electron microscopy studies (Shutova et al., 2012; Verkhovsky and Borisy, 1993). 
Thus, we could use the relative localization of motor and rod domains to group together 
structurally similar NMIIA-Fs. 
 We defined the structure of an individual NMIIA-F by measuring the number of 
discrete “motor-groups” that could be resolved by SIM (Figure 2-1 and 2-S1). We use the 
term “motor-groups” because each contained multiple NMIIA motor domains, which was 
required for detection, as our SIM microscope did not have single molecule imaging 
sensitivity. In fixed cells, we found the majority (71.1 +/- 11.0%) of individual NMIIA-Fs at 
the leading edge fell into one of four structural categories: 2-motor-group, 3-motor-group, 
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4-motor-group and >4-motor-group NMIIA-Fs. Morphologies of the remaining ~30% of 
NMIIA-Fs were difficult to define mainly because they overlapped with other NMIIA-Fs. 
Of the individually resolvable NMIIA-Fs, 2-motor-group NMIIA-Fs were the most common 
(35.0 +/- 1.7 %), and had one motor-group on each side of the rod domains (Figure 2-1, 
1 and 3;). Interestingly, the second most common organization was an asymmetric 3-
motor-group NMIIA-Fs (25.2 +/- 1.4%), which had two motor groups on one side of the 
rod domains and one on the other side (Figure 2-1, 2). In contrast, 4-motor-group NMIIA-
Fs (19.8 +/- 1.6 %) were relatively symmetrical with two motor groups on each side of the 
rod domain (Figure 2-1). 
 Several of the NMIIA-F organizations above have been reported by electron 
microscopy (EM) studies of fixed cells (Shutova et al., 2012; Verkhovsky and Borisy, 
1993; Verkhovsky et al., 1995). Notably, EM has shown the existence of the 3-motor-
group NMIIA-Fs in both crawling cells, and in vitro in a variety of salt and ATP 
concentrations (Billington et al., 2013; Verkhovsky et al., 1995). Importantly, this EM data 
shows that in the 3-motor-group orientation, NMII molecules of the same 3-motor-group 
filament are “linked” via interacting motor domain groups, which is consistent with our 
fluorescence data. However, there was still the possibility the 3-motor-group NMIIA-F in 
our SIM data was not a single unit, but two distinct filaments. Previous EM studies yielded 
inherently 2D views of NMII-Fs and the lateral and axial resolution of our 3D SIM data 
(~110 and ~250 nm respectively) may not be able to resolve two NMIIA-Fs close together, 
which also may result in an over-estimation of the percentage of 3-motor group filaments 
in our cells. Therefore, we turned to 3D PALM (Betzig et al., 2006; Brown et al., 2011) of 
U2-OS cells expressing NMIIA fused to mEOS2 on its N-terminus (i.e., motor). Our image 
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strategy yielded an average single molecule localization precision of μx = 11 +/- 5 nm and 
μz = 20 +/- 11 nm, respectively (Figure 2-S1), which afforded us higher spatial resolution 
than SIM to test if the 3-motor-group filaments indeed had 3 groups of motors, as opposed 
to 4 if they were composed of two distinct filaments. We observed the groups of motors 
in the 2-motor-group NMIIA-Fs were similar in dimension to those previously shown by 
2D PALM (Burnette et al., 2014b) (Figure 2-1 and 2-S2). Importantly, 3D PALM revealed 
isolated 3-group localization clusters, spaced by similar dimensions as 2-motor group 
clusters. Each motor-cluster visualized by 3D-PALM displayed a unimodal X,Y, and Z 
distribution, consistent with previous EM evidence and the interpretation of our SIM data 
(Figure 2-1 and 2-S2). 
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Figure 2-1: Organization of NMIIA-Fs at the leading edge.  
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A.) Classic model of the formation of a 2-motor-group NMIIA-F. An auto-inhibited NMIIA 
molecule (1) becomes polymerization competent (2) after phosphorylation of its 
regulatory light chain. Two polymerization competent NMIIA molecules then form a mini 
NMIIA-F (3) through electrostatic interactions of their rod domains. Addition of more 
NMIIA molecules to the mini-filament drives the growth of a 2-motor-group NMIIA-F (4). 
Steric hindrance limits the number of molecules that can be added to 2-motor-group 
NMIIA-F (Billington et al., 2013). Note a smaller number of myosins than the ~15 on each 
side of the filament are drawn for simplicity. Importantly, how larger contractile arrays (i.e., 
stacks) containing more myosins capable of generating more contractile forces is not 
understood (5). B) Time-lapse widefield epi-fluorescent recording of the motor domains, 
NMIIA-(N-terminal)-mEGFP, at the leading edge of a U2-OS cell. C) Representative 
montage shows the NMIIA-F in the box expanding into a stack. D) SIM of U2-OS cell 
expressing NMIIA heavy chain fused to mEmerald-N-terminal (magenta) and mApple-C-
terminal (green). E) High mag views of boxes 1, 2, and 3 show a 2, 3 and 2-motor-group 
NMIIA-F, respectively. F) Representative examples of 2, 3, 4, and >4-motor-group NMIIA-
Fs. G) Representative images of the ~30% of filaments which were too close (i.e., 
overlapping) for analysis. H) Percent of endogenous NMIIA-Fs (RLC and NMIIA 
antibodies) in a 2, 3, 4, or >4-motor-group organization at the edge of the cell. N= 246 
total NMIIA-Fs from 37 cells over 3 experiments. I) X/Y and Z/Y views of 2-motor-group 
NMIIA-Fs imaged with 3D PALM. J) X/Y and Z/Y views of 3-motor-group NMIIA-Fs 
imaged with 3D PALM. Molecular probability refers to the cumulative probability per unit 
volume (nm3) of all single molecules (mEOS2-NMIIA) detected within any given motor 
group (cluster of single molecule localizations). Our certainty for the location of each 
probe in a given image frame is dependent upon the number of photons detected for each 
mEOS2 molecule and the background parameters of the specimen and camera (Betzig 
et al., 2006). Scale bars: (B), 5 m; (D), 2 m; (E-G), 200 nm; (I-J), 100 nm. Error bars in 
(H) represent standard error of the mean (SEM). 
 
 
 
 
 
 
 
 
 
 
48 
 
The 3-motor-group filaments were the basis of previously proposed models of NMII 
stack formation (Verkhovsky et al., 1999b).  Previous studies have proposed a spatial 
and temporal relationship between “open” NMII-Fs like the 3-motor-group and “closed” 
NMII-Fs like the 2-motor-group NMII-Fs to explain how actin filament networks are 
contracted (i.e., actin filaments being moved closer together) (Verkhovsky et al., 1999b). 
The “network contraction” model predicts a 3-motor-group NMIIA-F would transition to a 
2-motor-group NMIIA-F similar to a pair of scissors closing (Figure 2-2) (Verkhovsky et 
al., 1999b). In theory, the two motor groups on the larger side of the 3-motor-group would 
pull different actin filaments together. Whether this type of transition occurs inside of cells 
or contributes to NMIIA-F expansion was unknown. Therefore, we turned to live-cell SIM 
to monitor the structural and dynamic changes during NMIIA-F stack formation. 
 We imaged NMIIA motor domains and found 2-motor-group NMIIA-Fs unfolded to 
become 3-motor-group NMIIA-Fs (Figure 2-2). Surprisingly, only a small percentage (5.3 
+/- 2.5%) of 3-motor-group NMIIA-Fs went back or “collapsed” to being a 2-motor-group 
NMIIA-F, as the “network contraction” model has predicted (Figure 2-2B). The vast 
majority (85.8 +/- 4.1%) of newly formed NMIIA-F expanded (Figure 2-2). This data 
indicated the 2, 3, and 4-motor-groups represented distinct structural steps underlying the 
formation of NMIIA-F stacks. We next wanted to explore the physical mechanisms 
underlying stack formation. 
 By increasing our sampling rate to 15 second-intervals, we were able to detect 
transitional structures between 2 to 3 and 3 to 4 motor-group NMIIA-Fs (Figure 2-2). New 
motor-groups did not simply appear next to preexisting motor-groups. Instead, a 
preexisting motor-group extended (Figure 2-2) before the appearance of a new motor-
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group (Figure 2-2). This data led us to hypothesize, that a subset of NMIIA molecules 
were moving away from one side of the 2-motor-group NMIIA-F. We also detected this 
type of extension during the transition between a 3-motor-group to 4-motor-group NMIIA-
F (Figure 2-2). In addition, rod domains extended and this occurred with the extension of 
the first motor-group of a 2-motor-group NMIIA-F (Figure 2-2). 
 We next used photo-conversion of NMII-A-mEOS2 (Burnette et al., 2014b), labeled 
on the N-terminal motor domains, to test if NMIIA molecules within filaments were 
spreading out in space as the extension of the motor-groups revealed by SIM (Figure 2-
2) suggested. EOS is a green fluorescent protein, which can be photo-converted to red 
by exposure to UV light (Wiedenmann et al., 2004). Using this method, we converted 
NMIIA-mEOS2 at the edge of cells and thus specifically marked NMIIA molecules that 
were incorporated into NMIIA-Fs (Figure 2-2). A subset of NMIIA-mEOS2 molecules were 
not converted and allowed us to monitor the expansion of stacks in the green channel 
(Figure 2-2). Note that the converted pool of NMIIA-mEOS2 also spread out during 
expansion (Figure 2-2), which is consistent with NMIIA molecules within a NMIIA-F 
spreading out in space. An alternative interpretation of this result is that converted NMIIA-
mEOS2 molecules are being removed from NMIIA-Fs or photo-converted in the 
cytoplasmic pool and then being added to expanding stacks. While this seems unlikely, 
as we did not detect incorporation of red-labeled NMIIA-mEOS2 in NMIIA-F outside of the 
region of conversion during the short time frame of the experiment, we still wanted to 
confirm NMIIA molecules could change position within individual NMIIA-Fs using another 
method. In addition, it is important to point out that, as this was done on a wide-field (i.e., 
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diffraction limited) microscope, we can only confidently detect expansion of the larger 
NMIIA filaments, such as the ones shown in Figure 2-2. 
 To further test if NMIIA molecules could move within a NMIIA-F, we monitored the 
precise movements of single molecules of NMIIA-mEOS2 (N-terminal motor domain) 
within NMIIA-Fs using single particle tracking photo-activated localization microscopy 
(sptPALM) (Betzig et al., 2006; Manley et al., 2008) (Figure 2). sptPALM allows for the 
precise localization and tracking of a single molecule, which has been photo-converted 
from green to red. Using sptPALM, we converted single NMIIA-mEOS2 molecules within 
NMIIA-Fs at the leading edge of cells, to test if individual NMIIA molecules could spread 
out in space within a NMIIA-F. To measure this, we drew a mask around the perimeter of 
a diffraction-limited image of the unconverted mEOS2 molecules (i.e., green channel) 
within a NMIIA-F for every image in the acquisition. We then tracked the movement of a 
single converted NMIIA-mEOS2 molecule within this NMIIA-F. Any molecule that moved 
a diffraction-limited distance (i.e., 250nm) within the NMIIA-F mask, was counted as 
moving. Indeed, sptPALM data revealed 32.8 +/- 4.3% of single NMIIA-mEOS2 molecules 
changed their position within their respective NMIIA-F (Figure 2-I). Interestingly, of the 
moving single NMIIA-mEOS2 molecules, our analysis revealed all but one moved 
relatively closer to the leading edge by moving slower than the respective expanding 
NMIIA-F (Figure 2-2). Taken together, our SIM, photo-conversion, and PALM results 
show the creation of stacks from NMIIA-Fs involved NMIIA molecules spreading out from 
pre-existing 2-motor-group NMIIA-Fs. We next asked if NMIIA-F stacks formed by other 
mechanisms. 
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 In vitro experiments have shown rabbit skeletal myosin II can align into stack like 
orientations in the presence of actin filaments. Mathematical modeling suggested this 
could arise as a result of distinct myosin II filaments coming closer together by contracting 
actin filaments (i.e., concatenation) (Stachowiak et al., 2012). To test if concatenation 
occurs inside of a living cell, we quantified how many NMIIA-Fs moved together (Figure 
2-2). We found ~10% of NMIIA-Fs concatenated with other NMIIA-Fs, and this was 
independent of whether the NMIIA-Fs were expanding (Figure 2-2). Concatenation was 
defined as two separate NMIIA-Fs aligning their rod domains within 4 pixels (160 nm) of 
each other (Figure 2-2). Thus, while concatenation did occur at a low rate at the leading 
edge, most NMIIA-F stacks arose from expansion. However, our data does not preclude 
network contraction and/or concatenation, as dominant mechanisms of NMIIA-F 
dynamics in parts of the cell other than the leading edge where NMIIA-F densities were 
too high for us to resolve individual NMIIA-Fs. 
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Figure 2-2: NMIIA-Fs expand into stacks. 
A) Cartoon of the network contraction model showing a 3-motor-group NMII-F 
transitioning to a 2-motor-group NMII-F by walking towards the barbed ends of actin 
filaments adapted from Figure 7 of (Verkhovsky et al., 1999b). B) Time montage from a 
live-cell SIM acquisition of NMIIA-(N-terminal)-mEmerald showing a 2-motor-group 
NMIIA-F expanding into a 3-motor-group and collapsing to a 2-motor-group NMIIA-F. C) 
Percent of collapsing (i.e, network contracting) NMIIIA-Fs. D) Time montage of NMIIA-(N-
terminal)-mEmerald showing a 2-motor-group NMIIA-F expanding into a 3-motor-group 
and then to a 4-motor-group NMIIA-F.  E) Percent of 2-motor-group NMIIA-Fs that 
expand. F) Time montage of NMIIA-(N-terminal)-mEmerald from a higher temporal 
resolution acquisition showing intermediate structures during NMIIA-F expansion. Yellow 
arrowhead denotes transition between 2-motor-group (open) and 3-motor-group NMIIA-
F (closed). Open blue arrowhead denotes transition between 3-motor-group and 4-motor-
group NMIIA-F (closed blue arrowhead).  G) Time montage from a dual-color acquisition 
of NMIIA-(N-terminal)-mEmerald/(C-terminal)-mApple showing rod domains expand 
concurrent with the initial asymmetric expansion of the motor domains (asterisks). H) 
Photo-converted (red) and unconverted (green) NMIIA-mEOS2 at 0 and 2 minutes after 
conversion of the leading edge (white dotted line). Time montage from yellow box shows 
the unconverted (green), converted (red), and overlay. Arrowheads denote expanding 
NMIIA-F. Note the converted NMIIA-mEOS2 (red) spread out during expansion. I) Time 
montage showing unconverted NMIIA-mEOS2 (green) and a single converted NMIIA-
mEOS2 molecule (red) localized with sptPALM. Yellow dotted line shows boundary of 
NMIIA-F and crosshairs denote the centroid of the NMIIA-F. The molecule moved 353 +/- 
25 nm within the NMIIA-F. Average velocity of converted NMIIA-mEOS2 molecules was 
0.75 +/- 0.25 μm/min (~12.5 nm/s). J) Quantification of the number of molecules, which 
moved in NMIIA-Fs. K) Montage showing a concatenation of expanding NMIIA-Fs into a 
larger stack. L) Quantification of the percentage of concatenation events 2 m from the 
edge. For C, E, and l, N= 211 NMIIA-Fs from 32 cells over 5 independent experiments. 
For I-J, N= 18 NMIIA molecules from 11 cells over 3 independent experiments.  * denotes 
P < 0.001. Scale bars in the low mag and montage of (H), 5 and 1 m, respectively. All 
other scale bars, 200 nm. Live-cell 3-D SIM data were acquired by taking 4 images with 
125 nm Z steps and creating a maximum projection of each time-point.   All images are 
oriented with the leading edge towards the top. Error bars in (C), (E), (J), and (L) indicate 
SEM. 
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We next wanted to test the molecular mechanisms driving NMIIA-F stack 
formation. Our data shows that both expansion and concatenation involves the movement 
of NMIIA-Fs, and movement of NMII-Fs in crawling cells is dependent on NMII motor 
activity (Wilson et al., 2010). Therefore, we tested if motor activity is required for stack 
formation by inhibiting the ATPase activity of the NMII motor domain using increasing 
concentrations of blebbistatin (Straight et al., 2003) (Figure 2-3). Cells treated with 5 μM 
and 50 μM blebbistatin showed an increased percentage of 2-motor-group NMIIA-Fs 
compared to control cells (Figure 2-3), while the percentage of 3, 4, and >4-motor-group 
NMIIA-Fs decreased (Figure 2-3.). Using a low concentration of blebbistatin, 500 nM, we 
observed the percentage of larger NMIIA-F groups (4 and >4-motor-groups) declined 
(Figure 2-3), 3-motor-group NMIIA-F percentage remained similar (Figure 2-3), and 2-
motor-group NMIIA-F percentage increased, with respect to control cells (Figure 2-3). 
Thus, NMIIA-F expansion was dependent on NMII motor activity (i.e., either binding to or 
generating force on actin filaments). Furthermore, even in low concentrations of 
blebbistatin, NMIIA-Fs could expand, but not to the same extent of cells that maintain full 
contractile potential. 
 The decrease in 4 and >4-motor-groups suggested NMIIA-F stack formation was 
inhibited by blebbistatin. Therefore, we directly quantified stack lengths by measuring the 
length of the rod domains as localized with a NMIIA specific antibody (Figure 2-3). 
Consistent with the measured decrease in 4 and >4-motor-group filaments, we found that 
stack lengths decreased with increasing amounts of blebbistatin. We also inhibited Rho-
associated kinase (ROCK) with 10 μM Y-27632 (Uehata et al., 1997), which indirectly 
reduces NMII contractility, and found a similar decrease in stack lengths as 50 μM 
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blebbistatin (Figure 2-3). Interestingly, the ability to form NMIIA-Fs (e.g., 2-motor-groups) 
was less sensitive to NMII ATPase inhibition than NMIIA stack expansion. For example, 
we found 5 M blebbistatin did not significantly reduce the density of NMIIA-Fs even 
though it did reduce overall NMIIA-F stack lengths. (Figure 2-3). Importantly, we found 
the widths of NMIIA-Fs (i.e., motor-group to motor-group across the rod domain) to be 
similar in all experimental conditions. This is not surprising as the width of NMIIA filaments 
in vitro are also extremely similar (Billington et al., 2013).  
 To further test if motor activity is required for NMIIA-F stack formation, we 
expressed either wild type or a N93K mutant NMIIA-mEGFP in a human fibroblast-like 
cell line with its endogenous NMIIA knocked out with CRISPR/Cas9 (Figure 2-3).  The 
N93K mutant has the ability to bind actin filaments but has reduced motor activity 
compared to wild type (Hu et al., 2002; Vicente-Manzanares et al., 2007). Consistent with 
motor activity driving stack formation, we found the N93K mutant NMIIA created shorter 
stacks with a slight reduction in filament density (Figure 2-3). As NMIIA motors pull on 
actin filaments, we next tested if the availability of actin filaments could also regulate stack 
formation. 
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Figure 2-3: NMIIA-F expansion requires motor activity. 
A) Immuno-localized regulatory light chain (RLC) showing motor-group distribution and 
NMIIA showing rod-domain localization in control and cells treated with 500nm, 5 M and 
50 M blebbitstatin for 1 hour. B-E) Distribution of 2 motor-groups (B), 3 motor-groups 
(C), 4 motor-groups (D), and >4 motor groups (E) in cells treated with increasing amounts 
of blebbistatin. N= control (225 NMIIA-Fs, 37 cells, 3 experiments); 500 nM blebbistatin 
(421 NMIIA-Fs, 27 cells, 3 experiments); 5 M blebbistatin (435 NMIIA-Fs, 32 cells, 3 
experiments); 50 M blebbistatin (237 NMIIA-Fs, 20 cells, 3 experiments). See Methods 
and Fig. S3-1 for a detailed description of analysis. F) Length of NMIIA-F stacks as 
measured from the NMIIA rod-domain localization in cells treated with increasing amounts 
of blebbistatin and 10 M Y-27632 (ROCK inhibitor). N= control (9145 NMIIA-Fs, 48 cells, 
3 experiments); 500 nM blebbistatin (5807 NMIIA-Fs, 38 cells, 3 experiments); 5 M 
blebbistatin (11049 NMIIA-Fs, 48 cells, 3 experiments); 50 M blebbistatin (1873 NMIIA-
Fs, 37 cells, 3 experiments); 10 M Y-27632 (1357 NMIIA-Fs, 28 cells, 3 experiments). 
See Methods and Fig. S3-2 for a detailed description of analysis. G) RLC/NMIIA rod-
domains in a cell treated with 10 M Y-27632 for 1 hour. H) Density of NMIIA-Fs. N is the 
same as (F). I) Western showing the absence of NMIIA from Hap1 knockout cells 
compared to control (Fig. S3-3). J) NMIIA rod domains localized in knockout Hap1 cells 
either expressing wild type N93K NMIIA. K) Length of NMIIA-F stacks in Hap1 knockout 
cells transfected with either wild type or N93K NMIIA. L) Density of NMIIA-Fs in Hap1 
knockout cells transfected with either wild type or N93K NMII.  * denotes P < 0.001, and 
# denotes P < 0.05 compared to control. Scale bars, 2 m. Error bars in (B)-(E), (F), (H), 
(K), and (L) indicate SEM. 
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To test if the availability of actin filaments regulated NMIIA stack formation, we 
sought a way to reduce actin filament density.  Therefore, we treated cells with 
Cytochalasin B (CB), a molecule that binds to the plus end of actin filaments and thus 
reduces the rate of actin filament polymerization (MacLean-Fletcher and Pollard, 1980; 
Smith et al., 1967). High concentrations of CB (i.e., 1-5 M) can inhibit the majority of 
actin filament polymerization and result in the removal of most of the actin filament 
cytoskeleton (Forscher and Smith, 1988). However, sub-saturating concentrations of CB 
have been shown to remove specific populations of actin filaments, such as the actin 
bundles that make the core of filopodia in neuronal growth cones (Burnette et al., 2007). 
Therefore, we tested several concentrations of CB and found that 100 nM specifically and 
significantly reduced the actin filaments in the region where NMIIA-F form (i.e., right 
behind the protrusive lamellipodium (Figure 2-4) with no effect on the amount of actin 
filaments in the protrusive lamellipodium (Figure 2-4). Furthermore, cells treated with 100 
nM CB also had a significant reduction in NMIIA-F stack lengths (Figure 2-4). These 
results were consistent with the concept that actin filament densities regulate the ability 
of NMIIA-Fs to expand into stacks. Together, our data supports a model in which NMIIA 
molecules split from a NMIIA-F through the interactions of motor domains and actin 
filaments. We next tested if the formation of contractile systems in other cellular contexts 
could also involve NMIIA-F expansion. 
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Figure 2-4: Reducing actin filament density reduced NMIIA-F stacks 
A) Actin filaments in a control U2-OS cell and a cell treated with 100 nM CB for 1 hour. 
Arrow denotes the drop in intensity behind the lamellipodium. B) Quantification of the drop 
in intensity of actin filaments treated with 100 nM CB compared to control. N= control (3 
measurements each from 42 cells over 3 experiments); 100nm CB (3 measurements 
each from 46 cells over 3 experiments). C) RLC/NMIIA rod-domains in a cell treated with 
100 nM CB for 1 hour. D) Lengths of NMIIA-Fs in control cells and cell treated with 100 
nM CB. N= control (9145 NMIIA-Fs, 48 cells, 3 experiments); 100 nm CB (925 NMIIA-Fs, 
20 cells, 3 experiments). * denotes P < 0.001 compared to control. Scale bars, 2 m. 
Error bars in (B) and (D) indicate SEM. 
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NMII is largely responsible for the forces driving ingression of the cleavage furrow 
during cytokinesis of vertebrate cells (Ma et al., 2012; Straight et al., 2003). Furthermore, 
there is electron microscopy evidence from both classic and recent studies that strongly 
suggest the presence of NMII stacks in the cleavage furrow (Ong et al., 2014; Sanger 
and Sanger, 1980). NMIIA is recruited to the membrane of dividing cells during the 
transition between anaphase and telophase, and this recruitment is followed by cleavage 
furrow ingression (Matsumura et al., 1998). We started by confirming this using spinning 
disk confocal microscopy of dividing HeLa cells expressing NMIIA-(N-terminal)-mEGFP 
and Histone 2B-mCherry to visualize chromosomes (Figure 2-5). As expected, NMIIA-(N-
terminal)-mEGFP localized to the membrane at the cleavage furrow during ingression 
(Figure 2-5). We next tested if there were similar NMIIA-F dynamics (e.g., expansion) 
during contractile ring formation in HeLa cells as we found at the leading edge of crawling 
U2-OS cells.  
 To test if there was NMIIA-F expansion in the cleavage furrow, we acquired high-
resolution time-lapse images of NMIIA-(N-terminal)-mEGFP of the very bottom of the 
forming contractile ring (Figure 2-5). We observed NMIIA-Fs both expanded and also 
lined up creating NMIIA-F stack-like arrays (Figure 2-5). To confirm the presence of 
NMIIA-F stacks, we imaged the motor domains with NMIIA-(N-terminal)-mEmerald and 
rod domains with an antibody in the cleavage furrow using SIM. Indeed, HeLa cells had 
prominent NMIIA-F stacks spanning the cleavage furrow (Figure 2-5). NMIIA-Fs within 
stacks were organized parallel to the division plane and the lengths of stacks were 
perpendicular to the division plane, consistent with a model wherein the furrow closes 
through a purse-string mechanism. Interestingly, the NMIIA-F stack lengths in the 
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cleavage furrow of HeLa cells were the same as at the leading edge of U2-OS crawling 
cells (Figure 2-5). Taken together, this data shows NMIIA-F expansion occurs in the 
cleavage furrow and results in a similar organization as found at the leading edge of a 
crawling cell during interphase.  
 We next wanted to determine if NMIIA-F stacks formed in the cleavage furrow by 
similar mechanisms as at the leading edge. Since NMIIA-F stack length in interphase 
cells can be modulated by varying the concentration of blebbistatin (Figure 2-3), we 
analyzed the effect of treating cytokinetic cells with a concentration of blebbistatin that 
would not halt furrow ingression.  As expected, a high concentration of blebbistatin (50 
M) stops furro2-w ingression (Straight et al., 2003) (Figure 2-S5). Cells treated with 20 
M blebbistatin, however, had significantly slower ingression rates, but still divided 
(Figure 2-S5).  Therefore, we used SIM to image and then quantify the NMIIA-F stack 
lengths in the cleavage furrows of control cells and those treated with 20 M blebbistatin. 
Cells treated with 20 M blebbistatin showed a decrease in overall NMIIA-F stack length 
(Figure 2-5), even though the numbers of filaments as defined by the numbers of rod 
localizations was not significantly different (Figure 2-5). Thus, the same number of NMIIA-
Fs formed but they failed to elongate into stacks. Thus, NMIIA-F stack formation was 
sensitive to NMII ATPase inhibition in both interphase and mitosis. 
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Figure 2-5: NMIIA-F stacks expand in the cleavage furrow 
A) Time-lapse montage of DIC and confocal section showing H2B-mCherry (magenta) 
and NMIIA-(N-terminal)-mEGFP in a HeLa between anaphase and G1. NMIIA 
accumulation occurs at the membrane from anaphase to telophase (yellow arrowheads). 
Arrows show NMIIA at sites of blebbing. B) Time-lapse widefield epi-fluorescence imaging 
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of NMIIA-(N-terminal)-mEGFP at the bottom of the cleavage furrow. Time-montage from 
the yellow box shows NMIIA-F expansion (yellow arrow). Note that expanding NMIIA-Fs 
appear to align into larger stacks. C) SIM of NMIIA-(N-terminal)-mEmerald and immuno-
localized NMIIA rod domains. Whole cell and zoomed view of the cleavage furrow. D) 
Stack lengths at the leading edge of U2-OS (N= 9145 NMIIA-Fs, 48 cells, 3 experiments) 
and cleavage furrow of HeLa (N= 362 NMIIA-Fs, 11 cells, 8 experiments) cells. E) SIM of 
immuno-localized NMIIA rod domains in a control and 20 M blebbistatin treated cleavage 
furrow. Note the loss of linear structures in the 20 M treated furrow. F-G) Length of 
NMIIA-F stacks (F) and density of NMIIA-Fs (G) in the cleavage furrow of control cells 
(N= 362 NMIIA-Fs, 11 cells, 8 experiments) and cell treated with 20 M Blebbistatin (N= 
94 NMIIA-Fs, 5 cells, 3 experiments). * denotes P < 0.001 compared to control. Scale 
bars: (A), (B) and, 10 m; (C) and (E), 2 m. Error bars in (D), (F), and (G) indicate SEM. 
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Discussion 
 We present evidence for a new model of NMIIA stack formation that occurs at both 
the leading edge of crawling cells and in the cleavage furrow of dividing cells.  Through a 
combination of high and super-resolution light microscopy techniques, we show that 
NMIIA stacks form from 2 non-mutually exclusive mechanisms, expansion and 
concatenation (Figure 2-2). Pharmacological and genetic perturbations showed that 
NMIIA motor activity, cellular contractility, and actin filament availability regulate NMIIA 
stack formation (Figures 2-3 and 2-4). Furthermore, we show that a slowing of cleavage 
furrow ingression is associated with a loss of large organized NMIIA stacks. As such, 
NMIIA filament expansion and concatenation could represent a universal mechanism of 
contractile unit assembly.  
 The initial steps of NMIIA-F formation have been well characterized (Vicente-
Manzanares et al., 2009a). Auto-inhibited NMIIA molecules become polymerization 
competent through phosphorylation (Figure 2-6), and form a 2-motor-group filament 
through electrostatic interactions of their rod domains (Figure 2-6) (Craig et al., 1983; 
Pollard, 1975; Ricketson et al., 2010) (Pollard, 1975; Ricketson et al., 2010). Steric 
hindrance limits the number of NMII molecules that can be added to a growing 2-motor-
group NMIIA-F (Billington et al., 2013; Pollard, 1975). Thus, a likely role for the formation 
of NMIIA-F stacks would be to circumvent this inherent limitation in order to create 
stronger contractile units. Our data shows that NMIIA-F stacks form by both a single 2-
motor-group NMIIA-F expanding and by concatenating of multiple NMIIA-F/NMIIA-F 
stacks (Figure 2-6). During expansion, NMIIA molecules within a NMIIA-F spread out in 
space (cartoon in Figure 2-6 and Figure 2-2). We envision “pioneer” myosins could move 
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relative to the filament in a number of mechanisms. Pioneers are seemingly left behind 
by moving slower than other NMII molecules in the NMIIA-F (Figure 2-2). This could be a 
result of either binding more strongly to actin filaments, walking along actin filaments (i.e., 
as NMIIB is capable of) (Nagy et al., 2013; Norstrom et al., 2010), or by being pulled out 
by another molecular motor. The spreading out of the original NMIIA molecules is 
accompanied by addition of new NMIIA molecules to the growing stack (Figure 2-6) as 
revealed in our live-cell data by an increase in fluorescent signal during expansion (Figure 
2-1 and 2-2).  
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Figure 2-6: Model of NMIIA-F stack formation 
A) Classic model of the formation of a 2-motor-group NMIIA-F. An auto-inhibited NMIIA 
molecule (1) becomes polymerization competent (2) after phosphorylation of its 
regulatory light chain. Two polymerization competent NMIIA molecules then form a mini 
NMIIA-F (3) through electrostatic interactions of their rod domains. Addition of more 
NMIIA molecules to the mini-filament drives the growth of a 2-motor-group NMIIA-F (4). 
Steric hindrance limits the number of molecules that can be added to 2-motor-group 
NMIIA-F(Billington et al., 2013). Note a smaller number of myosins than the ~15 on each 
side of the filament are drawn for simplicity. Importantly, how larger contractile arrays (i.e., 
stacks) containing more myosins capable of generating more contractile forces is not 
understood (5). B) Model of NMIIA-F expansion. After the formation of a 2-motor-group 
NMIIA-F (1), a subset of “pioneer” myosins separate themselves from one side of the 
filament (2). “Pioneer” myosins are then followed by myosins from the other side of the 
filament (3) to create a template for a stack (4). Growth of these templates is driven by 
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addition of new NMIIA molecules (5). We have drawn this addition at the end for simplicity, 
but it could occur as soon as the “pioneer” myosins have separated themselves enough 
from the 2-motor-group NMIIA-F to fit in new molecules as in (2). C) Stacks can also form 
through concatenation of multiple NMIIA-Fs. Expansion and concatenation are not 
mutually exclusive as expanding NMIIA-Fs can concatenate with other NMIIA-Fs as in 
Fig. 2K.  
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Exactly why expansion of NMIIA filaments occurs, as opposed to only addition of 
NMIIA molecules from a soluble cytoplasmic pool adjacent to a 2-motor group filament 
isn’t currently understood, but our data points to a few plausible explanations. Previous 
data has shown that a majority of NMIIA molecules are in a soluble, un-polymerized pool 
(i.e., not in a bipolar filament) (Breckenridge et al., 2009; Shutova et al., 2012). In addition, 
a finite number of NMIIA molecules make up an individual NMIIA bipolar filament before 
steric hindrance restricts addition of more NMIIA molecules (Billington et al., 2013; 
Niederman and Pollard, 1975; Pollard, 1975). Thus, expansion and separation of a NMIIA 
2-motor group filament would reduce steric hindrance in the filament and allow for addition 
of more NMIIA molecules, increasing the force generating capabilities of the ensemble. 
Continued expansion and addition would result in larger NMIIA ensembles (i.e., a NMIIA 
stack). This mechanism would conceivably be more efficient than polymerizing a 2-motor 
group filament “de novo” adjacent to a previously formed 2-motor-group filament. 
 Surprisingly, we found that only a small percentage of NMIIA filaments exhibit a 
network contraction like behavior (Figure 2-2) (Verkhovsky et al., 1999b). Despite this 
small percentage, we do not rule out a role for this population of NMIIA filaments in either 
crawling or dividing cells, or other cellular contexts. For example, this small percentage 
of NMIIA filaments could be locally remodeling actin filaments at the leading edge of 
crawling cells, just as the network contraction model has predicted. The larger percentage 
of expanding NMIIA filaments could be involved in NMII required processes, such as 
adhesion maturation and actin arc translocation, all of which are required for efficient cell 
migration (Medeiros et al., 2006; Vicente-Manzanares et al., 2007).  
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 NMIIA-F stacks have inherently more NMIIA molecules within them than nascent 
2-motor-group filaments. Thus, stacks are likely to be able to generate more force. This 
may be vital to the function of the sarcomere-like stress fibers driving the movement of 
crawling and the separation of dividing cells (Figure 2-S4) (Burnette et al., 2014b; Sanger 
and Sanger, 1980; Verkhovsky et al., 1995).  Another possible role for NMIIA-F stack 
formation could be to template the formation of other myosin isoforms with different 
biophysical properties, such as NMIIB, which has been shown to incorporate into NMIIA-
Fs over time (Beach et al., 2014; Shutova et al., 2014). Indeed, we found reducing NMIIA 
in U2-OS cells with RNAi does tend to abolish NMIIB filament stacks (Fig. S6).  
 Our SIM analysis of NMIIA organization in cleaving cells also provides insight 
into the force generating machinery that drives cytokinesis. Constriction of an annular 
actomyosin array is arguably the dominant model in the field, but other models are 
equally plausible (Eggert et al., 2006; Wang, 2005). Debate has continued in part 
because we lack information on how actomyosin is arranged within the cleavage furrow. 
In fission yeast, this problem was addressed through electron microscopic analysis of 
time-dependent changes in the three-dimensional arrangement of F-actin throughout 
cytokinesis (Kamasaki et al., 2007). Consistent with a purse string mechanism, actin 
filaments circumscribe the cortex, forming a circular structure composed of filaments 
oriented parallel to the plane of division. Our data clearly show that furrow NMIIA forms 
stacks that orient perpendicular to the plane of division (Figure 2-5), suggesting that 
they slide an array of actin filaments that are also arranged in parallel relative to the 
direction of ingression. Interestingly, the stack length and density of NMIIA correlate 
with the speed of ingression (Figure 2-5). Thus, although our analysis does not formally 
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prove that furrow localized NMIIA generates the forces that drive cell cleavage, they are 
consistent with the notion that cytokinesis in human cells is also driven by a purse string 
mechanism. 
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Supplemental figures 
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Figure 2-S1: Endogenous NMIIA-F organization 
A) SIM of RLC (magenta) and NMIIA-(N-terminal)-mApple motor domains (green). 
Signal from RLC channel aligns with NMIIA-(N-terminal)-mApple motor domains, and 
thus can be used to quantify motor domains. B) Examples of 2-motor-group, 3-motor-
group, and 4-motor-group NMIIA-Fs at the leading edge of crawling U2-OS cells. Scale 
bars, 200 nm. 
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Figure 2-S2: Spatial distributions and localization precision of NMIIA-mEOS 3D-
PALM measurements.  
A) Localization precision for all NMIIA-mEOS2 molecules detected within a cell. The 
mean of the localization precision was extracted from a lognormal fit to the histogram 
distribution (μz = 20 +/- 11 nm and μx = 11+/- 5 nm; error represents S.D.). B) 
Representative histogram distributions of individual NMIIA-mEOS2 localized within 
clusters from 2-motor-group filament. Isolated clusters of NMIIA-mEOS2, interpreted to 
represent NMIIA motor groups, were segmented, normalized to their respective means, 
and quantified along X and Z spatial dimensions. Histograms were fit to a normal 
distribution model and the standard deviation was extracted (σ). Cluster dimensions for 
Filament 1 were x = 19 and z = 37 nm and for Filament 2 were x = 22 and z = 34 
nm. C) Representative histogram distributions of individual NMIIA-mEOS2 localization 
clusters from 3-motor-group filament. Isolated clusters of NMIIA-mEOS2, interpreted to 
represent NMIIA motor groups, were segmented, normalized to their respective means, 
and quantified along X and Z spatial dimensions. Histograms were fit to a normal 
distribution model and the standard deviation was extracted (σ). Cluster dimensions for 
Filament 1 were x = 18 and z = 38 nm and for Filament 2 were x = 18 and z = 37 
nm. 
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Figure 2-S3: Defining region for 2, 3, 4, and >4 motor-group NMIIA-Fs 
Actual screen shots of data analyzed in Slidebook from cells visualized by endogenous 
RLC (green) and NMIIA (red). A) Left screen shot shows a control cell without the 
region in which 2, 3, 4, >4 motor-group NMIIA-Fs were quantified. A) Right screen shot 
shows the same control cell with the region in which 2, 3, 4, >4 motor-group NMIIA-Fs 
were quantified. NMIIA-Fs were quantified above the blue shaded area. Region was 
made by measuring 1.5 m towards cell body from the first visualized NMIIA-Fs along 
the edge of a migrating cell. Width of blue shaded area did not factor into quantification. 
B) Left screen shot shows a cell treated with 5 m blebbistatin before quantification, and 
the right screen shot shows the same cell including the region (blue shaded area), 
above which 2, 3, 4, >4 motor-group NMIIA-Fs were quantified. 
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Figure 2-S4: Measuring NMIIA-F stack length 
A 15x7 m region was used to crop cells visualized by endogenous NMIIA (red), 
starting at the first visualized NMIIA-F. Shown are screen shots from Slidebook, as in 
Fig. S3-1. a) Top screen shot shows the cropped region of a control cell. Bottom screen 
shot shows the same cell, including a mask of all NMIIA-Fs (blue lines), which give the 
number of overall NMIIA-Fs, and length of each filament. b) Top screen shot shows the 
cropped region of a cell treated with 5 M blebbistatin. Bottom screen shot shows the 
same cell including a mask of all NMIIA-Fs (blue lines), which give the length and 
number of overall NMIIA-Fs. 
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Figure 2-S5: Western blot analysis of HAP1 NMIIA knockout cells 
A) Cell lysates from control and myosin IIA knockout cells probed for NMIIA. Control 
cells show a prominent band at ~200kD corresponding to NMIIA heavy chain, while 
knockout cells lack this band. B) -tubulin loading control from the same gel as (A). 
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Figure 2-S6: Relative NMIIA-Fs and actin filament bundles in the cleavage furrow 
A) Whole cell view of endogenous NMIIA rod domains, actin filaments (visualized with 
phalloidin), and overlay of NMIIA rod domains (green) and actin filaments (magenta) at 
the bottom of a cleavage furrow in a HeLa cell. B) High mag views of the boxes in (A). 
Note the positions of actin filament bundles are consistent with published electron 
microscopy data(Sanger and Sanger, 1980). In addition, the NMIIA filaments and actin 
bundles resemble the sarcomere-like organization of the stress fibers at the leading 
edge of U2-OS cells (Burnette et al., 2014b). This cell was fixed with 4% 
paraformaldehyde without live-cell extraction (i.e., the same protocol as used for U2-OS 
cells) as the unlabeled phalloidin in the extraction buffer interfered with labeling with 
fluorescent Alexa-488 phalloidin. Scale bars: (a), 5 m; (b), 1 m. 
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Figure 2-S7: Rates of cleavage furrow ingression during cell division 
A) Phase contrast time-montages of control, 20 M blebbistatin, 50 M blebbistatin 
treated cells during. First frame is the time-point before chromosome separation. 
Kymographs showing ingression rates were created from the lines indicated in the first 
frame. Arrows in kymographs show ingression. Kymographs were created with Nikon 
Elements. B) Rates of ingression for control cells (N = 43 cells, 3 experiments), cells 
treated with 5 M blebbistatin (N = 37 cells, 3 experiments), and cells treated with 20 
M blebbistatin (N = 36 cells, 3 experiments). * denotes P < 0.001. Scale bars, 10 m. 
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Figure 2-S8: NMIIB-F stacks are absent after knockdown of NMIIA in U2-OS cells 
A) Actin filaments localized with phalloidin and NMIIA-F rod domains localized with an 
antibody in a cell treated with an RNA molecule of a random sequence (Scrambled 
control) or a pool of RNA molecules design to silence the expression of MYH9 (NMIIA). 
Images were acquired and are displayed using the same parameters. B) Actin filaments 
localized with phalloidin and NMIIB rod domains localized with an antibody in a cell 
treated with an RNA molecule of a random sequence (Scrambled control) or a pool of 
RNA molecules designed to silence the expression of MYH9 (NMIIA).  Images were 
acquired and are displayed using the same parameters. Note the absence of stack-like 
arrays of NMIIA-F when RNAi reduces the amount of NMIIA. Scale bars, 10 m. 
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Introduction 
 The sarcomere is the contractile unit within cardiomyocytes which drives heart 
muscle contraction, and thus, blood flow throughout the body. At its core, a sarcomere is 
composed of “thick” myosin II filaments, and “thin” actin filaments (Figure 3-1) (Au, 2004). 
One sarcomere is measured from Z-line to Z-line, which contain -actinin 2 (Figure 3-1). 
The proper establishment of cardiac sarcomeres during development and their 
subsequent maintenance is critical for heart function. Previous studies in cultured 
myocytes have shown the presence of actin bundles called “stress fiber-like structures” 
similar in appearance to classic stress fibers (Dlugosz et al., 1984). These stress fibers 
were often found to be close to the edge of the myocyte with sarcomeres existing further 
from the edge (Rhee et al., 1994). These studies proposed that the stress fibers served 
as a template for the formation of sarcomeres (Dlugosz et al., 1984; Rhee et al., 1994; 
Sanger et al., 2005). The original model that proposed this was called the Templating 
Model (Dlugosz et al., 1984), and was proposed before it was known these stress fibers 
contained both non-muscle and sarcomeric proteins (Rhee et al., 1994). Beyond non-
muscle myosin IIB (NMIIB), which is present in non-muscle cells, stress fibers in muscle 
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cells contain muscle specific proteins, such as -actinin, tropomyosin, troponins, and 
tropomodulin (Almenar-Queralt et al., 1999; Rhee et al., 1994; Sanger et al., 2005). Each 
of these proteins have non-muscle paralogs, which likely serve similar functions (Bryce 
et al., 2003; Colpan et al., 2013; Cote, 1983; Gunning et al., 2015; Lim et al., 1986; 
Sjoblom et al., 2008). Partly in response to the presence of muscle specific proteins in 
stress fibers, the Templating Model was modified to the “Pre-Myofibril Model” (Rhee et 
al., 1994; Sanger et al., 2005).  Even though these models have different names and are 
often presented as mutually exclusive, they are very similar in their predictions. 
Specifically, both models posit an actin bundle that appears structurally similar to a stress 
fiber will acquire a row of sarcomeres over time to become a “myofibril” (Dlugosz et al., 
1984; Rhee et al., 1994; Sanger et al., 2005) (Figure 3-1). There is a vast amount of 
localization data in fixed cardiomyocytes to support these models. However, there is very 
little dynamic data in live cells that suggests stress fibers give rise to sarcomeres.  The 
strongest dynamic support comes from imaging fluorescently tagged -actinin 2 in 
myocytes. Time montages from chick skeletal myotubes showed small puncta of -actinin 
2 adding to pre-existing Z lines (McKenna et al., 1986). Subsequently, a time montage 
was used to show a similar phenomenon occurring in chick cardiomyocytes (Dabiri et al., 
1997).  
Some in vivo data support the Template/Pre-Myofibril Model, while others do not. 
In strong support of the Template/Pre-Myofibril Model, static images of chick heart tissue 
have essentially revealed every structure described in primary cultured chick 
cardiomyocytes (Du et al., 2008). The presence of NMIIB-containing stress fibers in the 
cardiomyocytes was particularly clear (Du et al., 2008). NMIIB germline knockout (KO) 
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mice were also reported to have fewer and disorganized sarcomeres via EM (Tullio et al., 
1997). On the other hand, several studies have called into question the role of stress 
fibers in sarcomere assembly. First, several studies examining cardiomyocytes within 
mouse or chick heart tissue did not find stress fibers containing NMIIB (Ehler et al., 1999; 
Kan et al., 2012; Ma et al., 2009). In addition, a conditional KO mouse that removes NMIIB 
genetically at P9 apparently still had striated sarcomere structures (Ma et al., 2009). 
Finally, a conditional heart KO of the other major paralog of NMII, NMIIA, was also 
reported to have no apparent defects in heart formation (Conti et al., 2004; Conti et al., 
2015). Taken together, the lack of clear data showing stress fibers in cardiomyocytes and 
inconsistencies for a role of NMII in sarcomere assembly calls into question whether the 
Template/Pre-Myofibril Model is a viable construct for understanding sarcomere 
assembly (Sanger et al., 2005; Sparrow and Schock, 2009).  
There is further data to suggest that a mechanism other than that described in the 
Template/Pre-Myofibril model could be driving sarcomere assembly. This alternative 
model—called the “Stitching Model”—is based on the idea that parts of a sarcomere are 
assembled independently and then brought together (i.e., stitched) (Holtzer et al., 1997; 
Lu et al., 1992; Sanger et al., 2005). In support of the Stitching Model, studies in 
Drosophila have shown the presence of small myosin filaments following knockdown (KD) 
of separate Z-line components (Rui et al., 2010). This data suggests that myosin filaments 
can assemble independently of Z-lines. Indeed, there are also electron micrographs that 
appear to show stacks of myosin II filaments (i.e., A-bands) without detectable actin 
filaments in skeletal muscle (Holtzer et al., 1997; Lu et al., 1992; Sanger et al., 2005). 
Examination of electron micrographs also supports the idea that bodies containing Z-line 
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components and actin filaments—called “I-Z-I” bodies—could also exist in skeletal muscle 
without apparent myosin II filaments (Holtzer et al., 1997; Lu et al., 1992; Sanger et al., 
2005). Based on this data, it was proposed that stitching could occur through sequential 
assembly by adding new I-Z-I bodies and myosin II filaments (Holtzer et al., 1997; Lu et 
al., 1992; Sanger et al., 2005). 
The Template/Pre-Myofibril Model and Stitching Model have been proposed to 
be mutually exclusive explanations of how sarcomeres arise. The Template/Pre-
Myofibril Model predicts that multiple sarcomeres will appear approximately 
simultaneously along the length of a stress fiber, while the Stitching Model would predict 
that sarcomeres will appear adjacently one by one, sequentially (see original models in 
(Dlugosz et al., 1984; Holtzer et al., 1997; Rhee et al., 1994)). Here, we leverage our 
discovery that immature human induced pluripotent stem cell-derived cardiomyocytes 
(hiCMs) completely disassemble and then reassemble their sarcomeres following 
plating to test these possibilities. Using this assay, we show that sarcomeres are 
assembled directly from actin stress fiber templates, and we refer to these stress fibers 
as Muscle Stress Fibers (MSFs). Our data suggests sarcomere assembly is dependent 
on the formin actin filament nucleator, FHOD3, non-muscle myosin IIA and non-muscle 
myosin IIB. Surprisingly, our data does not fully support either the Template/Pre-
Myofibril Model or Stitching Model, but rather some aspects of each. As such, we now 
propose a unified model of sarcomere assembly based on the formation of MSFs and 
their subsequent transition into sarcomere-containing myofibrils. 
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Results 
 
Development of an assay to test sarcomere assembly 
To address how cardiac sarcomeres are assembled, we used hiCMs as a model 
system (Takahashi et al., 2007). We first noted the actin filaments in hiCMs, which had 
spread for 24 hours, had two distinct organizations, muscle stress fibers (MSFs) and 
sarcomere-containing myofibrils (Figure 3-1). Spread hiCMs displayed MSFs at the 
leading edge and organized sarcomere structures in the cell body (Figure 3-1). Strikingly, 
super-resolution imaging revealed the MSFs in hiCMs resembled a classic actin stress 
fiber found in non-muscle cells, referred to as actin arcs (Figure 3-1) (Heath, 1983; 
Hotulainen and Lappalainen, 2006). Actin arcs are stress fibers on the dorsal (top) surface 
of the cell that are parallel to the leading edge and stain continuously with fluorescent 
phalloidin (Figure 3-1). Similarly, both MSFs and sarcomeres in hiCMs are on the dorsal 
surface (Figure 3-1). We next sought to test the concept that a MSF obtained sarcomeres 
as predicted by the Templating/Pre-Myofibril Model. 
To test whether MSFs give rise to sarcomeres, we needed to develop a sarcomere 
assembly assay. We noticed that freshly plated hiCMs contained no sarcomere structures 
(Figure 3-S1). hiCMs subsequently assembled sarcomere structures over the course of 
24 hours. Loss of sarcomere structure following plating was confirmed by visualizing 
multiple sarcomeric proteins, including actin, beta cardiac myosin II (βCMII), -actinin 2, 
and TroponinT (Figure 3-S1). We next sought to ask if MSFs template sarcomeres. 
Indeed, time-lapse microscopy of hiCMs expressing the actin probe Lifeact-mEmerald 
(Riedl et al., 2008) revealed that MSFs acquire sarcomeres over time, with the first 
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sarcomeres appearing between 4 and 16 hours (Figure 3-1). As our SIM data suggests 
MSFs and sarcomeres are localized on the dorsal surface of the cell, the transition of 
MSFs to sarcomeres also occurs on the dorsal surface of the cell (Figure 3-1). 
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Figure 3-1:  Sarcomeres arise directly from Muscle Stress Fiber (MSF) precursors 
(A) Electron microscopy (EM) schematic of a cardiac sarcomere from adult mouse. 
Electron dense regions on border of sarcomere are Z-discs (Z), while the core of the 
sarcomere is composed of thin actin filaments and thick myosin II filaments (A). Multiple 
sarcomeres aligned adjacently form a myofibril (lower mag EM, right). (B) hiCM allowed 
to spread for 24 hours following plating and imaged with SIM. hiCM has been stained for 
actin and color coding is a representation of height (Z plane) within the cell following 3D 
imaging (Z-height, left). Notice the clear stress fiber and sarcomere-like actin organization 
at the front and rear of the cell in box 1 and 2, respectively. (C) Spread U2OS cell color 
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coded for Z as in Figure 3-1, displaying prominent actin arc stress fibers behind leading 
edge of cell and imaged with SIM. Box 1 shows actin arcs just behind the leading edge 
of cell, while box 2 shows actin arcs on dorsal surface in cell body (green and blue colored 
actin), while ventral stress fibers (red colored actin) are on bottom surface of cell.  (D) 
Percentage of hiCMs, U2OS, and HeLa cells with actin arc stress fibers. hiCMs; 1372 
cells over 3 experiments. U2OS; 37 cells over 4 experiments. HeLa; 186 cells over 4 
experiments. (E) Wide-field time lapse of hiCM transfected with Lifeact-mEmerald to 
visualize actin. MSF at front of hiCM undergoes retrograde flow and acquires sarcomeres 
(yellow arrows). (F) Laser-scanning confocal microscopy of hiCM expressing Lifeact-
mApple showing MSF to sarcomere transition. hiCM lacks sarcomeres at first time point, 
and MSF at edge of cell undergoes retrograde flow and acquires sarcomeres (yellow 
arrows). (G) 3D laser-scanning confocal microscopy of hiCM expressing Lifeact-mApple 
forming sarcomeres. Note how ventral surface (left montage) contains no sarcomere 
structures, while sarcomere assembly occurs on the dorsal surface of cell (right montage). 
Scale Bars; (A) 500 nm high mag, 2 µm low mag; (B), (C), (E), (F), (G), 10 µm. P-values 
denoted in graphs. 
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To further characterize our sarcomere assembly assay, we used -actinin 2, 
which is a classic marker of Z-lines (Luther, 2009). Endogenous -actinin 2 localized to 
both MSFs and sarcomeres (Figure 3-2). Small puncta of -actinin 2 localized to MSFs, 
while sarcomeres had linear -actinin 2 which labeled Z-lines (Figure 3-2). As has been 
shown in other systems (Dabiri et al., 1997; Du et al., 2008), the spacing between -
actinin 2 puncta increases during the MSF to sarcomere transition, with the spacing of 
-actinin 2 ~0.5 µm in MSFs and ~1.7 µm in sarcomeres (Figure 3-2). In hiCMs, -
actinin 2 puncta in MSFs alternates with NMII, as has been shown for other systems 
(Figure 3-S2) (Ehler et al., 1999; Hotulainen and Lappalainen, 2006; Rhee et al., 1994; 
Sanger et al., 2005). Interestingly, the spacing of -actinin 2 puncta associated with 
MSFs in hiCMs was very similar to the spacing of -actinin 4 (i.e., a non-muscle paralog 
of -actinin) in actin arcs in U2OS cells (Figure 3-2). If MSFs were serving as a template 
for sarcomeres, we asked whether the molecules in MSFs were also being incorporated 
into the sarcomere structures. Previous data suggests α-actinin 2 puncta join existing Z-
lines (Dabiri et al., 1997; McKenna et al., 1986). To test this hypothesis, we utilized a 
photo-convertible probe, mEOS2, which converts from green to red fluorescence to 
specifically mark the -actinin 2 puncta of MSFs (McKinney et al., 2009). We found that 
a subset of photo-converted -actinin 2-mEOS2 puncta were indeed incorporated into 
Z-lines (Figure 3-2). Collectively, these results strongly suggest MSFs give rise to 
sarcomeres in hiCMs. 
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Figure 3-2: -Actinin 2 spacing and dynamics in hiCMs 
(A) Color coded representation for Z-height of endogenous α-actinin 2 in MSFs (box 1) 
and sarcomeres (box 2) of hiCM imaged with SIM. Note difference in structure and 
spacing of α-actinin 2 in MSFs (box 1) and sarcomeres (box 2) (B) Distance between α-
actinin 2 structures in MSFs and sarcomeres. MSFs; 14 cells, 3 experiments, 827 
measurements, Sarcomeres; 15 cells, 3 experiments, 527 measurements. Distance 
between structures increases as MSFs transition to sarcomeres. (C) Histogram 
depicting distribution of distances between α-actinin 2 structures in MSFs in hiCMs (top) 
and α-actinin 4 found in actin arcs of non-muscle cells (bottom). Distribution is similar 
between cell types. (D) Wide-field montage of photoconversion of α-actinin 2-mEOS2 in 
hiCM. MSFs at leading edge of the cell were photoconverted (green to red) and imaged 
over time. Montage (middle) depicts α-actinin 2-mEOS2 puncta of MSFs (hollow yellow 
arrow heads) transition into sarcomere structures (middle, right). Scale Bars; (A), (D), 
10 µM. P-values denoted in graphs.  
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Actin Retrograde flow in hiCMs and non-muscle cells 
 
We next wanted to further investigate the similarities between MSFs and actin 
arcs. Actin arc stress fibers in non-muscle cells undergo robust “retrograde flow” away 
from the edge of the cell  as can be seen in U2OS cells, a classic model of mesenchymal 
migration (Figure 3-2) (Hotulainen and Lappalainen, 2006; Ponti et al., 2004). 
Kymography measurements found that actin arcs in U2OS cells moved at ~200 nm/min, 
in agreement with previously published findings (Figure 3-2) (Ponti et al., 2004). We found 
MSFs also underwent retrograde flow (Figure 3-3). Strikingly, however, kymography 
revealed MSFs in hiCMs moved significantly slower than actin arcs in U2OS cells (Figure 
3-3). This was the first indication that actin arcs in non-muscle cells are different than 
MSFs in hiCMs. We next wanted to define the mechanisms governing MSFs and their 
acquisition of sarcomeres. As the mechanisms of actin arc formation and maintenance 
have been well studied (Burnette et al., 2014a; Hotulainen and Lappalainen, 2006; 
Murugesan et al., 2016), we were interested in using our assay to test whether the same 
mechanisms driving actin arc dynamics were governing MSF dynamics. 
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Figure 3-3: Retrograde flow of actin in non-muscle cells and hiCMs 
(A) Still of U2OS cell expressing Lifeact-mEmerald (left) imaged with spinning disk 
confocal. Kymograph (right) taken from purple line of left image. Note robust movement 
of actin arc stress fibers (yellow arrow). (B) Still of hiCM expressing Lifeact-mApple (left) 
imaged with spinning disk confocal. Kymograph (right) taken from purple line of left image. 
Note slower movement of MSF in hiCM compared to actin arcs in U2OS cell, and 
stationary nature of sarcomeres. (C) Quantification of actin stress fiber translocation rates 
in U2OS cells and hiCMs. U2OS; 3 cells over 3 experiments. hiCMs; 12 cells over 3 
experiments. Scale Bars; (A), (B), 10 µM. P-values denoted in graph.  
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Formins, but not the Arp2/3 complex, are required for MSF-based sarcomere 
 
formation 
 
The Arp2/3 complex is well known to be required for actin arc formation in non-
muscle cells (Hotulainen and Lappalainen, 2006). To test the role of the Arp2/3 complex 
during sarcomere assembly, we allowed hiCMs to spread in the presence of CK666, an 
inhibitor of the Arp2/3 complex (Nolen et al., 2009). Surprisingly, hiCMs allowed to spread 
in the presence of CK666 formed robust MSFs and sarcomeres comparable to untreated 
control cells (Figure 3-4). Cells were quantified as containing sarcomeres if they 
contained three parallel Z lines in a row each separated from the adjacent Z line by 1µm 
– 2.5µm. An α-actinin 2 localization was defined as a Z line if it was as least 2x the length 
of the microscope’s resolution limit (see Methods). In addition, the spacing between Z-
lines between control and CK666 hiCMs was unchanged (Figure 3-4). We also found the 
retrograde flow of MSFs was unchanged between control and CK666-treated hiCMs 
(Figure 3-4). To confirm inhibition of the Arp2/3 complex by CK666, we examined the 
endogenous localization of the Arp2/3 complex with and without CK666 treatment. The 
strong localization of the Arp2/3 complex at the edge of control hiCMs was absent in 
CK666 treated hiCMs (Figure 3-4). To further confirm this observation, we analyzed the 
loss of p16b-mEGFP, a subunit of the Arp2/3 complex, from the leading edge of hiCMs 
via CK666 in live hiCMs. Indeed, hiCMs showed rapid loss of p16b-mEGFP from the 
leading edge following administration of CK666 (Figures 3-4). The delocalization of the 
Arp2/3 complex from the leading edge is consistent with inactivation by CK666, as shown 
previously in non-muscle cells (Henson et al., 2015). Taken together, our data suggests 
that the Arp2/3 complex does not need to be localized at the leading edge for sarcomeres 
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to be assembled. While we find it un-likely, it is possible a relatively small amount of 
Arp2/3, could be driving the retrograde flow in the CK666 treatment. However, the 
inhibitor is used at above saturation concentrations, so it is likely other mechanisms are 
driving retrograde flow in hiCMs.  
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Figure 3-4: The Arp2/3 complex is not required for sarcomere assembly 
(A) hiCM allowed to spread for 24 hours in the presence of 25 µM CK666, labeled with 
actin and α-actinin 2 (i.e., Z-lines) and imaged with SIM. Box indicates presence of MSFs. 
(B) Quantification of percentage of cells with sarcomeres at 24 hours post plating in 
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control and 25 µM CK666. Control: 76 cells, 10 experiments; 25 µM CK666: 41 cells, 3 
experiments. (C) Histogram of distribution of distances between α-actinin 2 Z-lines. Note 
tight distribution of Z-lines in both conditions. Control: 14 cells, 3 experiments, 317 
measurements. 25 µM CK666: 16 cells ,3 experiments, 530 measurements. (D) Stills of 
hiCM expressing Lifeact-mApple pre (top) and post (bottom) addition of 25 µM CK666 
and imaged with spinning disk confocal. Kymographs (right) taken from dotted yellow line 
(left). (E) Rates of retrograde flow of hiCMs depicted as percent change in CK666 from 
pre-drug condition. 8 cells over 3 experiments. (F) Localization of the Arp2/3 complex in 
control (top) and 25 µM CK666 treated (bottom) hiCMs imaged with SIM. Note loss of 
Arp2/3 at the edge of CK666 treated hiCM. Cells spread for 24 hrs in presence of 25 µM 
CK666 as in Figure 3-4A (G) Quantification of loss of the Arp2/3 complex from the leading 
edge of hiCMs. Control; 36 cells over 3 experiments. 25 uM CK666; 29 cells over 3 
experiments. (H) hiCM expressing P16B-mEGFP (a component of the Arp2/3 complex) 
and imaged with spinning disk confocal. Localization of P16B-mEGFP at leading edge in 
pre-drug control (top) is acutely lost after addition of 25 µM CK666 (bottom). (I) 
Quantification of hiCMs displaying localization of the Arp2/3 complex (P16B-mEGFP) pre- 
and post-25µM CK666 in live hiCMs (as in Figure 3-4H). 27 cells over 3 experiments. 
Scale bars; (A), (D), (F), (H), 10 µm. P-values denoted in graphs. 
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In addition to the Arp2/3 complex, formin-mediated actin polymerization has been 
shown to be crucial for actin arc formation and dynamics in multiple cell types 
(Hotulainen and Lappalainen, 2006; Murugesan et al., 2016). As a starting point to test 
whether formins are required for sarcomere assembly, we allowed hiCMs to spread in 
the presence of a pan-inhibitor of formin-mediated actin polymerization, small molecule 
inhibitor of formin homology domain 2, SMIFH2 (Rizvi et al., 2009). SMIFH2 has been 
shown to stop formin-mediated actin polymerization, actin arc formation and retrograde 
flow in non-muscle cells (Henson et al., 2015; Murugesan et al., 2016; Rizvi et al., 
2009). We found hiCMs spreading in the presence of SMIFH2 completely failed to form 
sarcomeres (Figures 3-5, and 3-S3). This effect was reversible, as sarcomeres formed 
after the removal of SMIFH2 (Figure 3-S4). Distances between α-actinin 2 structures 
were also significantly decreased in hiCMs treated with SMIFH2, with the distribution of 
α-actinin 2 more closely resembling MSFs than sarcomeres (Figures 3-5 and 3-2). 
However, the alignments of the α-actinin 2 puncta were not similar to MSFs in control 
hiCMs, as they were not periodic (Figure 3-5 and 3-2). This result strongly suggested 
formins are required for sarcomere assembly. 
We next asked if formin inhibition was affecting either the MSFs or sarcomeres 
directly. To test this, we allowed hiCMs to spread for 24 hours (after they have established 
sarcomeres) and imaged their actin cytoskeleton via live-cell microscopy before and after 
administering SMIFH2 (Figure 3-5). Following addition of SMIFH2, formation of new 
MSFs was immediately blocked, along with retrograde flow of existing MSFs (Figures 3-
5). However, we did not detect any changes in sarcomere structure over the short time of 
the experiment, and hiCMs continued to beat in the presence of SMIFH2 (note sarcomere 
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structure in Figure 3-5). As there are 15 mammalian formin genes, we next asked what 
specific formin was required for sarcomere assembly. 
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Figure 3-5: Formins are required for sarcomere assembly and MSF dynamics 
(A) hiCM allowed to spread in the presence of 25 µM SMIFH2 for 24 hours, labeled with 
actin and α-actinin 2 and imaged with SIM. Box indicates loss of transverse MSFs behind 
leading edge of hiCM. (B) Quantification of percentage of cells with sarcomeres at 24 
hours post plating. Control: 76 cells, 10 experiments; 25 µM SMIFH2, 16 cells, 3 
experiments (C) Histogram of distribution of distances between α-actinin 2 Z-lines. 
Control: 14 cells, 3 experiments, 317 measurements, 25 µM SMIFH2: 11 cells, 3 
experiments, 468 measurements.  (D) Stills from live hiCM expressing Lifeact-mApple 
before (left) and 90 minutes following addition of 25 µM SMIFH2 (right) and imaged with 
spinning disk microscopy. Note how sarcomeres and overall actin architecture remains 
unperturbed at 90 minutes post 25 µM SMIFH2. (E) Kymographs of MSF and sarcomere 
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retrograde flow taken from purple line in Fig. 4D. Note immediate loss of retrograde flow 
following addition of 25 µM SMIFH2. (F) Quantification of actin retrograde flow in hiCMs 
pre and post addition of 25 µM SMIFH2. Control: 12 cells, 3 measurements from each 
cell, 3 experiments; 25 µM SMIFH2, 12 cells, 3 measurements from each cell, 3 
experiments. Scale Bars: (A), (D) 10 µM. P-values denoted in graphs.  
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We performed RNA sequencing analysis of mRNA isolated from hiCMs. 
Normalized read counts revealed that one formin, FHOD3, was expressed higher than 
all other formins (Figure 3-6). Indeed, previous data from isolated rat cardiomyocytes 
has shown FHOD3 as crucial for sarcomere maintenance (Iskratsch et al., 2010; Kan et 
al., 2012; Taniguchi et al., 2009). Rat cardiomyocytes containing myofibrils 
subsequently lost their myofibrils following FHOD3 knockdown (Iskratsch et al., 2010; 
Taniguchi et al., 2009). However, the role of FHOD3 during de novo sarcomere 
assembly has not been tested. Therefore, we sought to use our assay to directly test if 
the formin FHOD3 was required for MSF based sarcomere assembly. We knocked 
down FHOD3 using siRNA, and hiCMs were unable to assemble sarcomeres following 
plating (Figure 3-6). Interestingly, KD of the two most highly expressed formins after 
FHOD3, DAAM1 and DIAPH1, did not stop sarcomere assembly (Figures 3-6 and 3-
S5). However, there are clear defects in the actin organization at the cell edge and in 
the sarcomeres (Figure 3-S5). As FHOD3 had the most prominent phenotype, we 
decided to focus our further analysis on this condition. In line with pan-formin inhibition, 
the actin organization and spacing between α-actinin 2 in FHOD3 KD hiCMs closely 
resembled hiCMs spread in the presence of SMIFH2 (Figures 3-5 and Figure 3-6).  
Based on our results, if FHOD3 is involved in sarcomere assembly, it should 
localize to MSFs. FHOD3-mEGFP localized to both MSFs at the edge of hiCMs, and then 
becomes increasingly organized away from the leading edge of the cell where 
sarcomeres are located (Figure 3-6). This localization is consistent with a role for FHOD3 
in mediating the transition from MSFs to sarcomeres. Taken together, our data show that 
the formin FHOD3 localizes to both MSFs and sarcomeres, and is required for de novo 
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sarcomere assembly. We next wanted to investigate other potential mechanisms 
regulating sarcomere assembly. 
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Figure 3-6: Formin FHOD3 is required for sarcomere assembly 
(A) Normalized Fragments Per Kilobase Million (FPKM) of mRNA expression of the top 3 
expressed formins in hiCMs. 3 experiments, 3 separate runs. (B) Actin of siRNA scramble 
control and siRNA FHOD3 hiCMs allowed to spread for 24 hours and imaged with SIM. 
Note loss of sarcomeres comparable to SMIFH2 treatment in FHOD3 KD hiCMs (Figure 
3-5A). Western blot (right) denotes protein loss in FHOD3 KD. (C) Quantification of 
percentage of cells with sarcomeres at 24 hours post plating in scramble control, 
siFHOD3, siDAAM1, and siDIAHP1 hiCMs. Control: 76 cells, 10 experiments; siRNA 
FHOD3: 33 cells, 3 experiments; siRNA DAAM1: 29 cells, 3 experiments; siRNA Dia1: 26 
cells, 3 experiments. (D) Histogram of distribution of distances between α-actinin 2 Z-
lines. Control: 14 cells, 3 experiments, 317 measurements; siFHOD3: 15 cells, 3 
experiments, 488 measurements. (E) hiCM transfected with FHOD3-mEGFP, fixed at 24 
hours, stained for Actin and imaged with SIM. Boxes 1-4 depict localization of FHOD3-
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mEGFP along MSFs (boxes 1 and 2) and in sarcomeres (boxes 3 and 4). Note 
increasingly organized structure, and localization between Z-lines of FHOD3-mEGFP. 
Scale bars; (B), (E) 10 µm. P-values denoted in graphs. 
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Non-muscle myosin II is required for cardiac sarcomere actin filaments 
 
In addition to actin nucleators, non-muscle myosin II (NMII) activity has been 
shown to be required for actin arc formation and organization in non-muscle cell types 
(Hotulainen and Lappalainen, 2006; Medeiros et al., 2006). Thus, we asked whether 
NMII was required for MSF formation and/or the MSF to sarcomere transition. We first 
localized the two major paralogs of NMII in humans, NMIIA and NMIIB, in spread hiCMs 
(Vicente-Manzanares et al., 2009b). Both NMIIA and NMIIB localize to actin arcs in non-
muscle cells (Kolega, 1998). Consistent with this, both NMIIA and NMIIB localized to 
MSFs, and were restricted from the middle of the cell where sarcomeres were localized 
(Figure 3-7). Indeed, time-lapse microscopy revealed NMIIA filaments formed at the 
edge of hiCMs and underwent retrograde flow as in non-muscle cells (Figure 3-7). 
However, NMIIA remained at the edge of hiCMs and was restricted from the cell body 
where sarcomeres are formed (Figure 3-7). The vast majority of NMIIA and NMIIB 
filaments overlapped, except at the very leading edge where NMIIA is localized slightly 
ahead of NMIIB in hiCMs (Figure 3-7). Super-resolution microscopy revealed that most 
NMII filaments contained NMIIA and NMIIB (Figure 3-7). NMIIA and NMIIB co-filaments 
have previously been reported in non-muscle cells (Beach et al., 2014; Shutova et al., 
2014). Muscle thick filaments have also been shown to contain multiple myosin isoforms 
in nematodes (Miller, DM., 1983). Measurements of the lengths of NMII co-filaments in 
hiCMs showed lengths agreeing with previously published measurements in non-
muscle cells (Figure 3-7) (Beach et al., 2014; Shutova et al., 2014). Taken together, 
these data suggest NMII organization and dynamics appear similar in MSFs of hiCMs 
as in actin arcs of non-muscle cells.  
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Figure 3-7: NMII Localization and Dynamics in hiCMs 
(A) hiCM localized for both endogenous NMIIA (left) and NMIIB (right) and imaged with 
SIM. Both NMIIA and NMIIB localize to MSFs at the leading edge of hiCMs. (B) Line 
scans starting from edge of hiCMs showing localization of NMIIA (black) and NMIIB (red). 
Note NMIIA is localized slightly, ~1 µm in front of NMIIB. NMIIA: 15 cells, 2 experiments; 
NMIIB: 32 cells, 4 experiments. (C) Color projection of time-lapse of hiCM expressing 
NMIIA-mEmerald and imaged with laser-scanning confocal. Note how NMIIA-mEmerald 
remains at the edge of hiCMs. (D) hiCM transfected with NMIIA-mEmerald (N-terminal 
motors), stained for endogenous NMIIB C-terminal rod domain (cartoon schematic and 
middle left), and imaged with SIM. High-mag views of NMIIA-NMIIB co-filaments (right) 
from yellow box 4D (middle left). High mag view of single NMIIA-NMIIB co-filament 
(bottom) and line scan across white dotted line, from N-terminal motors (purple) and C-
terminal rod domains (green). (E) Quantification of NMII co-filament length. Histogram 
displays the distribution of NMII co-filament lengths (motor-domain to motor-domain). 
Scale Bars; (A), (C), (D, top), 10 µm, (D, bottom), 200 nm. 
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Given the presence of both NMIIA and NMIIB in each filament within MSFs, we 
next asked whether NMIIA and/or NMIIB were required for sarcomere assembly. NMIIA 
has previously been shown to be required for actin arc assembly in non-muscle cells 
(Figure 3-S6) (Burnette et al., 2014a; Fenix et al., 2016). Thus, we hypothesized that 
NMIIA would likely be the key paralog required for MSF formation and subsequent 
sarcomere assembly. Surprisingly, KD of NMIIA did not result in a complete inhibition of 
MSF or sarcomere assembly, although the sarcomeres in NMIIA KD hiCMs were 
disorganized (Figures 3-8 and Figures 3-S7 and 3-S8). Notably, NMIIA KD hiCMs 
displayed a similar distribution of distances between α-actinin 2 structures compared to 
control hiCMs (Figure 3-8). This measurement shows that though there are fewer and 
more disorganized sarcomeres in the NMIIA KD, their widths as measured from Z-line 
to Z-line are similar to control hiCMs. However, NMIIA KD cells had significantly shorter 
Z-lines compared to control hiCMs (Figure 3-8). Taken together, this data suggests 
NMIIA is involved in sarcomere assembly and organization. 
It has previously been shown NMIIB is not required for actin arc formation in non-
muscle cells (Kuragano et al., 2018; Shutova et al., 2017) (Figure 3-S6). We hypothesized 
that NMIIB would not be required for MSFs or sarcomere assembly in hiCMs. Surprisingly, 
NMIIB KD resulted in a complete inability of hiCMs to form sarcomeres after plating 
(Figures 3-8 and Figures 3-S7 and 3-S9). In addition, the width between α-actinin 2 
structures was significantly smaller than control hiCMs (Figure 3-8).   These results argue 
NMIIB is also a major player required for sarcomere assembly in hiCMs. To further 
confirm that myosin II is required for sarcomere assembly, we then pharmacologically 
inhibited all myosin II paralogs in hiCMs with blebbistatin (Straight et al., 2003). hiCMs 
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spreading in the presence of blebbistatin were unable to assemble sarcomere structures 
(Figure 3-S10). While these defects in sarcomere assembly were dramatic, we noticed 
that hiCMs treated with siRNA against NMIIA or NMIIB were still beating before re-plating. 
This implied that the pre-existing sarcomeres of the hiCMs were still intact after KD but 
before plating. Therefore, we immuno-localized α-actinin 2 to visualize sarcomeres in 
hiCMs before plating. Surprisingly, we found there were no differences between control, 
NMIIA, and NMIIB KD cells before plating (Figures 3-8 and 3-S11) Collectively, this data 
would suggest NMIIA and NMIIB are required for de novo sarcomere formation, but not 
homeostasis (i.e., turnover) of pre-existing sarcomeres.  
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Figure 3-8: NMIIA and NMIIB are Required for Sarcomere Assembly in hiCMs 
(A) Actin of representative scramble control (top), NMIIA KD (siRNA MYH9, middle), and 
NMIIB KD (siRNA MYH10, bottom) hiCMs allowed to spread for 24 hours and imaged 
with SIM. NMIIA KD hiCMs (middle) display disorganized sarcomeres, while NMIIB KD 
hiCMs (bottom) display no actin-based sarcomeres. (B) Representative western blots of 
2 separate experiments showing knockdown of NMIIA (siRNA MYH9, top) and NMIIB 
(siRNA MYH10, bottom). (C) Percentage of scramble control, NMIIA KD (siRNA MYH9), 
and NMIIB KD (siRNA MYH10) hiCMs with actin based sarcomeres at 24 hours spread. 
Control: 49 cells, 6 experiments; NMIIA KD: 34 cells, 3 experiments; NMIIB KD: 59 cells, 
4 experiments. (D) Histogram of distribution of α-actinin 2 structures in scramble control, 
NMIIA KD (siMYH9) and NMIIB KD (siMYH10) hiCMs. siScrambled: 554 measurements, 
14 cells, 3 experiments; siMYH9: 332 measurements, 15 cells, 3 experiments; siMYH10: 
772 measurements, 15 cells, 3 experiments. (E) Quantification of Z-line lengths in 
scramble control and NMIIA KD (siMYH9) hiCMs. Control: 22 cells, 4 experiments; NMIIA: 
14 cells, 3 experiments. (F) Quantification of hiCMs with sarcomeres in scramble control, 
NMIIA KD (siMYH9), and NMIIB KD (siMYH10) hiCMs before re-plating. siScrambled: 
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772 cells, 4 experiments; siMYH9: 642 cells, 2 experiments; siMYH10: 385 cells, 2 
experiments. Scale bar; (A) 10 µm. P-values denoted in graphs. 
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We next sought to test whether NMIIA and NMIIB are required for sarcomere 
assembly in vivo. We utilized an in vivo model in which rapid KD of NMIIA and NMIIB 
could be achieved before sarcomere assembly has begun. In zebrafish, rapid KD of 
NMIIA and NMIIB can be achieved via morpholino (MO) injection before heart formation 
with little genetic compensation as seen in KD animals (Gutzman et al., 2015; Rossi et 
al., 2015). Therefore, single cell zebrafish embryos were injected with standard control 
MO, myh9b MO directed against NMIIA, or myh10 MO directed against NMIIB, each in 
conjunction with a p53 MO as previously described (Gutzman et al., 2015). Embryos 
were fixed 48 hours post-fertilization, a developmental time point when the heart has 
formed and is beating. Animals in all MO injection conditions formed 2-chambered 
hearts (Figure 3-9). Myh9b MO and myh10 MO injections resulted in a significant 
decrease in NMIIA and NMIIB protein levels, respectively (Figures 3-9 and 3-S12).  
Both NMIIA KD and NMIIB KD animals had a significant decrease in the number of 
sarcomeres formed compared to control animals (Figure 3-9). In addition, sarcomeres 
that did form were significantly smaller in both NMIIA and NMIIB KD animals compared 
to control animals as assessed by Z-line lengths (Figure 3-9), and similarly, the few 
myofibrils that did form contained fewer sarcomeres compared to control animals 
(Figure 3-9). Taken together, our data show that NMIIA and NMIIB are required for 
sarcomere assembly in zebrafish, which is largely consistent with our in vitro data with 
hiCMs. 
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Figure 3-9: NMIIA and NMIIB are required for Sarcomere Assembly in Zebrafish 
(A) Actin of Ventricles of control MO, NMIIA KD (myh9b MO), and NMIIB KD (myh10 MO) 
injected zebrafish embryos fixed at 48 hours post fertilization (hpf) (top) and imaged with 
laser-scanning confocal. Enlarged boxes from yellow boxes show myofibrils with 
sarcomeric pattern in control, which is lacking in NMIIA KD and NMIIB KD zebrafish. (B) 
Representative western blots showing KD of NMIIA (top), NMIIB (middle), and loading 
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control (bottom). (C) Quantification of number of sarcomeres in control MO, NMIIA KD 
(myh9b MO), and NMIIB KD (myh10 MO) treated zebrafish embryos at 48 hpf. (D) 
Quantification of the length of Z-lines in control MO, NMIIA KD (myh9b MO), and NMIIB 
KD (myh10 MO). (E) Quantification of the average of the number of sarcomeres in a given 
myofibril in control MO, NMIIA KD (myh9 MO), and NMIIB KD (myh10 MO). For (C), (D), 
and (E); Control MO: 15 animals, 3 experiments; myh9b MO: 16 animals, 3 experiments; 
myh10 MO: 17 animals, 3 experiments. Scale Bars, (A), 10 µm. P-values denoted in 
graphs. 
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Discussion 
 
The goal of this study was to address a decades-old question concerning the origin 
of sarcomeres assembling in cardiomyocytes. A number of labs have proposed 
sarcomeres arise from a stress fiber-like precursor, while others propose models where 
separate sarcomere components sequentially stitch together to form sarcomeres (Holtzer 
et al., 1997; Lin et al., 1994; Lu et al., 1992; Rhee et al., 1994; Rui et al., 2010; Sanger et 
al., 2005). Based on previous actin filament staining and NMII localization to these stress 
fibers, our initial hypothesis was that the mechanisms underlying actin filament 
polymerization and organization would be related to those governing the non-muscle 
stress fibers known as actin arcs (see model in Figure 3-S13). In support of this 
hypothesis, both previous reports in non-human cardiomyocytes and our own work with 
hiCMs show that the actin organization of these precursors appears identical to actin arcs 
(Heath, 1983; Rhee et al., 1994; Sanger et al., 2005; Tojkander et al., 2012). Indeed, both 
MSFs and actin arcs contain NMII, stain continuously with phalloidin, are on the dorsal 
surface of the cell, and display retrograde flow by which they move away from the cell’s 
edge (Figure 3-S13). However, our study also revealed distinct differences between the 
regulation and dynamics of MSFs and actin arcs. 
It has been well established that the actin filaments of actin arcs require both 
nucleation mediated by the Arp2/3 complex and formins (Henson et al., 2015; Hotulainen 
and Lappalainen, 2006; Murugesan et al., 2016). Our data would suggest the Arp2/3 is 
not formally required for MSF or sarcomere assembly. However, the Arp2/3 is at the edge 
of hiCMs, and future work will be needed to elucidate its role in cardiac biology. In contrast 
to the Arp2/3 complex, our data suggests that formins are required for MSFs and 
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sarcomere assembly. Specifically, we found the formin FHOD3 has a major role in MSF 
and sarcomere assembly (Figure 3-S13). This adds to the already established role of 
FHOD3 in sarcomere homeostasis (i.e., turn-over) (Iskratsch et al., 2010; Kan et al., 2012; 
Taniguchi et al., 2009). While FHOD3 KD displayed the most severe phenotype, KD of 
DAAM1 and DIAPH1 in hiCMs resulted in both sarcomeric and non-sarcomeric defects 
in actin architecture. This agrees with previous literature showing roles for multiple 
formins in explanted mouse cardiomyocytes in maintenance of sarcomere structure 
(Rosado et al., 2014). The diverse roles of formins during sarcomere assembly and 
subsequent maintenance should be explored in future work. In addition, we show that 
NMIIA and NMIIB are required for proper sarcomere assembly both in our hiCM model 
and during heart development in zebrafish.  
Collectively, our data provide new mechanistic and dynamic insight surrounding 
sarcomere assembly, and highlights key differences between classic, well-studied non-
muscle stress fibers, and MSFs in cardiac myocytes (Figure 3-S13). In addition, our 
model unifies certain aspects of previously proposed models of sarcomere assembly 
(Figure 3-S13). These previously proposed models, while presented as mutually 
exclusive from one another, are actually quite similar in certain respects. Highlighting this, 
our data supports a major feature shared between the Template Model and Pre-Myofibril 
Model. Specifically, that stress fibers are precursors to sarcomere containing myofibrils 
rise to sarcomeres. These stress fibers were originally called “stress fiber-like structures” 
when the Template Model was proposed (Dlugosz et al., 1984; Sanger et al., 2005). Later, 
they were renamed to Pre-Myofibrils in lieu of more thorough characterization (Rhee et 
al., 1994; Sanger et al., 2005). It was shown these stress fibers did not contain the same 
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proteins as non-muscle stress fibers (Rhee et al., 1994). However, most of the known 
proteins in stress fibers found in cardiomyocytes have paralogs in non-muscle stress 
fibers. We find non-muscle-like stress fiber is an apt description. Therefore, we find calling 
these structures stress fibers as acceptable. In this study, we are comparing regulatory 
mechanisms of the non-muscle stress fiber referred to as actin arcs, to sarcomere 
precursors in cardiac myocytes. Thus, we decided to call them Muscle Stress Fibers 
(MSFs) to avoid confusion.  
Our data supports the concept that MSFs transition into sarcomere-containing 
myofibrils over time. This is the way the cartoon models of both the Template and Pre-
Myofibril Models are presented (see original models (Dlugosz et al., 1984; Rhee et al., 
1994)). An open question remains as to whether there is true templating during this 
process. The original Template Model posited that “stress fiber-like structures” [MSFs] 
would disappear after they were used as a template to build a myofibril (Dlugosz et al., 
1984). While some components of MSFs (e.g., -actinin 2) do appear to persist during 
the MSF to sarcomere transition, others clearly do not (e.g.,NMIIA/B). In addition to the 
Templating/Pre-myofibril Models, our data also supports aspects of the Stitching Model. 
The Stitching Model originally proposed that pre-assembled components of the 
sarcomere (i.e., A-bands and I-Z-I bodies) would stitch together sequentially to form a 
myofibril (Holtzer et al., 1997). We did not detect pre-formed I-Z-I bodies or A-bands in 
our assay (Figure 3-S1) or sequential assembly of sarcomeres to form a myofibril (Figure 
3-1).  
Our data shows the transition of a MSF to a sarcomere-containing myofibril occurs 
on the dorsal (top) surface of the cell. However, a recent study also imaging iPSC derived 
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cardiac myocytes claims that sarcomeres are formed on the ventral (bottom) surface of 
the cell near extracellular matrix adhesions (Chopra et al., 2018). This group also report 
that the first sarcomeres forms between 24-48 hours after plating, well after we detect the 
first sarcomere appearing (Chopra et al., 2018). This led us to question what could be 
leading to these two seemingly opposite results. Importantly, it appears that this group 
was imaged the ventral (bottom) surface of their myocytes. Close inspection of their time-
lapse movies revealed faint structures corresponding to sarcomeric pattern that show up 
in the frame right before the appearance of sarcomeres. This supports the notion that 
they are imaging sarcomeres that are coming into focus, and not assembling “de novo”. 
To test this idea, we imaged hiCMs with 3D confocal microscopy after they had been 
plated for 24 hrs (Figure 3-S14). While we also see similar patterns of sarcomeres 
appearing on the ventral surface as (Chopra et al., 2018), our data revealed these 
sarcomeres are moving down from the dorsal surface and not assembling on the ventral 
surface (Figure 3-S17). Of interest, the phenomenon of actin arcs moving down to the 
ventral surface of non-muscle cells has also been reported previously (Gao et al., 2012; 
Hotulainen and Lappalainen, 2006). Finally, (Chopra et al., 2018) also claim that neither 
NMIIA nor NMIIB are required for sarcomere assembly. We also find this strange. While 
their double NMIIA/NMIIB knockout (KO) cardiomyocyte cell line has α-actinin 2 positive 
structures, they do not contain continuous labeled Z-lines aligned parallel to each other 
comparable to the control cell line. The authors did not measure Z-line lengths, spacing, 
or other criteria needed to define sarcomeres. These discrepancies between our study 
and theirs, including the role of NMII, need to be harmonized, as it will directly affect our 
interpretation of future in vivo data concerning sarcomere assembly. 
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Data from in vivo studies attempting to answer the question of NMII contribution to 
sarcomere assembly in mice have been difficult to interpret (Sparrow and Schock, 2009). 
Germline NMIIA KO mice fail to gastrulate and thus sarcomere assembly is impossible to 
examine (Conti et al., 2004). A conditional NMIIA KO mouse was generated using a 
promoter which is activated after heart formation has begun, and no heart defects were 
noted (Conti et al., 2015). A germline NMIIB KO mouse formed a functional heart, though 
most pups died before birth due to heart failure (Tullio et al., 1997). Only one high 
magnification image of the KO animal was shown, which demonstrated severe sarcomere 
disorganization (Tullio et al., 1997). Of interest, the NMIIB KO animals also showed highly 
increased NMIIA protein levels compared to controls (Tullio et al., 1997). Thus, the 
observed capacity of this animal to form sarcomere like structures could be due to genetic 
compensation by NMIIA. A conditional KO NMIIB mouse has also been made (Ma et al., 
2009). While the authors showed an impressive NMIIB KD in the cerebellum via a 
neuronal specific driver, there were high levels of NMIIB protein in the heart at the time 
of analysis in the heart specific KO (Ma et al., 2009).  In addition, the heart specific 
conditional KO is driven off of the alpha myosin heavy chain promoter, which switches on 
after sarcomere assembly has begun and indeed after the heart fields have begun to beat 
(Ma et al., 2009; Ng et al., 1991). Complicating the issue further, NMIIB has been difficult 
to localize in tissue. We believe this to be a result of paraffin embedding and subsequent 
paraffin removal and rehydration protocols. For example, we successfully localized NMIIB 
in formalin fixed human and mouse tissue (Figures 3-10 and 3-S15), but failed to localize 
NMIIB in paraffin embedded tissue.   
123 
 
Future comparisons between in vivo and in vitro data sets will need to be 
addressed. Intriguing and unanswered questions also remain to be tested. For example, 
how are the observed gradients of NMII and βCMII in cardiac myocytes established and 
maintained? Such questions have been previously difficult to impossible to test due 
complicated and technically challenging model systems. Importantly, we present a 
relatively easy to use model system to test these questions. The hiCMs we use in this 
study are commercially available for purchase. Our Methods outline protocols to transfect 
with DNA for protein expression and siRNA for protein knockdown, and trypsinization 
protocols for re-plating. Going forward, we believe studies using the experimental setup 
we describe here will not only clarify previous models but also reveal new insights into 
both sarcomere assembly, and cardiac cell biology. 
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Supplemental figures 
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Figure 3-S1: hiCMs don’t contain sarcomeres at early time points post plating 
(A) hiCM stained for actin and βCMII and imaged with SIM at 1.5 hours (top) and 24 
hours (bottom) following trypsinization. (B) hiCM stained for actin and α-actinin 2 and 
imaged with SIM at 1.5 hours (top) and 24 hours (bottom) following trypsinization. (C) 
hiCM stained for actin and TroponinT and imaged with SIM at 1.5 hours (top) and 24 
hours (bottom) following trypsinization. Note how hiCMs at 1.5 hours contain Muscle 
Stress Fibers (MSFs), but contain neither actin nor βCMII based sarcomeres. hiCMs at 
24 hours however contain prominent sarcomere structures. Scale bars, 5 µm. 
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Figure 3-S2: SIM of NMIIA and α-actinin 2 localizations in hiCM 
NMIIA localizes to MSFs but is excluded from sarcomeres (see Figure 3-7). NMIIA is 
found between small α-actinin 2 puncta in MSFs at edge of hiCM (alternating green and 
magenta in right image), and is excluded from large α-actinin 2 Z-lines in hiCM body. 
Scale Bar: 10 μm. 
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Figure 3-S3: hiCM spreading in the presence of 25 µM SMIFH2 
Spinning-disk confocal microscopy of hiCM expressing Lifeact-mApple and spreading in 
the presence of 25 µM SMIFH2 (added 1.5 hours post plating). Note sarcomeres do not 
form in the presence of 25 µM SMIFH2. Scale Bar; 20 µm. 
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Figure 3-S4: hiCMs assemble sarcomeres following washout of SMIFH2 
Examples of two hiCMs containing MSFs and sarcomeres following washout of 25 µM 
SMIFH2 and imaged with SIM. hiCMs were spread in 25 µM SMIFH2 (as in Figure 3-6) 
for 24hrs, and fresh media without drug was exchanged. hiCMs were subsequently 
allowed to spread for an additional 24 hours before fixation. Scale Bar; 10 µm. 
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Figure 3-S5: hiCMs assemble sarcomeres following knockdown (KD) of DAAM1 
and DIAPH1 
(A) siRNA DAAM1 hiCM spread for 24 hours stained for actin, and imaged with SIM 
(left). DAAM1 KD hiCMs still assemble sarcomeres, and have extended lamellipodia. 
Representative western blot showing KD of DAAM1 protein (right). (B) siRNA DIAPH1 
hiCM spread for 24 hours, stained for actin and imaged with SIM (left). DIAPH1 KD 
hiCMs appear to have fewer sarcomeres than scramble control hiCMs, but still 
assemble sarcomeres. Representative western blot showing KD of DIAPH1 protein 
(right). Scale Bars; (A), (B), 10 µm.  
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Figure 3-S6: NMIIA but not NMIIB is required for actin arc formation in HeLa cells. 
(A) HeLa cells treated with control, anti myh10, or anti myh9 (top, middle, bottom, 
respectively) siRNA, stained for actin, and imaged with SIM. Note how control and 
NMIIB KD cells display prominent actin arc stress fibers, but NMIIA KD cells contain no 
actin arcs. (B) Quantification of HeLa cells with actin arc stress fibers in indicated 
conditions. Scale Bars: 5 µm. 
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Figure 3-S7: Knockdown of NMIIA and NMIIB in hiCMs 
(A) Quantification from western blots showing KD of NMIIA (siMYH9) and NMIIB 
(siMYH10) in hiCMs compared to scramble control. N = 3 for each condition. (B) 
Quantification of NMIIB levels in siMYH9 hiCMs (left) and NMIIA levels in siMYH10 
hiCMs (right) compared to scramble control. N = 3 for each condition. 
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Figure 3-S8: Live montage of spreading NMIIA KD hiCM 
Laser-scanning confocal of spreading NMIIA KD hiCM expressing Lifeact-mApple. 
NMIIA KD hiCM is able to assemble sarcomere structures. Scale Bar; 10 µm. 
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Figure 3-S9: Live montage of spreading NMIIB KD hiCM 
Laser-scanning confocal of spreading NMIIB KD hiCM expressing Lifeact-mApple. 
NMIIB KD hiCM does not form sarcomeres. Scale Bar; 20 µm. 
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Figure 3-S10: Live montage of hiCM spreading in 100 µM blebbistatin 
Laser-scanning confocal of hiCM spreading in the presence of 100 µM blebbistatin 
added 1.5 hrs post plating. hiCM does not assemble sarcomeres in the presence of 100 
µM blebbistatin. Scale Bar; 20 µm. 
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Figure 3-S11: NMIIA KD and NMIIB KD hiCMs contain sarcomeres before plating 
138 
 
(A) siScrambled (top) siMYH9 (NMIIA KD, middle), and siMYH10 (NMIIB KD, bottom) 
hiCMs treated in 96 well plates, fixed, and localized for α-actinin 2 imaged with wide-
field microscopy. hiCMs were allowed to attach for 4 days (as per manufacturer’s 
recommendation, see Methods), ensuring robust sarcomere assembly before siRNA 
treatment began. Note all conditions contain sarcomeric staining of α-actinin 2. Look up 
table is mpl-magma in (Fiji is Just) ImageJ. 
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Figure 3-S12: Knockdown of NMIIA and NMIIB in Zebrafish 
(A) Quantification from western blots of NMIIA protein levels in indicated condition 
compared to control MO. N = 3 for each condition. (B) Quantification of NMIIB levels in 
indicated condition compared to control MO. N = 3 for each condition. 
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Figure 3-S13: Model of actomyosin stress fiber formation in non-muscle cells and 
human cardiomyocytes 
(A) Actin and myosin II stress fiber formation in non-muscle cells. Actin stress fibers are 
formed via the Arp2/3 complex and the formin mDia1. NMIIA is the predominant isoform 
at the leading edge of non-muscle cells, and stress fiber formation is NMIIA dependent. 
Non-muscle cells display robust retrograde flow of actin stress fibers and display rapid 
turnover. Large NMIIA stacks are formed via growth and expansion of smaller NMIIA 
filaments. Citations leading to this model are presented in the cartoon. (B) Model of 
actin-based stress fiber formation in human cardiomyocytes. Sarcomeres are templated 
by Muscle Stress Fibers (MSFs). MSFs do not require the Arp2/3 complex, and require 
the formin FHOD3. MSFs display slow retrograde flow compared with non-muscle 
stress fibers. Both NMIIA and NMIIB are localized to the edge of hiCMs, and display 
prominent NMII co-filaments. 
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Figure 3-S14: Sarcomeres form on dorsal surface of hiCMs and subsequently 
move towards ventral surface 
(A) hiCM expressing α-actinin 2-mCherry plated for 24 hours and imaged with laser-
scanning confocal. Note that when viewing the ventral (bottom) surface (left image), no 
sarcomeric pattern of α-actinin 2 can be seen. However, when viewing the dorsal (top) 
surface of the cell (right image), sarcomeres are clearly present. (B) Time montage from 
yellow box in (A). Myofibril from top of the cell (right montage, yellow arrow) moves 
towards the bottom of the cell (left image, yellow arrow). Arrow head (left montage) 
denotes α-actinin 2 containing adhesion. 
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Figure 3-S15: NMIIB localization in vivo 
Localization of NMIIB and actin in tissue slice from heart ventricle of P3 mouse and 
imaged with laser-scanning confocal. Green arrows denote strong localization of NMIIB 
outside of but adjacent to sarcomere structures as in hiCMs (Figures 7A and 10A). 
Scale Bar: 10 µm. 
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Introduction 
 Our work in sarcomere assembly thus far has focused on the actin cytoskeleton 
within cardiac myocytes (Chapter III). However, beta cardiac myosin II (βCMII) filaments 
also represent a major structural and functional protein within cardiac myocytes. βCMII 
filaments bind to and pull on actin filaments to generate force within cardiac myocytes, a 
process referred to as “sarcomere shortening”. On a structural level, we know βCMII 
filaments form large βCMII filament stacks which make up the core of the sarcomere 
(FIGURE 3-1). This structure is referred to as the A-band. Despite a wealth of structural 
and functional data surrounding βCMII filaments, how an organized stack of βCMII 
filaments (i.e., the A-band) is dynamically assembled is unknown. This information is 
crucial, as mutations in βCMII are the leading cause of inherited hypertrophic 
cardiomyopathies (HCM). A more thorough understanding of βCMII filament dynamics 
during sarcomere assembly would allow for a better understanding of how HCM causing 
mutations are affecting sarcomere assembly and function. Thus, we sought to utilize our 
sarcomere assembly assay (presented in Chapter III), and build upon previous work 
investigating how a similar myosin, non-muscle myosin IIA (NMIIA, presented in 
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Chapter II), to investigate how βCMII filament stacks are assembled in human cardiac 
myocytes. 
Results 
 
NMII and FHOD3 are required for organized A-band formation 
Thus far, our results highlight the importance of formin-mediated actin 
polymerization and NMII for proper actin filament architecture during sarcomere assembly 
(Chapter III). We next wanted to address how the thick, β Cardiac Myosin II (βCMII) 
filaments at the core of the sarcomere (i.e., A-band, Figure 3-1) assemble. Therefore, we 
started by localizing endogenous βCMII and NMIIB filaments (Figure 4-1). βCMII 
predominately localized behind NMIIB in organized sarcomere structures and showed a 
peak localization ~15 microns behind the leading edge of the cell, with a slight area of 
overlap with NMIIB (Figure 4-1). We noted that the area of overlap contained NMIIB-
βCMII co-filaments (Figure 4-1 and 4-S1). In addition, we also found NMIIA-βCMII co-
filaments in hiCMs (Figure 4-S2). To our knowledge, this is the first time a myosin II 
species has been reported that contains a non-muscle and muscle paralog inside cells. 
Furthermore, we also found NMIIB-βCMII co-filaments in mouse and human heart tissue, 
indicating NMIIB-βCMII co-filaments are present in vivo (Figures 4-1 and 4-S1). The co-
filaments containing NMIIB and βCMII were of similar length to NMIIA/B filaments (Figure 
4-1). Indeed, we noticed that near the leading edge of the cell, βCMII filaments are 
typically smaller and not organized into stacks resembling A-bands (Figure 4-1). This 
suggests βCMII filaments are polymerized at the edge and subsequently grow larger as 
they move away from the leading edge (Figure 4-1). The presence of NMII before βCMII 
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filaments grow into larger filaments led us to test the hypothesis that NMII would play a 
role in βCMII filament formation. 
To test if NMII was also required for βCMII filament and A-band formation, we 
depleted hiCMs of NMIIB and localized βCMII 24 hours after plating. Compared to control 
hiCMs, NMIIB KD hiCMs displayed a significant decrease in the ability to form A-band-
like structures and a reduced overall number of βCMII filaments (Figure 4-1). Although 
βCMII filaments formed, they were highly disorganized compared to control cells, as 
assessed by Fourier transform (Pasqualini et al., 2015) (Figure 4-1). As NMIIB KD results 
in highly disorganized actin filament architecture, we asked if βCMII was using residual 
actin filaments as a template to polymerize.  
To test if actin was serving as a template for βCMII filament formation, we sought 
to remove all the actin filaments in hiCMs. To do so, we allowed hiCMs to form 
sarcomeres for 18 hours, then treated hiCMs with the actin monomer sequestration agent 
Latrunculin B for 6 hours in order to disassemble actin filaments acutely before fixation 
(Spector et al., 1983; Wakatsuki et al., 2001). Latrunculin B-treated hiCMs showed a lack 
of actin-based sarcomeres, and no βCMII filament stacks, but conspicuous βCMII 
filament aggregates (Figure 4-1). These results argue that actin filaments are required for 
the organization of CMII filaments of the A-band. As both FHOD3 and NMIIA KDs also 
resulted in disorganized actin filament architecture, we localized βCMII in these 
conditions. Both conditions also resulted in disorganized βCMII filaments compared to 
control hiCMs (Figure 4-S3).  
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Figure 4-1: β Cardiac Myosin II (βCMII) Filament Assembly in hiCMs 
(A) Endogenous localization of NMIIB (left) and βCMII in the same hiCM and imaged with 
SIM. (B) Averaged line-scans of NMIIB (Figure 3-7 and βCMII localization in hiCMs 
spread for 24 hours. Note the peak fluorescence of βCMII is more towards the cell body 
than peak fluorescence of NMIIB. 23 cells from 4 experiments were used for βCMII 
localization. (C) Schematic (top) of NMIIB-βCMII co-filaments in hiCMs. High-mag views 
of βCMII-NMIIB co-filaments in hiCMs (left) imaged with SIM. Endogenous staining of 
hiCM (bottom, left) for βCMII (N-terminal motors) and NMIIB (rod domain). Mouse and 
human tissue (bottom middle, and bottom right, respectively) stained for βCMII (motors) 
and NMIIB (rod domain) and imaged using Zeiss 880 with Airyscan. (D) Histograms 
displaying width of NMII filaments (top), βCMII filaments (middle), and NMIIB-βCMII co-
filaments in hiCMs. Measurements made from motor-domain to motor domain as in 
Figure 3-7. (E) Histograms displaying distribution of βCMII filaments widths with respect 
to their location in hiCMs. Note βCMII filaments tend to grow larger as they move towards 
the center of the cell. Measurements were not taken from “mature” sarcomere structures 
in highly organized A-bands. (F) Actin and βCMII of scramble control hiCM (top) and 
NMIIB KD (siMYH10) hiCM (bottom) spread for 24 hours. Note loss of organized A-bands 
but presence of βCMII filaments in NMIIB KD hiCM. (G) Fourier transforms of βCMII signal 
from white boxes in Figure 4-1 from scramble control and NMIIB KD hiCMs (above and 
below respectively). Yellow arrows indicate sarcomeric periodicity in scramble control 
hiCMs, which is lacking in NMIIB KD cells. (H) High mag views of actin and βCMII in 
NMIIB KD (siRNA MYH10) hiCM imaged with SIM. βCMII filaments localize to residual 
actin filaments. (I) βCMII in hiCM spread for total of 24hrs, with final 6 hours in 5 µM 
Latrunculin B and imaged with SIM. Notice lack of βCMII A-bands, and large βCMII 
filament aggregates (yellow box). (J) Percentage of scramble control, NMIIB KD (siRNA 
MYH10), and 5 µM Latrunculin B hiCMs with βCMII A-bands. Control: 26 cells, 3 
experiments; NMIIB KD: 26 cells, 2 experiments; Latrunculin B: 11 cells, 3 experiments. 
Scale Bars; (A), (H), (I) 10 µm, (C) 200 nm, (F), (G), 5 µm. P-values denoted in graphs. 
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Dynamics of A-band assembly 
To further investigate the mechanisms of A-band assembly, we created a full 
length, human βCMII construct containing a mEGFP tag on the motor domain (i.e., N-
terminal) (Figure 4-2). This construct properly integrated into both single filaments and 
more mature myofibrils (Figure 4-2). In non-muscle U2OS cells, A-band-like stacks of 
NMIIA filaments are often formed through a process called “Expansion” (Fenix et al., 
2016). During Expansion, NMIIA filaments that are close to each other (i.e., in a tight 
bundle) move away from each other in space but remain part of the same ensemble, 
where they are aligned in a stack similar to muscle myosin II in the A-band. In addition 
to Expansion, NMIIA filaments also, but more rarely, “Concatenated” (Fenix et al., 
2016). Concatenation is defined by spatially separated NMIIA filaments moving towards 
one another to create a stack. To test how βCMII filament stacks form, we repeated our 
live-cell sarcomere formation assay using our βCMII-mEGFP construct. In contrast to 
our previous results with NMIIA, we found the major physical mechanism of βCMII 
filament stack formation to be concatenation, where pre-existing βCMII filaments ran 
into one another and stitched together to form the A-band (Figure 4-2). A small 
percentage of hiCMs showed an expansion event of βCMII-mEGFP, however this was 
significantly less frequent than in non-muscle cells and did not appear to result in a 
more organized A-band (Figure 4-2). Indeed, each of the hiCMs quantified in Figure 1 
showed only 1 expansion event. 
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Figure 4-2: βCMII filaments concatenate to form larger A-band structures  
(A) Cartoon of βCMII filament (left, above). N-terminal tagged human βCMII-mEGFP 
filament expressed in hiCM (left, below). Gap in signal represents bare-zone lacking 
motors (green arrows). βCMII single filament and A-band filament (βCMII filaments found 
within organized A-bands) widths measured by line scans (right). βCMII Filaments: 16 
filaments, 3 experiments. βCMII myofibrils: 28 myofibrils, 3 experiments. Note more level 
“plateau” of signal from motors in A-band βCMII filaments. (B) SIM of representative 
βCMII-mEGFP myofibril in hiCM (top) and laser scanning confocal (bottom). (C) 
Representative montage showing two separate concatenation events. Yellow arrowhead 
denotes a large stack of βCMII-mEGFP filaments concatenating with a smaller stack of 
βCMII-mEGFP filaments as they undergo retrograde flow. Green arrowhead denotes 
smaller βCMII-mEGFP filament concatenating with larger βCMII-mEGFP stack as they 
undergo retrograde flow. Both events result in larger and more organized βCMII-mEGFP 
filament stack (i.e. the A-band). (D) Example of βCMII-mEGFP filament splitting event. 
Note how small βCMII-mEGFP stack splits to create 2 smaller βCMII-mEGFP filaments 
and does not result in larger or more organized βCMII-mEGFP filament stacks. (E) 
Quantification of % of hiCMs which display concatenation or expansion events of βCMII 
filaments. Scale Bars; (A) 200 nm, (B), (C) and (D) 2 µm. P-values denoted in graph. 
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Discussion 
 
This work is in part, inspired by Chapter II, and builds upon the work in Chapter III 
to create a fuller pictures of sarcomere assembly. In addition to showing NMIIA and NMIIB 
were required for sarcomere assembly (Chapter III), we show NMIIA and NMIIB form 
myosin II co-filaments with βCMII. βCMII filaments found in co-filaments were relatively 
small, (~300nm), and subsequently grew larger as they transitioned to the larger filaments 
of the A-band (~1.6 microns), and lost NMII. Furthermore, in support of a Template Model, 
our data suggests that NMIIA/B filaments could be themselves a template for the addition 
of CMII as all three paralogs can be found in co-filaments together in the region where 
NMIIA/B and CMII overlap. A-band assembly was perturbed in FHOD3 KD, NMIIA KD, 
and most strongly in NMIIB KD hiCMs. Complete removal of the actin cytoskeleton 
resulted in a loss of βCMII filaments.  
At the beginning of this work, we expected βCMII filaments to expand to form 
βCMII filament stacks. Previously, we had shown NMIIA expands to form NMIIA stacks 
(Chapter II) Surprisingly, we found individual βCMII filaments (or a small bundle below 
the resolution limit of our imaging modality) concatenate to form the βCMII filament stacks 
of the A-band.  This process requires the presence of actin tracks. This result demands 
certain aspects of βCMII dynamics warrant comparison to the Stitching Model (reviewed 
in Introduction and Chapter III). Though we did not detect I-Z-I-Bodies and myosin II 
filaments stitching together, we found separate βCMII filaments concatenated and 
“stitched” together to form larger βCMII filament stacks (i.e., the A-band) (Figure 3-11). 
Thus, we can add βCMII stack assembly to our model of sarcomere assembly presented 
in Chapter III (Figure 4-S4). 
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Figure 4-S1: Myosin II co-filaments in vivo 
(A) hiCM transfected with βCMII-mEGFP (N-terminal motors), stained for endogenous 
NMIIB rods and imaged with SIM. Schematic depicts visualization strategy. Low mag of 
hiCM left, and high mag examples bottom right. (B) Low mag view of P3 mouse heart 
tissue stained for βCMII (motors) and NMIIB (rods), and imaged with laser-scanning 
confocal. As in hiCMs, NMIIB is restricted from sarcomere structures but is localized 
adjacently to sarcomeres. Arrow indicates area of possible co-filaments. High mag 
example shown at right is taken from P3 mouse tissue imaged on Zeiss 880 with 
AiryScan from similar area indicated by arrow on low mag image. Schematic indicates 
visualization strategy. (C) High mag examples of NMIIA (left) and NMIIB-βCMII (right) 
co-filaments from human hypertrophic cardiomyopathy patients imaged on Zeiss 880 
with AiryScan. Cartoon schematic indicates imaging strategy. Scale bars: (A, left), 10 
μm; (A, right), (B), (C), 200 nm (right). 
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Figure 4-S2: Endogenous localization of NMIIA and βCMII in hiCMs 
(A) SIM of endogenous localization of NMIIA (green) and βCMII (magenta) in hiCM. 
Yellow boxes denote areas of overlap between NMIIA and βCMII. (B) High-mag views 
of NMIIA-βCMII co-filaments taken from yellow boxes in (A). 
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Figure 4-S3: βCMII filament assembly is perturbed in NMIIA and FHOD3 KD hiCMs 
(A) Endogenous βCMII localized in NMIIA KD (siRNA MYH9) hiCMs (left) imaged with 
SIM. Fourier transform (right) of hiCM shows some periodicity of βCMII which is not as 
readily apparent compared to scramble control hiCMs (Figure 10G). (B) Endogenous 
βCMII localized in FHOD3 KD (siRNA FHOD3) hiCM (left) imaged with SIM. Note loss 
of βCMII A-bands. Fourier transforms (right) show loss of sarcomeric periodicity. Scale 
Bars: 10 μms. 
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Figure 4-S4: Model of actomyosin stress fiber formation in non-muscle cells and 
human cardiomyocytes 
(A) Actin and myosin II stress fiber formation in non-muscle cells. Actin stress fibers are 
formed via the Arp2/3 complex and the formin mDia1. NMIIA is the predominant isoform 
at the leading edge of non-muscle cells, and stress fiber formation is NMIIA dependent. 
Non-muscle cells display robust retrograde flow of actin stress fibers and display rapid 
turnover. Large NMIIA stacks are formed via growth and expansion of smaller NMIIA 
filaments. Citations leading to this model are presented in the cartoon. (B) Model of 
actin and myosin II stress fiber formation in human cardiomyocytes. Sarcomeres are 
templated by Muscle Stress Fibers (MSFs). MSFs do not require the Arp2/3 complex, 
and require the formin FHOD3. MSFs display slow retrograde flow compared with non-
muscle stress fibers. Both NMIIA and NMIIB are localized to the edge of hiCMs, and 
display prominent NMII co-filaments. NMIIB-βCMII co-filaments are also present with 
MSFs. Large βCMII filament stacks form via concatenation and stitching of individual 
βCMII filaments. 
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Chapter V 
 
Chapter summaries and future directions 
 
 
 
Chapter II summary 
 
 In Chapter II, we investigated the mechanisms and dynamics of NMIIA stack 
formation in non-muscle cells. We used structured illumination microscopy (SIM) to 
demonstrate a variety of NMIIA filament organizations at the leading edge of crawling 
cells. Live-cell SIM revealed that smaller NMIIA filaments (i.e., a “2-motor group 
filament”) expanded into the larger NMIIA stacks via distinct structural steps. NMIIA 
stack formation could also occur via “concatenation” of distinct NMIIA filaments, though 
this occurred less often, and was not mutually exclusive from expansion. Through a 
series of genetic and pharmacological perturbations, we demonstrated NMIIA filament 
expansion and stack assembly was dependent on NMIIA motor activity and actin 
filament availability. Interestingly, we also demonstrated that the cleavage furrow of 
dividing cells was made up of prominent NMIIA stacks which appeared to assemble via 
similar mechanisms as at the leading edge of crawling cells. We summarized our results 
in a new model of NMIIA stack assembly we called the Expansion Model of NMIIA 
Stack Assembly (Fenix and Burnette, 2018; Fenix et al., 2016). 
 The Expansion Model was in direct contradiction to the major model of NMIIA 
stack assembly, referred to as the Network Contraction Model (Verkhovsky and Borisy, 
1993; Verkhovsky et al., 1999a). This model has been the textbook model of acto-
myosin stress fiber assembly for ~20 years. Our work was subsequently reproduced 
and confirmed in two publications. Though it is possible “network contraction” occurs 
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where myosin II filaments are very dense, our data suggests at the edge of crawling 
cells and the cleavage furrow of dividing cells, Expansion is the major mechanism. We 
believe our model of NMIIA stack assembly now provides a framework for future studies 
to mechanistically parse out the intricate details of NMIIA stack assembly. 
 
Chapter II future directions 
 Our Expansion Model of NMIIA stack assembly now affords an experimental 
framework to elucidate the mechanisms regulating NMIIA stack assembly. While we 
demonstrated that NMIIA motor activity and actin filament availability were important for 
stack assembly, this is only the tip of the iceberg as far as mechanisms regulating 
NMIIIA stack assembly are concerned. There are likely inherent modes of regulation 
(i.e., upon NMIIA itself), and mechanisms acting through the action of actin binding 
proteins which could affect NMIIA stack assembly.  
 NMIIA contains numerous phosphorylation sites along both its heavy chain, and 
light chains (Vicente-Manzanares et al., 2009b). A recent publication demonstrated these 
phosphorylation sites are critical for the proper localization of NMIIA and NMIIB in 
crawling cells (Juanes-Garcia et al., 2015). It is highly likely these phosphorylation sites 
are involved in NMIIA stack formation, and are prime targets for future work. In addition, 
NMIIA has been shown to form co-filaments with NMIIB and another myosin, myosin 18 
(Billington et al., 2015). It is possible that different filament organizations and 
compositions promote or inhibit stack assembly.  
 In addition to inherent NMII regulation, actin binding and actin nucleating factors 
likely affect NMII stack assembly. Indeed, we should inhibiting plus end actin 
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polymerization reduced NMIIA stack assembly (Chapter II). The most obvious candidates 
are proteins involved in organizing the actin arc stress fibers NMIIA stacks assemble 
upon. These include the Arp2/3 complex, formins such as dia1/2, tropomyosin IV, and α-
actinin 1/4. These proteins have been shown to disrupt actin arc formation and dynamics, 
but how they affect NMIIA filament assemblies is unknown (Hotulainen and Lappalainen, 
2006; Murugesan et al., 2016; Tojkander et al., 2012; Tojkander et al., 2011). Inhibiting 
or depleting cells of these proteins and investigating both actin architecture and the ability 
of cells to assemble NMIIA stacks will be fascinating. This is especially important as 
recent work has suggested increased acto-myosin II based forced generation is critical 
for cancer metastasis (Derycke et al., 2011; Lopez et al., 2011; Maeda et al., 2008; 
Paszek et al., 2005; Samuel et al., 2011). An understanding of how cells build the 
contractile machinery required for metastasis could reveal novel therapeutic targets.   
 Recent work is revealing the presence of NMII stacks in a variety of cellular 
contexts (Ebrahim et al., 2013). In these diverse processes, it will be interesting to 
establish whether Expansion, Network Contraction, or different mechanisms of NMIIA 
stack assembly is occurring. Future work will determine how well conserved these 
processes are in different cellular contexts, and with respect to other myosin II paralogs, 
such as NMIIB. Indeed, this question initially inspired aspects of the work presented in 
Chapters III and IV. 
 
Chapters III and IV summaries  
 In Chapter III of this work, we investigated the mechanisms leading to sarcomere 
assembly in human iPSC-derived cardiac myocytes (hiCMs), with an emphasis on the 
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actin cytoskeleton. To carry out this work, we developed a model system amenable to 
live-cell imaging and robust quantification of experimental perturbations. Using this 
system, we described a population of acto-myosin stress fibers in hiCMs we refer to as 
Muscle Stress Fibers (MSFs). MSFs were structurally similar to actin arcs in non-muscle 
cells, but displayed significantly slower retrograde flow. Live-cell imaging revealed 
sarcomeres were directly assembled via a MSF template. This transition from MSF to 
sarcomeres occurred on the dorsal (top) surface of cell. MSF assembly and subsequent 
transition to sarcomeres was dependent on formins, and specifically the formin FHOD3. 
Though the Arp2/3 complex has been shown to be required for actin arc assembly, it 
was not required for MSF or sarcomere assembly. Both NMIIA and NMIIB were required 
for sarcomere assembly in hiCMs and Zebrafish, though NMIIB showed the more 
dramatic phenotype in hiCMs. These results demonstrated sarcomeres are assembled 
via a template (MSF) structure, and the template – though structurally similar – is 
regulated differently than actin arcs in non-muscle cells. 
 In Chapter IV of this work, we investigated the mechanisms leading to β cardiac 
myosin II (βCMII) filaments stack assembly (i.e., the A-band) in hiCMs. This work was in 
part inspired and guided by experiments conducted in Chapter II, showing how large, 
structurally similar NMIIA filament stacks assembled in non-muscle cells. We 
demonstrated NMIIA and NMIIB localized to MSFs but were restricted from sarcomeres. 
βCMII localized with a slight overlap to NMIIA and NMIIB but predominately localized 
behind NMII. βCMII filaments formed co-filaments with NMIIA and NMIIB. βCMII-NMII 
co-filaments were roughly the size of NMIIA/NMIIB filaments (~250nm). Indeed, βCMII 
filaments grew progressively larger towards the cell body, suggesting they polymerized 
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at the edge of hiCMs and grew larger over time. Similar to the actin thin filaments, 
FHOD3, NMIIA, and NMIIB were required for βCMII filament stack assembly, with 
NMIIB showing the most dramatic effect. Complete removal of the actin cytoskeleton 
(via Latrunculin B) resulted in a complete loss of βCMII filament stacks, suggesting 
βCMII filaments require an actin “track”. Interestingly, βCMII filament stacks formed 
almost exclusively via concatenation and “stitching” of distinct βCMII filaments to create 
a larger ensemble (i.e., the A-band). This is opposed to NMIIA stack assembly which 
occurs almost exclusively via Expansion of NMIIA filaments (Chapter II).  
 Collectively, our data led us to propose a new and unifying model of sarcomere 
assembly. Rather than being mutually exclusive from previous models, our model 
incorporates aspects from multiple models which our data supports. We believe our 
unified model of sarcomere assembly, combined with the model system we describe, 
represents a powerful framework to thoroughly test molecular and dynamic mechanisms 
of sarcomere assembly and subsequent regulation. 
 
Chapters III and IV future directions 
 
Actin Nucleating and Actin Binding Proteins During Sarcomere Assembly 
Much remains to be elucidated in the complex process of sarcomere assembly in 
hiCMs. One particular area of intrigue concerns actin nucleating factors. FHOD3 was 
required outright for sarcomere assembly. However, in knockdown experiments of the 
next two most highly expressed formins in our hiCMs – DAAM1 and DIAPH1 – 
sarcomeres still formed. However, the DAAM1 and DIAPH1 KD hiCMs displayed MSFs 
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defects and the sarcomeres which formed were disorganized compared to controls. 
Thus, it is likely formins (of which there are 15 in mammals), have non-redundant roles 
during sarcomere assembly. Though the Arp2/3 complex did not appear to be important 
for sarcomere assembly, it is highly expressed in hiCMs, and could have roles we did 
not observe. For example, the Arp2/3 complex has recently been implicated in 
chromosome capture during cell division and DNA damage repair (Burdyniuk et al., 
2018; Schrank et al., 2018).  
In addition to these actin nucleating proteins, there are likely additional actin 
binding proteins which affect sarcomere assembly. Prime targets include actin 
bundling/actin organizing proteins such as α-actinin, spectrin, and filamin. As MSFs and 
sarcomeres have dramatic structural differences, these bundling proteins could be 
essential for the transition from MSFs to sarcomeres. Other interesting candidates 
include capping protein and actin severing proteins, which have been shown to be 
important for regulating thin filament length in assembled sarcomere structures (Gokhin 
and Fowler, 2013; Kremneva et al., 2014). Furthermore, proteins which regulate actin 
filament length, potentially control how the spacing of the observed sarcomere structure, 
both in width from Z-disc to Z-disc, and between actin filaments themselves. Our model 
system amenable to live-cell experiments will help answer these tantalizing questions. 
 
Non-muscle myosin IIs during sarcomere assembly 
Our data showed that NMIIB was required outright for sarcomere assembly, and 
NMIIA knockdown resulted in fewer and smaller sarcomeres. How these proteins were 
resulting in sarcomere disruption is still unclear. It is likely both NMIIA and NMIIB are 
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required for both MSF assembly and transition into sarcomeres (MSFs are mostly 
absent/highly disorganized in NMII knockdown conditions). NMIIA and NMIIB form 
myosin II co-filaments. One intriguing idea is that NMIIA/NMIIB are serving as bona-fide 
templates which βCMII filaments are seeded onto and subsequently grow larger. NMIIA 
and NMIIB are then lost (as our data shows) and exclusive βCMII filaments assemble to 
form the A-band. This idea needs to be explored in more detail. Alternatively, 
NMIIA/NMIIB could be creating the proper tension on actin filaments which βCMII 
“recognizes” and then is loaded on to. In vitro experiments have demonstrated 
load/tension can alter myosin II kinetics and binding (Hundt et al., 2016; Kovacs et al., 
2007). 
There is also conflicting data surrounding the roles of NMIIA and NMIIB during 
sarcomere assembly in hiCMs. A paper was recently published using CRISPR/Cas9 
NMIIA/NMIIB double knockout hiCMs and proposed NMIIA/NMIIB were not required for 
sarcomere assembly (Chopra et al., 2018). This data is highly suspect as these hiCMs 
do not resemble control hiCMs and clearly do not contain sarcomeres. These conflicting 
data need to be remedied. Furthermore, in vivo data regarding the role of NMII during 
sarcomere assembly is conflicting (see Introduction and Chapter III). A model system 
which can ensure efficient knockdown of NMIIA and/or NMIIB prior to sarcomere 
assembly combined with rigorous analysis will be required to answer this question in the 
in vivo context. 
Separate or linked mechanisms of thin and thick filament assembly 
 Certain pieces of our data suggests thin and thick filament assembly are linked. 
For example, NMIIB KD and Latrunculin B treatment abolished both thin and thick 
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filament assembly. However, on “residual” actin filaments, βCMII filaments were 
observed to form. Thus it appears that βCMII requires an actin track. However, data not 
presented in Chapters III and IV would contradict this result. For example, in hiCMs 
treated with CytochalasinD to prevent actin polymerization, display prominent βCMII 
filament stacks assembled on actin resembling MSFs, not sarcomeric actin (Figure 5-1). 
In addition, recent work from Chuck Murry’s lab contradicts (Chopra et al., 2018) and 
suggests actin thin filaments still form comparable to control cells in βCMII KO hiCMs. 
This is an intriguing area of research which should be investigated further and has the 
potential to reveal a wealth of information regarding how cells establish contractile units. 
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Figure 5-1: hiCMs treated with CytochalasinB display βCMII stacks 
hiCM spread for 24 hrs in the presence of 5 μM CytochalasinB display prominent βCMII 
filament stacks (yellow asterisks). Notably, these βCMII filament stacks localize to actin 
resembling MSFs not sarcomeric actin. 
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Myofibril maintenance and turnover 
Thus far, our work as solely concerned sarcomere assembly. However, 
tantalizing pieces of data in the literature suggest sarcomere components turnover at a 
slow rate (compared to protein turnover in non-muscle cells). How do cells replace the 
massive proteins of the sarcomere (titin is over 1 mega Dalton, making the relatively 
large 250kd myosin II seem small) over time? Preliminary data from our lab suggests 
myofibrils are quite dynamic within the cell, at least at early time points post plating. 
Longer time-lapse imaging experiments could reveal differing mechanisms between 
sarcomere assembly and turnover. This is especially relevant during sarcomere “repair”, 
as it has been shown skeletal muscle can tear and repair itself over the course of a few 
days (Jarvinen et al., 2013). Indeed, during hypertrophy in multiple cardiac disease 
states, when cardiomyocytes grow larger, how/do they assemble new myofibrils? 
 
Sarcomere assembly and maintenance with disease causing mutations 
Thus far, all our experiments concerning sarcomere assembly were conducted in 
“wild-type” hiCMs. However, a majority of mutations leading to inherited 
cardiomyopathies are found within sarcomeric proteins (Konno et al., 2010; Watkins et 
al., 2011). How do these mutations affect MSFs structure/dynamics and sarcomere 
assembly? Similar experiments we present in Chapter III should be conducted in the 
context of relevant mutations leading to cardiomyopathies in humans. This is an 
intriguing question, as it is currently not understood when the observed post-mortem 
hallmark of sarcomere disarray is first initiated in patients. A better understanding of 
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sarcomere assembly in disease states could inform therapies aimed at preventing 
and/or reversing disease states. 
 
Sarcomere assembly in 3-dimensions (3D) 
One qualm often directed at studies like those performed in Chapters III and IV is 
that they are not in a biologically relevant environment. I will spare the reader a 
historical documentation of this ridiculous reasoning, though even experiments 
presented in the most recent 2018 Nobel Prize in Physiology or Medicine for targeting 
immune cells for cancer therapy were conducted in “2D”, but I digress. We must 
address these criticism as they are, at some level, valid, and will enhance our 
knowledge of cardiac cell biology. Indeed, in vivo, cardiomyocytes are elongated, in a 
thick layer of cells including cardiomyocytes, fibroblasts, endothelial cells, 
macrophages, and basement membrane to name a few important factors. Future 
studies adding increasing layers of complicating have the potential to reveal new 
mechanisms of sarcomere assembly and the impact of diverse cellular interactions.  
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MATERIALS AND METHODS 
 
Cell Culture Conditions 
Non-muscle cells 
U2-OS (ATCC, Manassas, VA, HTB-96,) and HeLa (ATTC, CCL-2) cells were cultured in 
growth media comprised of DMEM (Mediatech, Inc., Manassas, VA, 10-013-CV) 
containing 4.5g/L L-glutamine, L-glucose, sodium pyruvate and supplemented with 10% 
fetal bovine serum (Sigma-Aldrich, St. Louis, MO, F2442). WT HAP1 cells and HAP1 cells 
with MYH9 (myosin IIA) knocked out using CRISPR were purchased from Haplogen 
Genomics (Vienna, Austria). The company confirmed knockout with PCR, and we 
confirmed using Western blotting (Fig. 3i, S3-3). HAP1 cells were cultured in IMDM (Life 
Technologies, Grand Island, NY, 12440-053). Cells were kept at 37o C and 5% CO2. 
Growth substrates were prepared by coating #1.5 glass coverslips (In Vitro Scientific, 
D35C4-20-1.5N or D35-20-1.5N) with 25 g/mL Laminin (Sigma-Aldrich, L2020) in PBS 
(Mediatech, Inc., 46-013-CM) at 37o C for 1 hour. Cells were plated on a growth substrate 
and then experiments were performed the next day. For protein expression experiments, 
cells were transiently transfected with Fugene 6 (Promega, Madison, WI, E2691) 
according to the manufacturer’s instructions overnight in a 25-cm2 cell culture flask 
(Genessee Scientific Corporation, San Diego, CA, 25-207) before plating on a growth 
substrate.  
Human induced pluripotent stem cell derived cardiac myocytes (hiCMs) 
hiCMs were purchased from either Axiogenesis (Cor.4u, Ncardia Cologne, Germany) or 
Cellular Dynamics International (iCell caridomyocytes2, Madison, WI). Cells were cultured 
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as per manufacturer’s instructions. hiCMs were cultured in 96 well plates and maintained 
in proprietary manufacturer provided media exchanged every  two days until ready for 
experimental use. Knockdown experiments in hiCMs were started 4 days after the initial 
thaw.  
Live-cell sarcomere assembly visualization assay (chapters III and IV) 
To visualize sarcomere formation, we developed a repeatable method, which can be used 
to visualize any fluorescently tagged protein during sarcomere formation in hiCMs. Prior 
to performing this assay, cells are maintained in desired culture vessel (our hiCMs were 
maintained in 96 well plates). In this assay, cells are transiently transfected with desired 
fluorescently tagged protein, trypsinized, plated on desired imaging dish, and imaged to 
observe sarcomere formation. A sarcomere assembly assay proceeds as follows. First, 
hiCMs are transfected with desired fluorescently tagged protein as described below 
(Viafect, overnight transfection). Transfection mix is washed out with culture media. Cells 
are then detached from culture vessel using trypsinization method described below. Cells 
are then plated on a desired culture vessel (in this study, 10mm #1.5 glass bottom dishes 
were used, CellVis, Mountain View, CA) for live cell imaging. Imaging vessels were pre-
coated with 25 µg/mL laminin for 1 hour at 37° C and washed with 1x PBS containing no 
Mg2+/Ca2+. Cells were allowed to attach for ~1.5 hrs and media was added to fill the glass 
bottom dish. Cells were then imaged using desired imaging modality at 3-6 hrs post 
plating. The 3-6 hr time window was optimal, as cells had not yet established sarcomeres, 
but were healthy enough to tolerate fluorescence imaging. This powerful assay can be 
adapted to visualize the kinetics during sarcomere formation of any fluorescently tagged 
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protein. We have used this assay to visualize actin (Lifeact), FHOD3, βCMII, α-actinin 2, 
NMIIA, and NMIIB. The latter two proteins being large (i.e., >250 KD). 
Trypsinization of hiCMs (chapters III and IV) 
To trypsinize Cellular Dynamics hiCMs, manufacturers recommendations were used, as 
follows. All volumes apply were modified from 24 well format for 96 well plates. hiCMs 
were washed 2x with 100uL 1x PBS with no Ca2+/Mg2+ (PBS*). PBS* was completely 
removed from hiCMs and 40uL 0.1% Trypsin-EDTA with no phenol red (Invitrogen) was 
added to hiCMs and placed at 37° C for 2 minutes. Following incubation, culture dish was 
washed 3x with trypsin inside well, rotated 180 degrees, and washed another 3x. 
Trypsinization was then quenched by adding 160 µL of culture media and total cell mixture 
was placed into a 1.5mL Eppendorf tube. Cells were spun at 1000gs for 5 minutes, and 
supernatant was aspirated. Cells were then re-suspended in 200uL of culture media and 
plated on a 10mm glass bottom dish pre-coated with 25 µg/mL laminin for 1 hr. Cells were 
then allowed to attach for at least 1 hour, and 2-3 mLs of culture media with or without 
drug was added to cells. 
To trypsinize Axiogenesis hiCMs, manufacturers recommendations were used, as 
follows. Cells were washed 2x with 500µL PBS*. Cells were placed in 37° C incubator for 
7 minutes in PBS*. Following 7 minutes, PBS* was aspirated and 40 µL 0.5% Trypsin 
(Invitrogen) was placed on cells for 3 minutes in 37° C incubator. Following 3 minutes, 
160 µL full Cor.4u media was used to quench trypsinization and re-suspend cells. Cells 
were then plated on pre-coated glass bottom dish and media added 1.5 hrs later to dilute 
trypsin and fill chamber. Note* this trypsinization protocol has since been modified by 
Axiogenesis (now Ncardia). See manufacturer for new protocol. 
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It is important to note that the trypsinization protocol is based off of the hiCMs 
manufacturers protocols for cell plating, and these hiCMs have been trypsinized prior to 
functional assays of cardiomyocyte performance and characterization (e.g., drug 
response, electro-physiology, maturation, etc…) (Fine et al., 2013; Ivashchenko et al., 
2013; Mioulane et al., 2012). 
Transient transfection of hiCMs (chapters III and IV) 
Cellular Dynamics hiCMs were transfected via modification of manufacturer’s 
recommendations as follows. Volumes used are for transfection in 96 well plates. 2 µL of 
total 200 ng plasmid (containing fluorescently tagged protein of interest, diluted in Opti-
MEM) and 2 µL 1:5 diluted Viafect (Promega, E4981, in Opti-MEM) was added to 6 µL 
Opti-MEM. Entire mixture of 10 µL was added to single 96 well of hiCMs containing freshly 
exchanged 100 µL full culture media. Transfection was allowed to go overnight (~15 hrs), 
and washed 2x with full culture media. For transfection of multiple probes, 2 µL of 200ng 
plasmid was used for each probe together with 4 µL 1:5 diluted Viafect, into 2 µL Opti-
MEM and mixture was applied to cells as above. 
Axiogenesis hiCMs were transfected via modification of manufacturer’s 
recommendations as follows. A 3.5:1 Fugene to DNA ratio was used to transfect 
Axiogenesis hiCMs. 1.2 µL Fugene + 0.33 µg DNA per 96 well into 5µL serum free Cor.4u 
media was incubated for 15 minutes at room temperature. 95 µL full Cor.4u media was 
added to mixture and entire mixture was added to hiCMs (on top of 100 µL already in 
well). For transfection of 2 separate plasmids, 3.5:1 ratio was used for both plasmids and 
additional volume was subtracted from 95 µL dilution. Note* this transfection protocol has 
since been modified by Axiogenesis. See manufacturer for new protocol.  
173 
 
Protein knockdown (chapters III and IV) 
Cellular Dynamics hiCMs were used for knockdown experiments via modification of 
manufacturers recommendations. Volumes used are for siRNA application in 96 well 
plates. Dharmacon SmartPool siRNA (GE Dharmacon, Lafayette, CO) targeted to MYH9 
(NMIIA), MYH10 (NMIIB), FHOD3, DAAM1, and DIAPH1 were used (E-007668-00-0005, 
E-023017-00-0010, E-023411-00-0005, E-012925-00-0005, and E-010347-00-0005, 
respectively). To achieve KD, a master mixture of 100 μl Opti-MEM (ThermoFisher, 
Waltham, MA) + 4 μl Transkit-TKO (Mirus Bio, Madison WI) + 5.5 μl 10μM siRNA was 
incubated for 30 min at room temperature. 80 μl of fresh, pre-warmed media was added 
to hiCMs. Following incubation of siRNA mixture, 8.3 μl of mixture was added to each 
individual well of 96 well plate. hiCMs were then incubated for 2 days at 37° C. hiCMs 
were then washed 2x with fresh, pre-warmed media. To achieve KD of NMIIA, NMIIB, 
FHOD3, DAAM1, and DIAPH1, 3 rounds of siRNA mediated KD described above were 
necessary. Following 3 rounds of scramble control siRNA treatment, hiCMs still beat and 
maintained sarcomere structure (see Figure S11). 
Western blotting  
Gel samples were prepared by mixing cell lysates with LDS sample buffer (Life 
Technologies, #NP0007) and Sample Reducing Buffer (Life Technologies, #NP00009) 
and boiled at 95°C for 5 minutes. Samples were resolved on Bolt 4-12% gradient Bis-Tris 
gels (Life Technologies, #NW04120BOX). Protein bands were blotted onto a nylon 
membrane (Millipore). Blots were blocked using 5% NFDM (Research Products 
International Corp, Mt. Prospect, IL, #33368) in TBST. Antibody incubations were also 
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performed in 5% NFDM in TBST. Blots were developed using the Immobilon 
Chemiluminescence Kit (Millipore, #WBKLS0500). 
Fixation and immunohistochemistry 
U2-OS cells, HeLa cells, and hiCMs were fixed with 4% paraformaldehyde (PFA) in PBS 
at room temperature for 20 min and then extracted for 5 min with 1% Triton X-100 and 
4% PFA in PBS as previously described (Burnette et al., 2014). Cells were washed three 
times in 1× PBS. To reduce background for transfected proteins in fixed cells, cells were 
live-cell extracted before fixation as described previously to reduce background and non-
cytoskeletal myosin II filaments (i.e., the soluble pool). Briefly, a cytoskeleton-stabilizing 
live-cell extraction buffer was made fresh containing 2 ml of stock solution (500 mM 1,4-
piperazinediethanesulfonic acid, 25 mM ethylene glycol tetraacetic acid, 25 mM MgCl2), 
4 ml of 10% polyoxyethylene glycol (PEG; 35,000 molecular weight), 4 ml H2O, and 100 
μl of Triton X-100, 10 μM paclitaxel, and 10 μM phalloidin. Cells were treated with this 
extraction buffer for 1 min, followed by a 1-min wash with wash buffer (extraction buffer 
without PEG or Triton X-100). Cells were then fixed with 4% PFA for 20 min. After fixation, 
the following labeling procedures were used: for actin visualization, phalloidin-488 in 1× 
PBS (15 μl of stock phalloidin per 200 μl of PBS) was used for 3 h at room temperature. 
For immunofluorescence experiments, cells were blocked in 10% bovine serum albumin 
(BSA) in PBS. Primary antibodies were diluted in 10% BSA. RLC antibody was used at 
1:200. NMIIA antibody (BioLegend, P909801) was used at 1:1000. NMIIB antibody (Cell 
Signaling, 3404S and BioLegend 909901) were used at 1:200. βCMII antibody (Iowa 
Hybridoma Bank, A4.1025) was used undiluted from serum. α-actinin 2 (Sigma-Aldrich, 
clone EA-53) antibody was used at 1:200. FHOD3 antibody (Santa Cruz Biotechnology, 
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G-5, sc-374601) was used at 1:100. Arp2/3 antibody (Anti-p34-Arc/ARPC2, Millipore 
Sigma, 07-227) was used at 1:100. DAAM1 antibody (Bethyl Laboratories, A300-078A) 
was used at 1:100. DIAPH1 antibody (Sigma-Aldrich, HPA026605) was used at 1:100. 
Cardiac Troponin T antibody (Santa Cruz Biotechnology, CT3, sc-20025) was used at 
200 µg/ml.  Secondary antibodies were diluted in 10% BSA at 1:100 and centrifuged at 
13,000 rpm for 10 min before use. Cells were imaged in VECTASHIELD Antifade 
Mounting Media with DAPI (H-1200, VECTOR LABORATORIES, Burlingame, CA, USA). 
To label both NMIIA and NMIIB in the same sample (as in Figure 7A), NMIIA primary 
antibody was directly labeled using a primary antibody labeling kit from Biotium (Mix-n-
Stain CF Antibody Labeling Kits, Biotium, Inc. Fremont, CA). Following manufacturers 
protocol, NMIIA was primary labeled, and stain was visually compared to standard 
immunofluorescence protocol to validate localization pattern. 
Pharmacological treatments  
Growth media was equilibrated at 37o C and 5% CO2 for 1 hour before adding drugs. For 
Blebbistatin, Cytochalasin B, and Y-27632 in Chapter II experiments, drugs were diluted 
in media and cells were treated for 1 hour at 37o C and 5% CO2 followed by immediate 
fixation (see “Fixation and Immunohistochemistry”). For cell division studies, plates were 
treated with RO-3306 to catch more cells in telophase (Vassilev et al., 2006). RO-3306 
was used as described (Vassilev et al., 2006). Briefly, following plating on growth 
substrate and attachment, cells were incubated with 9 M RO-3306 for 12 hours and 
washed out two times with pre-equilibrated media. Cells were fixed 45 minutes after 
washout. For sarcomere assembly assay (Chapter III), hiCMs were allowed to attach for 
~1.5 hours and media containing CK666 or SMIFH2 was added. For live-cell acute drug 
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treatments, equilibrated media containing either CK666 or SMIFH2 was exchanged on 
the microscope so the same cells could be visualized. For Latrunclin B experiments 
(Chapter IV), cells were cultured in glass-bottom dishes in incubator and equilibrated 
media containing Latrunculin B was exchanged and administered for 6 hours before 
fixation. 
Plasmids (chapters II, III, and IV) 
Plasmids encoding NMIIA-(N-terminal)-mEGFP (11347; Addgene, Cambridge, MA) with 
mEGFP on the N-terminus of NMIIA heavy chain were used as described previously 
(Chua et al., 2009). Plasmid encoding Lifeact-mEmerald and Lifeact-mApple were gifts 
from Michael Davidson. Plasmid encoding NMIIB-(N-terminal)-mEmerald was purchased 
from Addgene (54192; Addgene, Cambridge, MA). Plasmid encoding human βCMII was 
synthesized by Genscript (Piscataway, NJ, USA). Briefly, the wild-type human MYH7 
(βCMII) sequence from the National Center for Biotechnology Information (NCBI, 
Bethesda, MD, USA) was cloned into a pUC57 along with Gateway DNA recombination 
sequences in order to facilitate rapid fluorescent protein integration and swapping 
(Gateway Technology, ThermoFisher Scientific, Waltham, MA). mEGFP containing a 
previously published linker sequence was added to the βCMII plasmid using Gateway 
Vector Conversion System with One Shot ccdB Survival Cells (ThermoFisher Scientific, 
Waltham, MA) for the βCMII-(N-terminal)-mEGFP construct used in this study. FHOD3-
mEGFP plasmid lacking the T(D/E)5XE exon was a gift from Elizabeth Ehler. This 
construct has previously been shown to localize to sarcomeres in neonatal rat 
cardiomyocytes (Iskratsch et al., 2010) (see top left panel of Figure 2A in reference). The 
plasmids encoding mEmerald-MyosinIIA-C-18 (i.e., NMIIA-(N-terminal)-mEmerald) 
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(Addgene, #54190) or mEos2-MyosinIIA-C-18 (i.e., NMIIA-(N-terminal)-mEOS2) 
(Addgene #57403) with mEmerald or mEOS2 on the N-terminus of NMIIA heavy chain 
were used as described previously(Burnette et al., 2014b). Briefly, cDNA (Blue Heron) 
was ligated into a mEmerald-C1 or mEOS2 cloning vector (Clontech-style). The plasmid 
encoding mEmerald-C-16-mApple-N-14-MyosinIIA (i.e., NMIIA-(N-terminal)-
mEmerald/(C-terminal)-mApple) with mEmerald and mApple on the N and C-termini of 
NMIIA heavy chain, respectively, was used as described previously(Burnette et al., 
2014b). Briefly, mEmerald was PCR amplified and ligated into a mApple-MyosinIIA-N-14. 
The plasmid encoding NMIIA-N93K-mEGFP (Vicente-Manzanares et al., 2007) was a 
generous gift from Dr. Alan “Rick” Horwitz. 
RNA-seq data analysis (chapter III) 
RNA-seq reads were aligned to the human reference genome hg19 using STAR (Dobin 
et al., 2013) and quantified by featureCounts (Liao et al., 2014). Read counts were 
normalized by the Relative Log Expression (RLE) method and FPKM values for each 
sample were generated by DESeq2 (Love et al., 2014). 
Zebrafish maintenance and husbandry (chapter III) 
Standard procedures were used to raise and maintain zebrafish (Kimmel et al., 1995; 
Monte Westerfield, 2007). All experiments were conducted using the wild-type AB strain 
zebrafish in accordance with the University of Wisconsin-Milwaukee Institutional Animal 
Care and Use Committee. 
 
Antisense morpholino oligonucleotide injections 
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For zebrafish morpholino knockdown experiments, splice-blocking antisense morpholinos 
(MO) oligonucleotides were injected into singe-cell wild-type embryos. Morpholino 
sequences used: 
myh10 MO (5’–CTTCACAAATGTGGTCT- TACCTTGA-3’; Gene Tools). 
myh9b MO (5’ - AGCAAGAGAGACTTACAAATCGAGA-3’; Gene Tools). 
Standard control MO (5’–CCTCTTACCTCAGTTACAATTTATA-3’; Gene Tools). 
Zebrafish p53 MO (5’ –GCGCCATTGCTTTGCAA- GAATTG-3’; Gene Tools). 
Control experiments have been previously published to confirm morpholino efficacy and 
specificity including; examination of the morpholino effect on the myh10 and myh9b 
transcripts using RT-PCR, rescue of the myh10 and myh9b morpholino knockdown 
phenotype with expression of human MYH10 or MYH9 mRNA, and Western blot analysis 
of morpholino effects on NMIIB protein levels (Gutzman et al., 2015). Additional 
morpholino controls are presented here to further confirm knockdown protein levels and 
to evaluate compensatory effects for both myh10 MO and myh9b MO.  
3 ng of each morpholino was used for all experiments. p53 MO was used in conjunction 
with either standard control MO, myh9b MO or myh10 MO. 25 pg of membrane Cherry 
mRNA was co-injected with each condition to screen for injection efficiency. For heart 
experiments, embryos were allowed to develop until 48 hours post fertilization (hpf) and 
then fixed for analysis. For Western analyses, 24 somite stage embryos were 
dechorionated and deyolked to remove interfering yolk sac proteins (Link et al., 2006). 
Deyolked, whole embryo tissue was collected in 1X lysis buffer containing 5 mMTris, 400 
mM EDTA, 2% Glycerol, and 0.2% Triton X, with cOmplete Protease inhibitor 
(4693124001, Sigma-Aldrich) and Phosphatase inhibitor (88667, Thermo). 20 mg of 
179 
 
protein was analyzed for each sample. Primary antibodies: NMIIA (ab55456; Abcam) at 
1:1000, NMIIB (sc-376942; SCBT) at 1:500, and -tubulin (T6199; Sigma-Aldrich) at 
1:2000. Secondary antibody: anti-mouse HRP (7076; Cell Signaling Technology) at 
1:2000. Blots were imaged on a Syngene G-BOX Chemi XRQ imaging system. Blots were 
quantified using Photoshop (Adobe). 
Microscopy methods (chapters II, III, and IV) 
Structured illumination microscopy  
Two SIM imaging modalities were used in this study (individual experiments were always 
imaged using the same modality). SIM imaging and processing was performed on a GE 
Healthcare DeltaVision OMX equipped with a 60×/1.42 NA oil objective and sCMOS 
camera at room temperature. SIM imaging and processing was also performed on a 
Nikon N-SIM structured illumination platform equipped with an Andor DU-897 EMCCD 
camera and a SR Apo TIRF (oil) 100x 1.49 NA WD 0.12 objective at room temperature. 
Spinning disk microscopy 
Spinning disk confocal images were taken on a Nikon Spinning Disk equipped with a 
Yokogawa CSU-X1 spinning disk head, Andor DU-897 EMCCD camera and 100x Apo 
TIRF (oil) 1.49 NA WD 0.12mm objective at 37 degrees C and 5%CO2. 
Laser-scanning confocal microscopy 
Laser-scanning confocal images were taken on a Nikon A1R laser scanning equipped 
with a 60x/1.40 Plan Apo Oil objective at 37 degrees C and 5%CO2. Confocal images for 
Figure 6E (in vivo, right) and Figure S13C were taken on a Zeiss 880 with AiryScan 
equipped with a 63x/1.40 Plan-Apochromat Oil objective at room temperature.  
Wide-field microscopy 
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Wide-field images were taken on a high-resolution wide-field Nikon Eclipse Ti equipped 
with a Nikon 100x Plan Apo 1.45 NA oil objective and a Nikon DS-Qi2 CMOS camera. 
Figure 5 Chapter II montages were taken on a Leica DMIL cell culture microscope 
equipped with a N PLAN L 40x/0.55 CORR PH2 at room temperature. Data presented in 
Figure 7H was acquired on an Incucyte S3 (Ann Arbor, MI) Live-Cell Analysis system with 
the 20x objective. Photo-conversion experiments were performed as previously described 
(Fenix et al., 2016). 
Live-cell photo-activated localization microscopy (PALM) 
Live-cell PALM imaging was performed as previously described(Manley et al., 2008). 
Total internal reflection microscopy was performed with a Nikon N-STORM microscope 
using a Nikon 100x Plan Apo 1.49 NA objective and an Andor iXon Ultra EMCCD camera. 
An image of the unconverted green channel (excited with 488 nm) and converted red 
channel (excited with 561 nm) was acquired every 5 seconds. Integration times for the 
green channel varied between 100-150 ms and the red channel integration time was 150 
ms. Camera gain was set to 400. We did not use the 405 nm laser as imaging the green 
channel with the 488 nm laser alone was sufficient to convert enough molecules for 
analysis as previously described (Sengupta et al., 2011). The precise localization of single 
converted NMIIA-mEOS2 molecules was determined with the ThunderSTORM ImageJ 
plugin as previously described (Ovesny et al., 2014). The average localization precision 
for the NMIIA-mEOS2 molecules analyzed was 24.6 +/- 4.0 nm. 
Three-dimensional photo-activated localization microscopy (3D-PALM) 
3D-PALM measurements were performed as previously described (Betzig et al., 2006; 
Brown et al., 2011; Xu et al., 2012). Briefly, U2OS cells expressing NMIIA-mEOS2 were 
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fixed with 4% paraformaldehyde and .25% glutaraldehyde and imaged with a custom-
built dual objective (4Pi; Nikon 1.49 NA TIRF objectives; Melville,NY) epifluorescence 
microscope. Astigmatism was introduced on both objective images using deformable 
mirrors (Brown et al., 2011) and were collected on separate EM-CCD cameras (Andor 
iXon Ultra, DU-897; Belfast, UK). Z-coordinate parameters were extracted using the 
ellipticity of image localizations for multiple gold fiducials embedded in the coverslip 
(Hestzig, Leesburg, VA). Images from each objective were independently drift corrected 
in all dimensions and registered with one another using gold fiducials (typically, less than 
10-20 nm of residual error persisted after these corrections). Localization pairs were 
spatially correlated in each image frame and those with less than 0.3 pixel (133.3 nm 
pixels) deviations were used to recalculate the number of photons collected for each 
localization. Those localizations which did not display a correlating image from the other 
objective were discarded (typically 10-20% of the total localizations). All images were 
rendered using custom Matlab software (Natick, MA) using the positional uncertainty as 
a probability distribution for each localization dimension (Betzig et al., 2006). Using our 
imaging approach, discrete clusters of NMIIA-mEOS2 localizations yielded 30-40 nm and 
60-90 nm Full-Width at Half-Maximum in the X/Y and Z dimensions, respectively. 
 
Data quantification 
ImageJ, Slidebook 6 (Intelligent Imaging Innovations, Denver, CO), and Nikon Elements 
software were used for data quantification. For 2-3-4 and stack length quantification, 
regions of interests (ROIs) were used and placed at the leading edge of a migrating cell. 
For 2-3-4 and filament density quantification, a region of interest extending 1.5 m from 
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the leading edge was defined (Fig. S3-1), and every discrete myosin II ensemble that 
could be quantified as a 2, 3, 4, or >4-motor-group in this region was counted. Increasing 
the distance from the edge of the region of interest further increased the number of 
overlapping NMIIA-Fs, whose structures could not be defined. For stack length 
quantification in U2OS cells, a 15x7 m box (determined empirically as the best size for 
all cells measured) was placed starting with the first NMIIA-F in the protrusive area of a 
migrating cell, and all NMIIA-Fs were measured (Fig. S3-2). For stack length 
quantification in cleavage furrow of HeLa cells, an 8x6 micron box (determined empirically 
as the best size for all cells measured) was placed in the middle of the cleavage furrow 
and every NMIIA-F was measured. For actin filament intensities, all cells were imaged 
with the same laser intensity and exposure, and maximum projections of the cells were 
analyzed. Three, 1x1 m boxes were used per cell and averaged to measure intensity. 
Boxes were placed 2 m behind cell edge in between the dorsal stress fibers, which do 
not contain myosin II(Hotulainen and Lappalainen, 2006) and were unchanged by 
cytochalasin B treatment (Fig. 4). P-values from student T-tests and standard error of the 
mean (SEM) were calculated using Microsoft Excel. 
 
 
 
QUANTIFICATION AND STATISTICAL ANALYSIS (chapters III and IV) 
Data quantification 
To quantify percent of hiCMs with sarcomeres (i.e., Figure 4B), the actin cytoskeleton (via 
fluorescently labeled phalloidin) was imaged using structured illumination microscopy. 
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hiCMs were quantified as containing sarcomere structures if they contained at least 1 
myofibril containing at least 3 Z-discs (bright phalloidin staining which overlaps with α-
actinin 2 staining as in Figure 4A) spaced ~1.5-2 μm apart. By these metrics our 
quantification of sarcomere formation is not a measure of sarcomere maturity or 
alignment, but a measure of the hiCMs ability to assemble the building blocks of the 
sarcomere (i.e., the thin actin filaments) in response to a perturbation. Thus, while NMIIA 
KD hiCMs clearly form unaligned, disorganized, and fewer sarcomeres and myofibrils 
than control hiCMs, they still maintain the ability to assemble sarcomere structures, which 
is reflected in our quantification (Figures 8A and 8C). In the same vein, we realize our 
quantification is a very liberal quantification of sarcomere assembly. While we don’t 
expect a small array of sarcomeres to represent a functionally capable cardiomyocyte, 
we are investigating the early steps of sarcomere assembly and the ability of hiCMs to 
form the basic actin-myosin structure of the sarcomere. A similar methodology was used 
to quantify βCMII A-band filament stacks in Figure 10, using endogenous βCMII staining 
and SIM instead of the actin cytoskeleton. hiCMs were quantified as containing βCMII A-
band filament stacks if they contained even one βCMII filament stack, comparable to the 
smallest βCMII filament stacks found in control hiCMs. A βCMII filament stack is a βCMII 
filament ensemble which is thicker (i.e., contains more SIM resolve-able βCMII filaments) 
than a single βCMII filament. Sarcomere formation in Zebrafish experiments is described 
below.  
For actin arc and MSF retrograde flow rates (as in Figure 3), 3 regions of interest (ROIs) 
were used per cell. ROIs were drawn using the line tool in FIJI starting from in front of the 
leading edge (to ensure new MSF formation was captured) to the cell body where 
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sarcomere structures were localized. ROIs were then used to measure MSF translocation 
rates using the kymograph tool (line width = 3) on hiCMs which had been aligned using 
StackReg function. Kymographs generated in this manner were then manually measured 
by counting pixels on the X axis (distance) and the Y axis (time) for a distance/time 
measurement resulting in translocation rates. This method is similar to previously 
described methods of actin arc translocation in non-muscle cells. 
To measure distance between α-actinin 2 structures, the line tool and measure tool in FIJI 
(Fiji is Just ImageJ) was used. Lines were drawn, positions recorded (using ROI tool), 
and distances measured between α-actinin 2 structures. Multiple regions per cell for α-
actinin 2 in MSFs, and whole cells for distances between sarcomeres were used. 
To measure Z-line sizes in hiCMs, the line tool and measure tool in FIJI was used. Lines 
were drawn on individual Z-lines and their positions were recorded using the ROI tool. 
This gave a measurement of Z-line size and position within the cell. For Z-line 
measurements, such as Figure 8E, all Z-lines which could be reliably measured were 
measured. 
Actin staining and sarcomere quantification in zebrafish ventricles 
48 hours post fertilization (hpf), embryos were fixed in 4% paraformaldehyde in PBT for 
2 hours or overnight at 4°C. Embryos were then washed three times in PBT. To visualize 
actin, embryos were incubated in Alexa Fluor 488 phalloidin (Invitrogen A12379) at a ratio 
of 1:40 in PBT at 4°C for 2 days. Next, embryos were washed five times in PBT. For 
imaging, embryos were manually deyolked and heart tissue dissected. Heart tissue was 
mounted on a microscope slide in 100% glycerol for imaging. Imaging was conducted 
using a Nikon CS2 laser-scanning confocal microscope with NIS Elements software. 
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Maximum projections were created by the last author of each ventricle and each image 
file was labeled by a random number. The first author then measured each Z line in a 
blinded fashion using FIJI. The bright actin staining representing Z-discs was used to 
count all Z-discs present in all conditions. The number of Z-discs per image were divided 
by the size in microns of that individual animal heart for the Z-disc/μm measurement in 
Figure 9. Z lines were also measured from “top” to “bottom” of the long axis of every Z 
line for each condition for sarcomere size measurements. This gave number of Z lines 
and size (length) of each Z line. For persistence measurements, the number of 
sarcomeres in every myofibril for each image were counted (thus if a myofibril contained 
4 sarcomeres, it had a persistence of 4).  
Immunofluorescence localization quantification 
To quantify localization of NMIIA, NMIIB, and βCMII, line scans starting from the edge of 
the cell were taken for every cell and the normalized average localizations were used to 
average the number of indicated experiments for the final localization patterns depicted 
in the graph (as in Figure 7B). 
To quantify Arp2/3 intensity, a similar but altered strategy was taken. 4 separate boxes 
for each cell were placed along the edge of the cell (i.e., the lamellipodium) using the 
actin channel for guidance. These boxes were then used to measure average intensity of 
the anti-p34 channel (i.e., the Arp2/3 complex). Background subtracted averages for each 
cell in control and CK666 treated hiCMs were used to quantify percent decrease as 
depicted in Figure 4F.  
Statistics 
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Statistical significance was calculated using 2-tailed, unpaired Students T-tests 
performed in Excel. All independent experiments represent biological replicates. Error 
bars in all graphs represent standard error of the mean (SEM). For all graphs depicting 
% of cells (for example, Figure 1D), number of cells and experiments is indicated in figure 
legend. Percents displayed represent the average of the averages of the all experiments 
performed. For example, if controls cells displayed 95%, 90%, and 100% of all cells 
displaying actin arcs in 3 separate experiments, the represented percentage in the graph 
would be 95%. SEM was calculated by dividing the standard deviation by the square root 
of the number of separate experiments. For actin translocation rates at least 3 
measurements per cell were used to calculate the average translocation rates per cell. 
Translocation rates were then calculated in same manner as described above. Line-scan 
graphs represent normalized relative fluorescence.  
Selection of cells used for chapter II 
Polarized migrating U2-OS cells were chosen for this study by finding cells that had a 
curved leading edge and characteristic protrusive elements (i.e., lamellipodium), as 
described previously (Burnette et al., 2014b). HeLa cells in telophase were chosen based 
on chromosome position/morphology and having an ingressed furrow but not a midbody. 
Selection of cells used for chapter III and IV 
In order to have comparable results, cells used for this study were standardized based 
on morphology. Specifically, spread non-muscle cells and hiCMs with a broad leading 
edge and lamella were chosen as previously shown in studies of both non-muscle and 
muscle contractile system formation (Burnette et al., 2014a; Rhee et al., 1994). This also 
facilitated the ability to observe the MSF to sarcomere transition in live hiCMs, and is 
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recommended for future studies investigating sarcomere assembly. All experiments 
measuring sarcomere assembly were conducted at least 3 times, separately, and cells 
were imaged using SIM. Though this results in a relatively small number of cells for some 
of the experiments, we believe super-resolution imaging modalities such as SIM offer 
invaluable insight into sarcomere assembly (Gustafsson, 2005). Indeed, sub-diffraction 
imaging is required to reliably localize myosin II co-filaments both in vitro and in vivo. 
Furthermore, as has been seen in Drosophila, even high-resolution imaging modalities 
such as laser-scanning confocal microscopy are not sufficient to detect subtle, yet 
important, structural changes in response to perturbation (Fernandes and Schock, 2014). 
  
188 
 
REFERENCES 
 
Adelstein, R.S., T.D. Pollard, and W.M. Kuehl. 1971. Isolation and characterization of 
myosin and two myosin fragments from human blood platelets. Proceedings of 
the National Academy of Sciences of the United States of America. 68:2703-
2707. 
Almenar-Queralt, A., C.C. Gregorio, and V.M. Fowler. 1999. Tropomodulin assembles 
early in myofibrillogenesis in chick skeletal muscle: evidence that thin filaments 
rearrange to form striated myofibrils. Journal of cell science. 112 ( Pt 8):1111-
1123. 
Au, Y. 2004. The muscle ultrastructure: a structural perspective of the sarcomere. 
Cellular and molecular life sciences : CMLS. 61:3016-3033. 
Babbin, B.A., S. Koch, M. Bachar, M.A. Conti, C.A. Parkos, R.S. Adelstein, A. Nusrat, 
and A.I. Ivanov. 2009. Non-muscle myosin IIA differentially regulates intestinal 
epithelial cell restitution and matrix invasion. Am J Pathol. 174:436-448. 
Beach, J.R., G.S. Hussey, T.E. Miller, A. Chaudhury, P. Patel, J. Monslow, Q. Zheng, 
R.A. Keri, O. Reizes, A.R. Bresnick, P.H. Howe, and T.T. Egelhoff. 2011. Myosin 
II isoform switching mediates invasiveness after TGF-beta-induced epithelial-
mesenchymal transition. Proceedings of the National Academy of Sciences of 
the United States of America. 108:17991-17996. 
Beach, J.R., L. Shao, K. Remmert, D. Li, E. Betzig, and J.A. Hammer, 3rd. 2014. 
Nonmuscle myosin II isoforms coassemble in living cells. Current biology : CB. 
24:1160-1166. 
Betzig, E., G.H. Patterson, R. Sougrat, O.W. Lindwasser, S. Olenych, J.S. Bonifacino, 
M.W. Davidson, J. Lippincott-Schwartz, and H.F. Hess. 2006. Imaging 
intracellular fluorescent proteins at nanometer resolution. Science. 313:1642-
1645. 
Billington, N., J.R. Beach, S.M. Heissler, K. Remmert, S. Guzik-Lendrum, A. Nagy, Y. 
Takagi, L. Shao, D. Li, Y. Yang, Y. Zhang, M. Barzik, E. Betzig, J.A. Hammer, 
3rd, and J.R. Sellers. 2015. Myosin 18A coassembles with nonmuscle myosin 2 
to form mixed bipolar filaments. Current biology : CB. 25:942-948. 
Billington, N., A. Wang, J. Mao, R.S. Adelstein, and J.R. Sellers. 2013. Characterization 
of three full-length human nonmuscle myosin II paralogs. The Journal of 
biological chemistry. 288:33398-33410. 
Breckenridge, M.T., N.G. Dulyaninova, and T.T. Egelhoff. 2009. Multiple regulatory 
steps control mammalian nonmuscle myosin II assembly in live cells. Molecular 
biology of the cell. 20:338-347. 
Breitsprecher, D., and B.L. Goode. 2013. Formins at a glance. Journal of cell science. 
126:1-7. 
Brown, T.A., A.N. Tkachuk, G. Shtengel, B.G. Kopek, D.F. Bogenhagen, H.F. Hess, and 
D.A. Clayton. 2011. Superresolution fluorescence imaging of mitochondrial 
nucleoids reveals their spatial range, limits, and membrane interaction. Molecular 
and cellular biology. 31:4994-5010. 
Bryce, N.S., G. Schevzov, V. Ferguson, J.M. Percival, J.J. Lin, F. Matsumura, J.R. 
Bamburg, P.L. Jeffrey, E.C. Hardeman, P. Gunning, and R.P. Weinberger. 2003. 
189 
 
Specification of actin filament function and molecular composition by tropomyosin 
isoforms. Mol Biol Cell. 14:1002-1016. 
Burdyniuk, M., A. Callegari, M. Mori, F. Nedelec, and P. Lenart. 2018. F-Actin nucleated 
on chromosomes coordinates their capture by microtubules in oocyte meiosis. J 
Cell Biol. 217:2661-2674. 
Burnette, D.T., S. Manley, P. Sengupta, R. Sougrat, M.W. Davidson, B. Kachar, and J. 
Lippincott-Schwartz. 2011. A role for actin arcs in the leading-edge advance of 
migrating cells. Nature cell biology. 13:371-381. 
Burnette, D.T., A.W. Schaefer, L. Ji, G. Danuser, and P. Forscher. 2007. Filopodial actin 
bundles are not necessary for microtubule advance into the peripheral domain of 
Aplysia neuronal growth cones. Nat Cell Biol. 9:1360-1369. 
Burnette, D.T., L. Shao, C. Ott, A.M. Pasapera, R.S. Fischer, M.A. Baird, C. Der 
Loughian, H. Delanoe-Ayari, M.J. Paszek, M.W. Davidson, E. Betzig, and J. 
Lippincott-Schwartz. 2014a. A contractile and counterbalancing adhesion system 
controls the 3D shape of crawling cells. J Cell Biol. 205:83-96. 
Burnette, D.T., L. Shao, C. Ott, A.M. Pasapera, R.S. Fischer, M.A. Baird, C. Der 
Loughian, H. Delanoe-Ayari, M.J. Paszek, M.W. Davidson, E. Betzig, and J. 
Lippincott-Schwartz. 2014b. A contractile and counterbalancing adhesion system 
controls the 3D shape of crawling cells. The Journal of cell biology. 
Chen, B.C., W.R. Legant, K. Wang, L. Shao, D.E. Milkie, M.W. Davidson, C. 
Janetopoulos, X.S. Wu, J.A. Hammer, 3rd, Z. Liu, B.P. English, Y. Mimori-
Kiyosue, D.P. Romero, A.T. Ritter, J. Lippincott-Schwartz, L. Fritz-Laylin, R.D. 
Mullins, D.M. Mitchell, J.N. Bembenek, A.C. Reymann, R. Bohme, S.W. Grill, J.T. 
Wang, G. Seydoux, U.S. Tulu, D.P. Kiehart, and E. Betzig. 2014. Lattice light-
sheet microscopy: imaging molecules to embryos at high spatiotemporal 
resolution. Science. 346:1257998. 
Chopra, A., M.L. Kutys, K. Zhang, W.J. Polacheck, C.C. Sheng, R.J. Luu, J. Eyckmans, 
J.T. Hinson, J.G. Seidman, C.E. Seidman, and C.S. Chen. 2018. Force 
Generation via beta-Cardiac Myosin, Titin, and alpha-Actinin Drives Cardiac 
Sarcomere Assembly from Cell-Matrix Adhesions. Dev Cell. 44:87-96 e85. 
Chua, J., R. Rikhy, and J. Lippincott-Schwartz. 2009. Dynamin 2 orchestrates the global 
actomyosin cytoskeleton for epithelial maintenance and apical constriction. 
Proceedings of the National Academy of Sciences of the United States of 
America. 106:20770-20775. 
Colpan, M., N.A. Moroz, and A.S. Kostyukova. 2013. Tropomodulins and tropomyosins: 
working as a team. Journal of muscle research and cell motility. 34:247-260. 
Conti, M.A., S. Even-Ram, C. Liu, K.M. Yamada, and R.S. Adelstein. 2004. Defects in 
cell adhesion and the visceral endoderm following ablation of nonmuscle myosin 
heavy chain II-A in mice. The Journal of biological chemistry. 279:41263-41266. 
Conti, M.A., A.D. Saleh, L.R. Brinster, H. Cheng, Z. Chen, S. Cornelius, C. Liu, X. Ma, 
C. Van Waes, and R.S. Adelstein. 2015. Conditional deletion of nonmuscle 
myosin II-A in mouse tongue epithelium results in squamous cell carcinoma. Sci 
Rep. 5:14068. 
Costa, M., M. Fava, M. Seri, R. Cusano, M. Sancandi, P. Forabosco, M. Lerone, G. 
Martucciello, G. Romeo, and I. Ceccherini. 2000. Evaluation of the HOX11L1 
190 
 
gene as a candidate for congenital disorders of intestinal innervation. J Med 
Genet. 37:E9. 
Cote, G.P. 1983. Structural and functional properties of the non-muscle tropomyosins. 
Mol Cell Biochem. 57:127-146. 
Craig, R., R. Smith, and J. Kendrick-Jones. 1983. Light-chain phosphorylation controls 
the conformation of vertebrate non-muscle and smooth muscle myosin 
molecules. Nature. 302:436-439. 
Dabiri, G.A., K.K. Turnacioglu, J.M. Sanger, and J.W. Sanger. 1997. Myofibrillogenesis 
visualized in living embryonic cardiomyocytes. Proceedings of the National 
Academy of Sciences of the United States of America. 94:9493-9498. 
De Pascalis, C., and S. Etienne-Manneville. 2017. Single and collective cell migration: 
the mechanics of adhesions. Mol Biol Cell. 28:1833-1846. 
Derycke, L., C. Stove, A.S. Vercoutter-Edouart, O. De Wever, L. Dolle, N. Colpaert, H. 
Depypere, J.C. Michalski, and M. Bracke. 2011. The role of non-muscle myosin 
IIA in aggregation and invasion of human MCF-7 breast cancer cells. Int J Dev 
Biol. 55:835-840. 
Dlugosz, A.A., P.B. Antin, V.T. Nachmias, and H. Holtzer. 1984. The relationship 
between stress fiber-like structures and nascent myofibrils in cultured cardiac 
myocytes. J Cell Biol. 99:2268-2278. 
Dobin, A., C.A. Davis, F. Schlesinger, J. Drenkow, C. Zaleski, S. Jha, P. Batut, M. 
Chaisson, and T.R. Gingeras. 2013. STAR: ultrafast universal RNA-seq aligner. 
Bioinformatics. 29:15-21. 
Dominguez, R., and K.C. Holmes. 2011. Actin structure and function. Annu Rev 
Biophys. 40:169-186. 
Du, A., J.M. Sanger, and J.W. Sanger. 2008. Cardiac myofibrillogenesis inside intact 
embryonic hearts. Developmental biology. 318:236-246. 
Ebrahim, S., T. Fujita, B.A. Millis, E. Kozin, X. Ma, S. Kawamoto, M.A. Baird, M. 
Davidson, S. Yonemura, Y. Hisa, M.A. Conti, R.S. Adelstein, H. Sakaguchi, and 
B. Kachar. 2013. NMII forms a contractile transcellular sarcomeric network to 
regulate apical cell junctions and tissue geometry. Current biology : CB. 23:731-
736. 
Eddinger, T.J., and D.P. Meer. 2007. Myosin II isoforms in smooth muscle: 
heterogeneity and function. American journal of physiology. Cell physiology. 
293:C493-508. 
Eggert, U.S., T.J. Mitchison, and C.M. Field. 2006. Animal cytokinesis: from parts list to 
mechanisms. Annual review of biochemistry. 75:543-566. 
Ehler, E., B.M. Rothen, S.P. Hammerle, M. Komiyama, and J.C. Perriard. 1999. 
Myofibrillogenesis in the developing chicken heart: assembly of Z-disk, M-line 
and the thick filaments. Journal of cell science. 112 ( Pt 10):1529-1539. 
Even-Ram, S., A.D. Doyle, M.A. Conti, K. Matsumoto, R.S. Adelstein, and K.M. 
Yamada. 2007. Myosin IIA regulates cell motility and actomyosin-microtubule 
crosstalk. Nature cell biology. 9:299-309. 
Fenix, A.M., and D.T. Burnette. 2018. Assembly of Myosin II Filament Arrays: Network 
Contraction vs. Expansion. Cytoskeleton (Hoboken). 
Fenix, A.M., N. Taneja, C.A. Buttler, J. Lewis, S.B. Van Engelenburg, R. Ohi, and D.T. 
Burnette. 2016. Expansion and concatenation of non-muscle myosin IIA 
191 
 
filaments drive cellular contractile system formation during interphase and 
mitosis. Mol Biol Cell. 
Fernandes, I., and F. Schock. 2014. The nebulin repeat protein Lasp regulates I-band 
architecture and filament spacing in myofibrils. J Cell Biol. 206:559-572. 
Fine, M., F.M. Lu, M.J. Lin, O. Moe, H.R. Wang, and D.W. Hilgemann. 2013. Human-
induced pluripotent stem cell-derived cardiomyocytes for studies of cardiac ion 
transporters. American journal of physiology. Cell physiology. 305:C481-491. 
Forscher, P., and S.J. Smith. 1988. Actions of cytochalasins on the organization of actin 
filaments and microtubules in a neuronal growth cone. J Cell Biol. 107:1505-
1516. 
Gao, L., L. Shao, C.D. Higgins, J.S. Poulton, M. Peifer, M.W. Davidson, X. Wu, B. 
Goldstein, and E. Betzig. 2012. Noninvasive imaging beyond the diffraction limit 
of 3D dynamics in thickly fluorescent specimens. Cell. 151:1370-1385. 
Gardel, M.L., I.C. Schneider, Y. Aratyn-Schaus, and C.M. Waterman. 2010. Mechanical 
integration of actin and adhesion dynamics in cell migration. Annu Rev Cell Dev 
Biol. 26:315-333. 
Gokhin, D.S., and V.M. Fowler. 2013. A two-segment model for thin filament 
architecture in skeletal muscle. Nature reviews. Molecular cell biology. 14:113-
119. 
Gunning, P.W., E.C. Hardeman, P. Lappalainen, and D.P. Mulvihill. 2015. Tropomyosin 
- master regulator of actin filament function in the cytoskeleton. Journal of cell 
science. 128:2965-2974. 
Gupton, S.L., and C.M. Waterman-Storer. 2006. Spatiotemporal feedback between 
actomyosin and focal-adhesion systems optimizes rapid cell migration. Cell. 
125:1361-1374. 
Gustafsson, M.G. 2005. Nonlinear structured-illumination microscopy: wide-field 
fluorescence imaging with theoretically unlimited resolution. Proceedings of the 
National Academy of Sciences of the United States of America. 102:13081-
13086. 
Gustafsson, M.G., L. Shao, P.M. Carlton, C.J. Wang, I.N. Golubovskaya, W.Z. Cande, 
D.A. Agard, and J.W. Sedat. 2008. Three-dimensional resolution doubling in 
wide-field fluorescence microscopy by structured illumination. Biophys J. 
94:4957-4970. 
Gutzman, J.H., S.U. Sahu, and C. Kwas. 2015. Non-muscle myosin IIA and IIB 
differentially regulate cell shape changes during zebrafish brain morphogenesis. 
Developmental biology. 397:103-115. 
Hamdan, F.F., M. Srour, J.M. Capo-Chichi, H. Daoud, C. Nassif, L. Patry, C. 
Massicotte, A. Ambalavanan, D. Spiegelman, O. Diallo, E. Henrion, A. Dionne-
Laporte, A. Fougerat, A.V. Pshezhetsky, S. Venkateswaran, G.A. Rouleau, and 
J.L. Michaud. 2014. De novo mutations in moderate or severe intellectual 
disability. PLoS genetics. 10:e1004772. 
Hartman, M.A., and J.A. Spudich. 2012. The myosin superfamily at a glance. Journal of 
cell science. 125:1627-1632. 
Harunaga, J.S., and K.M. Yamada. 2011. Cell-matrix adhesions in 3D. Matrix Biol. 
30:363-368. 
192 
 
Harvey, P.A., and L.A. Leinwand. 2011. The cell biology of disease: cellular 
mechanisms of cardiomyopathy. The Journal of cell biology. 194:355-365. 
Heath, J.P. 1983. Behaviour and structure of the leading lamella in moving fibroblasts. I. 
Occurrence and centripetal movement of arc-shaped microfilament bundles 
beneath the dorsal cell surface. Journal of cell science. 60:331-354. 
Henson, J.H., M. Yeterian, R.M. Weeks, A.E. Medrano, B.L. Brown, H.L. Geist, M.D. 
Pais, R. Oldenbourg, and C.B. Shuster. 2015. Arp2/3 complex inhibition radically 
alters lamellipodial actin architecture, suspended cell shape, and the cell 
spreading process. Mol Biol Cell. 26:887-900. 
Hill, J.A.O., E.N. 2012. Muscle Fundamental Biology and Mechanisms of Disease. 
ELSEVIER. 
Ho, C.Y. 2010. Hypertrophic cardiomyopathy. Heart failure clinics. 6:141-159. 
Holtzer, H., T. Hijikata, Z.X. Lin, Z.Q. Zhang, S. Holtzer, F. Protasi, C. Franzini-
Armstrong, and H.L. Sweeney. 1997. Independent assembly of 1.6 microns long 
bipolar MHC filaments and I-Z-I bodies. Cell Struct Funct. 22:83-93. 
Hotulainen, P., and P. Lappalainen. 2006. Stress fibers are generated by two distinct 
actin assembly mechanisms in motile cells. J Cell Biol. 173:383-394. 
Hu, A., F. Wang, and J.R. Sellers. 2002. Mutations in human nonmuscle myosin IIA 
found in patients with May-Hegglin anomaly and Fechtner syndrome result in 
impaired enzymatic function. The Journal of biological chemistry. 277:46512-
46517. 
Hughes, S.E. 2004. The pathology of hypertrophic cardiomyopathy. Histopathology. 
44:412-427. 
Hughes, S.E., and W.J. McKenna. 2005. New insights into the pathology of inherited 
cardiomyopathy. Heart. 91:257-264. 
Hundt, N., W. Steffen, S. Pathan-Chhatbar, M.H. Taft, and D.J. Manstein. 2016. Load-
dependent modulation of non-muscle myosin-2A function by tropomyosin 4.2. Sci 
Rep. 6:20554. 
Hussein, B.A., K. Gomez, and R.A. Kadir. 2013. May-Hegglin anomaly and pregnancy: 
a systematic review. Blood Coagul Fibrinolysis. 24:554-561. 
Huxley, A.F., and R. Niedergerke. 1954a. Measurement of muscle striations in stretch 
and contraction. J Physiol. 124:46-47P. 
Huxley, A.F., and R. Niedergerke. 1954b. Structural changes in muscle during 
contraction; interference microscopy of living muscle fibres. Nature. 173:971-973. 
Huxley, H.E. 1969. The mechanism of muscular contraction. Science. 164:1356-1365. 
Iskratsch, T., S. Lange, J. Dwyer, A.L. Kho, C. dos Remedios, and E. Ehler. 2010. 
Formin follows function: a muscle-specific isoform of FHOD3 is regulated by CK2 
phosphorylation and promotes myofibril maintenance. J Cell Biol. 191:1159-
1172. 
Ivashchenko, C.Y., G.C. Pipes, I.M. Lozinskaya, Z. Lin, X. Xiaoping, S. Needle, E.T. 
Grygielko, E. Hu, J.R. Toomey, J.J. Lepore, and R.N. Willette. 2013. Human-
induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in 
phenotype. American journal of physiology. Heart and circulatory physiology. 
305:H913-922. 
Jarvinen, T.A., M. Jarvinen, and H. Kalimo. 2013. Regeneration of injured skeletal 
muscle after the injury. Muscles Ligaments Tendons J. 3:337-345. 
193 
 
Juanes-Garcia, A., J.R. Chapman, R. Aguilar-Cuenca, C. Delgado-Arevalo, J. Hodges, 
L.A. Whitmore, J. Shabanowitz, D.F. Hunt, A.R. Horwitz, and M. Vicente-
Manzanares. 2015. A regulatory motif in nonmuscle myosin II-B regulates its role 
in migratory front-back polarity. J Cell Biol. 209:23-32. 
Kamasaki, T., M. Osumi, and I. Mabuchi. 2007. Three-dimensional arrangement of F-
actin in the contractile ring of fission yeast. The Journal of cell biology. 178:765-
771. 
Kan, O.M., R. Takeya, T. Abe, N. Kitajima, M. Nishida, R. Tominaga, H. Kurose, and H. 
Sumimoto. 2012. Mammalian formin Fhod3 plays an essential role in 
cardiogenesis by organizing myofibrillogenesis. Biol Open. 1:889-896. 
Kelley, M.J., W. Jawien, T.L. Ortel, and J.F. Korczak. 2000. Mutation of MYH9, 
encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nature 
genetics. 26:106-108. 
Kimmel, C.B., W.W. Ballard, S.R. Kimmel, B. Ullmann, and T.F. Schilling. 1995. Stages 
of embryonic development of the zebrafish. Dev Dyn. 203:253-310. 
Kolega, J. 1998. Cytoplasmic dynamics of myosin IIA and IIB: spatial 'sorting' of 
isoforms in locomoting cells. Journal of cell science. 111 ( Pt 15):2085-2095. 
Konno, T., S. Chang, J.G. Seidman, and C.E. Seidman. 2010. Genetics of hypertrophic 
cardiomyopathy. Current opinion in cardiology. 25:205-209. 
Kovacs, M., K. Thirumurugan, P.J. Knight, and J.R. Sellers. 2007. Load-dependent 
mechanism of nonmuscle myosin 2. Proceedings of the National Academy of 
Sciences of the United States of America. 104:9994-9999. 
Krause, M., and A. Gautreau. 2014. Steering cell migration: lamellipodium dynamics 
and the regulation of directional persistence. Nature reviews. Molecular cell 
biology. 15:577-590. 
Kremneva, E., M.H. Makkonen, A. Skwarek-Maruszewska, G. Gateva, A. Michelot, R. 
Dominguez, and P. Lappalainen. 2014. Cofilin-2 controls actin filament length in 
muscle sarcomeres. Dev Cell. 31:215-226. 
Kuhne, W. 1864. Untersuchungen uber das Protoplasma und die Contractilitat. W. 
Engelmann, Leipzig. 
Kuragano, M., T.Q.P. Uyeda, K. Kamijo, Y. Murakami, and M. Takahashi. 2018. 
Different contributions of nonmuscle myosin IIA and IIB to the organization of 
stress fiber subtypes in fibroblasts. Mol Biol Cell. 29:911-922. 
Liao, Y., G.K. Smyth, and W. Shi. 2014. featureCounts: an efficient general purpose 
program for assigning sequence reads to genomic features. Bioinformatics. 
30:923-930. 
Lim, S.S., G.E. Hering, and G.G. Borisy. 1986. Widespread occurrence of anti-troponin 
T crossreactive components in non-muscle cells. Journal of cell science. 85:1-19. 
Lin, Z., M.H. Lu, T. Schultheiss, J. Choi, S. Holtzer, C. DiLullo, D.A. Fischman, and H. 
Holtzer. 1994. Sequential appearance of muscle-specific proteins in myoblasts 
as a function of time after cell division: evidence for a conserved myoblast 
differentiation program in skeletal muscle. Cell motility and the cytoskeleton. 
29:1-19. 
Link, V., A. Shevchenko, and C.P. Heisenberg. 2006. Proteomics of early zebrafish 
embryos. BMC Dev Biol. 6:1. 
194 
 
Liu, T.L., S. Upadhyayula, D.E. Milkie, V. Singh, K. Wang, I.A. Swinburne, K.R. 
Mosaliganti, Z.M. Collins, T.W. Hiscock, J. Shea, A.Q. Kohrman, T.N. Medwig, D. 
Dambournet, R. Forster, B. Cunniff, Y. Ruan, H. Yashiro, S. Scholpp, E.M. 
Meyerowitz, D. Hockemeyer, D.G. Drubin, B.L. Martin, D.Q. Matus, M. Koyama, 
S.G. Megason, T. Kirchhausen, and E. Betzig. 2018. Observing the cell in its 
native state: Imaging subcellular dynamics in multicellular organisms. Science. 
360. 
Lopez, J.I., I. Kang, W.K. You, D.M. McDonald, and V.M. Weaver. 2011. In situ force 
mapping of mammary gland transformation. Integr Biol (Camb). 3:910-921. 
Love, M.I., W. Huber, and S. Anders. 2014. Moderated estimation of fold change and 
dispersion for RNA-seq data with DESeq2. Genome Biol. 15:550. 
Lu, M.H., C. DiLullo, T. Schultheiss, S. Holtzer, J.M. Murray, J. Choi, D.A. Fischman, 
and H. Holtzer. 1992. The vinculin/sarcomeric-alpha-actinin/alpha-actin nexus in 
cultured cardiac myocytes. J Cell Biol. 117:1007-1022. 
Luther, P.K. 2009. The vertebrate muscle Z-disc: sarcomere anchor for structure and 
signalling. Journal of muscle research and cell motility. 30:171-185. 
Ma, X., and R.S. Adelstein. 2014a. A point mutation in Myh10 causes major defects in 
heart development and body wall closure. Circulation. Cardiovascular genetics. 
7:257-265. 
Ma, X., and R.S. Adelstein. 2014b. The role of vertebrate nonmuscle Myosin II in 
development and human disease. Bioarchitecture. 4:88-102. 
Ma, X., M. Kovacs, M.A. Conti, A. Wang, Y. Zhang, J.R. Sellers, and R.S. Adelstein. 
2012. Nonmuscle myosin II exerts tension but does not translocate actin in 
vertebrate cytokinesis. Proceedings of the National Academy of Sciences of the 
United States of America. 109:4509-4514. 
Ma, X., K. Takeda, A. Singh, Z.X. Yu, P. Zerfas, A. Blount, C. Liu, J.A. Towbin, M.D. 
Schneider, R.S. Adelstein, and Q. Wei. 2009. Conditional ablation of nonmuscle 
myosin II-B delineates heart defects in adult mice. Circulation research. 
105:1102-1109. 
Ma, X.J., R. Salunga, J.T. Tuggle, J. Gaudet, E. Enright, P. McQuary, T. Payette, M. 
Pistone, K. Stecker, B.M. Zhang, Y.X. Zhou, H. Varnholt, B. Smith, M. Gadd, E. 
Chatfield, J. Kessler, T.M. Baer, M.G. Erlander, and D.C. Sgroi. 2003. Gene 
expression profiles of human breast cancer progression. Proceedings of the 
National Academy of Sciences of the United States of America. 100:5974-5979. 
Mabuchi, I., and M. Okuno. 1977. The effect of myosin antibody on the division of 
starfish blastomeres. J Cell Biol. 74:251-263. 
MacLean-Fletcher, S., and T.D. Pollard. 1980. Mechanism of action of cytochalasin B 
on actin. Cell. 20:329-341. 
Maeda, J., T. Hirano, A. Ogiwara, S. Akimoto, T. Kawakami, Y. Fukui, T. Oka, Y. Gong, 
R. Guo, H. Inada, K. Nawa, M. Kojika, Y. Suga, T. Ohira, K. Mukai, and H. Kato. 
2008. Proteomic analysis of stage I primary lung adenocarcinoma aimed at 
individualisation of postoperative therapy. Br J Cancer. 98:596-603. 
Manley, S., J.M. Gillette, G.H. Patterson, H. Shroff, H.F. Hess, E. Betzig, and J. 
Lippincott-Schwartz. 2008. High-density mapping of single-molecule trajectories 
with photoactivated localization microscopy. Nature methods. 5:155-157. 
195 
 
Matsumura, F., S. Ono, Y. Yamakita, G. Totsukawa, and S. Yamashiro. 1998. Specific 
localization of serine 19 phosphorylated myosin II during cell locomotion and 
mitosis of cultured cells. The Journal of cell biology. 140:119-129. 
Mayor, R., and S. Etienne-Manneville. 2016. The front and rear of collective cell 
migration. Nature reviews. Molecular cell biology. 17:97-109. 
Miller, DM., Ortiz, I., Berliner, GC., Epstein, HF. 1983. Differential localization of two 
moysins within nematode thick filaments. Cell. 34(2):477-90 
McKenna, N.M., C.S. Johnson, and Y.L. Wang. 1986. Formation and alignment of Z 
lines in living chick myotubes microinjected with rhodamine-labeled alpha-actinin. 
J Cell Biol. 103:2163-2171. 
McKinney, S.A., C.S. Murphy, K.L. Hazelwood, M.W. Davidson, and L.L. Looger. 2009. 
A bright and photostable photoconvertible fluorescent protein. Nature methods. 
6:131-133. 
Medeiros, N.A., D.T. Burnette, and P. Forscher. 2006. Myosin II functions in actin-
bundle turnover in neuronal growth cones. Nat Cell Biol. 8:215-226. 
Mioulane, M., G. Foldes, N.N. Ali, M.D. Schneider, and S.E. Harding. 2012. 
Development of high content imaging methods for cell death detection in human 
pluripotent stem cell-derived cardiomyocytes. J Cardiovasc Transl Res. 5:593-
604. 
Monte Westerfield, I.o.N., University of Oregon. 2007. A Guide for the Laboratory Use of 
Zebrafish Danio (Brachydanio) rerio. University of Oregon. 
Murugesan, S., J. Hong, J. Yi, D. Li, J.R. Beach, L. Shao, J. Meinhardt, G. Madison, X. 
Wu, E. Betzig, and J.A. Hammer. 2016. Formin-generated actomyosin arcs 
propel T cell receptor microcluster movement at the immune synapse. J Cell Biol. 
215:383-399. 
Nagy, A., Y. Takagi, N. Billington, S.A. Sun, D.K. Hong, E. Homsher, A. Wang, and J.R. 
Sellers. 2013. Kinetic characterization of nonmuscle myosin IIb at the single 
molecule level. The Journal of biological chemistry. 288:709-722. 
Ng, W.A., I.L. Grupp, A. Subramaniam, and J. Robbins. 1991. Cardiac myosin heavy 
chain mRNA expression and myocardial function in the mouse heart. Circulation 
research. 68:1742-1750. 
Niederman, R., and T.D. Pollard. 1975. Human platelet myosin. II. In vitro assembly and 
structure of myosin filaments. The Journal of cell biology. 67:72-92. 
Nolen, B.J., N. Tomasevic, A. Russell, D.W. Pierce, Z. Jia, C.D. McCormick, J. 
Hartman, R. Sakowicz, and T.D. Pollard. 2009. Characterization of two classes of 
small molecule inhibitors of Arp2/3 complex. Nature. 460:1031-1034. 
Norstrom, M.F., P.A. Smithback, and R.S. Rock. 2010. Unconventional processive 
mechanics of non-muscle myosin IIB. The Journal of biological chemistry. 
285:26326-26334. 
Ong, K., C. Wloka, S. Okada, T. Svitkina, and E. Bi. 2014. Architecture and dynamic 
remodelling of the septin cytoskeleton during the cell cycle. Nature 
communications. 5:5698. 
Ovesny, M., P. Krizek, J. Borkovec, Z. Svindrych, and G.M. Hagen. 2014. 
ThunderSTORM: a comprehensive ImageJ plug-in for PALM and STORM data 
analysis and super-resolution imaging. Bioinformatics. 30:2389-2390. 
196 
 
Pasqualini, F.S., S.P. Sheehy, A. Agarwal, Y. Aratyn-Schaus, and K.K. Parker. 2015. 
Structural phenotyping of stem cell-derived cardiomyocytes. Stem Cell Reports. 
4:340-347. 
Paszek, M.J., N. Zahir, K.R. Johnson, J.N. Lakins, G.I. Rozenberg, A. Gefen, C.A. 
Reinhart-King, S.S. Margulies, M. Dembo, D. Boettiger, D.A. Hammer, and V.M. 
Weaver. 2005. Tensional homeostasis and the malignant phenotype. Cancer 
Cell. 8:241-254. 
Petrie, R.J., and K.M. Yamada. 2012. At the leading edge of three-dimensional cell 
migration. Journal of cell science. 125:5917-5926. 
Pollard, T.D. 1975. Electron microscopy of synthetic myosin filaments. Evidence for 
cross-bridge. Flexibility and copolymer formation. J Cell Biol. 67:93-104. 
Pollard, T.D. 2007. Regulation of actin filament assembly by Arp2/3 complex and 
formins. Annu Rev Biophys Biomol Struct. 36:451-477. 
Pollard, T.D. 2016. Actin and Actin-Binding Proteins. Cold Spring Harb Perspect Biol. 8. 
Pollard, T.D., and G.G. Borisy. 2003. Cellular motility driven by assembly and 
disassembly of actin filaments. Cell. 112:453-465. 
Ponti, A., M. Machacek, S.L. Gupton, C.M. Waterman-Storer, and G. Danuser. 2004. 
Two distinct actin networks drive the protrusion of migrating cells. Science. 
305:1782-1786. 
Resnicow, D.I., J.C. Deacon, H.M. Warrick, J.A. Spudich, and L.A. Leinwand. 2010. 
Functional diversity among a family of human skeletal muscle myosin motors. 
Proceedings of the National Academy of Sciences of the United States of 
America. 107:1053-1058. 
Rhee, D., J.M. Sanger, and J.W. Sanger. 1994. The premyofibril: evidence for its role in 
myofibrillogenesis. Cell motility and the cytoskeleton. 28:1-24. 
Ribeiro, A.J., Y.S. Ang, J.D. Fu, R.N. Rivas, T.M. Mohamed, G.C. Higgs, D. Srivastava, 
and B.L. Pruitt. 2015. Contractility of single cardiomyocytes differentiated from 
pluripotent stem cells depends on physiological shape and substrate stiffness. 
Proceedings of the National Academy of Sciences of the United States of 
America. 112:12705-12710. 
Ricketson, D., C.A. Johnston, and K.E. Prehoda. 2010. Multiple tail domain interactions 
stabilize nonmuscle myosin II bipolar filaments. Proceedings of the National 
Academy of Sciences of the United States of America. 107:20964-20969. 
Riedl, J., A.H. Crevenna, K. Kessenbrock, J.H. Yu, D. Neukirchen, M. Bista, F. Bradke, 
D. Jenne, T.A. Holak, Z. Werb, M. Sixt, and R. Wedlich-Soldner. 2008. Lifeact: a 
versatile marker to visualize F-actin. Nature methods. 5:605-607. 
Rizvi, S.A., E.M. Neidt, J. Cui, Z. Feiger, C.T. Skau, M.L. Gardel, S.A. Kozmin, and D.R. 
Kovar. 2009. Identification and characterization of a small molecule inhibitor of 
formin-mediated actin assembly. Chem Biol. 16:1158-1168. 
Rosado, M., C.F. Barber, C. Berciu, S. Feldman, S.J. Birren, D. Nicastro, and B.L. 
Goode. 2014. Critical roles for multiple formins during cardiac myofibril 
development and repair. Mol Biol Cell. 25:811-827. 
Rossi, A., Z. Kontarakis, C. Gerri, H. Nolte, S. Holper, M. Kruger, and D.Y. Stainier. 
2015. Genetic compensation induced by deleterious mutations but not gene 
knockdowns. Nature. 524:230-233. 
197 
 
Rui, Y., J. Bai, and N. Perrimon. 2010. Sarcomere formation occurs by the assembly of 
multiple latent protein complexes. PLoS Genet. 6:e1001208. 
Samuel, M.S., J.I. Lopez, E.J. McGhee, D.R. Croft, D. Strachan, P. Timpson, J. Munro, 
E. Schroder, J. Zhou, V.G. Brunton, N. Barker, H. Clevers, O.J. Sansom, K.I. 
Anderson, V.M. Weaver, and M.F. Olson. 2011. Actomyosin-mediated cellular 
tension drives increased tissue stiffness and beta-catenin activation to induce 
epidermal hyperplasia and tumor growth. Cancer Cell. 19:776-791. 
Sandquist, J.C., K.I. Swenson, K.A. Demali, K. Burridge, and A.R. Means. 2006. Rho 
kinase differentially regulates phosphorylation of nonmuscle myosin II isoforms A 
and B during cell rounding and migration. The Journal of biological chemistry. 
281:35873-35883. 
Sanger, J.M., and J.W. Sanger. 1980. Banding and polarity of actin filaments in 
interphase and cleaving cells. The Journal of cell biology. 86:568-575. 
Sanger, J.W., S. Kang, C.C. Siebrands, N. Freeman, A. Du, J. Wang, A.L. Stout, and 
J.M. Sanger. 2005. How to build a myofibril. Journal of muscle research and cell 
motility. 26:343-354. 
Schrank, B.R., T. Aparicio, Y. Li, W. Chang, B.T. Chait, G.G. Gundersen, M.E. 
Gottesman, and J. Gautier. 2018. Nuclear ARP2/3 drives DNA break clustering 
for homology-directed repair. Nature. 559:61-66. 
Sengupta, P., T. Jovanovic-Talisman, D. Skoko, M. Renz, S.L. Veatch, and J. 
Lippincott-Schwartz. 2011. Probing protein heterogeneity in the plasma 
membrane using PALM and pair correlation analysis. Nature methods. 8:969-
975. 
Seri, M., R. Cusano, S. Gangarossa, G. Caridi, D. Bordo, C. Lo Nigro, G.M. Ghiggeri, R. 
Ravazzolo, M. Savino, M. Del Vecchio, M. d'Apolito, A. Iolascon, L.L. Zelante, A. 
Savoia, C.L. Balduini, P. Noris, U. Magrini, S. Belletti, K.E. Heath, M. Babcock, 
M.J. Glucksman, E. Aliprandis, N. Bizzaro, R.J. Desnick, and J.A. Martignetti. 
2000. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and 
Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. 
Nature genetics. 26:103-105. 
Shutova, M., C. Yang, J.M. Vasiliev, and T. Svitkina. 2012. Functions of nonmuscle 
myosin II in assembly of the cellular contractile system. PLoS One. 7:e40814. 
Shutova, M.S., S.B. Asokan, S. Talwar, R.K. Assoian, J.E. Bear, and T.M. Svitkina. 
2017. Self-sorting of nonmuscle myosins IIA and IIB polarizes the cytoskeleton 
and modulates cell motility. J Cell Biol. 216:2877-2889. 
Shutova, M.S., W.A. Spessott, C.G. Giraudo, and T. Svitkina. 2014. Endogenous 
species of mammalian nonmuscle myosin IIA and IIB include activated 
monomers and heteropolymers. Current biology : CB. 24:1958-1968. 
Sjoblom, B., A. Salmazo, and K. Djinovic-Carugo. 2008. Alpha-actinin structure and 
regulation. Cellular and molecular life sciences : CMLS. 65:2688-2701. 
Small, V.J.R., K.; Kaverina, I.; Anderson, K.I. 1998. Assembling an actin cytoskeleton 
for cell attachment and movement. BBA Molecular Cell Research. 1404:271-281. 
Smith, G.F., M.A. Ridler, and J.A. Faunch. 1967. Action of cytochalasin B on cultured 
human lymphocytes. Nature. 216:1134-1135. 
Sparrow, J.C., and F. Schock. 2009. The initial steps of myofibril assembly: integrins 
pave the way. Nature reviews. Molecular cell biology. 10:293-298. 
198 
 
Spector, I., N.R. Shochet, Y. Kashman, and A. Groweiss. 1983. Latrunculins: novel 
marine toxins that disrupt microfilament organization in cultured cells. Science. 
219:493-495. 
Spudich, J.A. 2014. Hypertrophic and dilated cardiomyopathy: four decades of basic 
research on muscle lead to potential therapeutic approaches to these 
devastating genetic diseases. Biophysical journal. 106:1236-1249. 
Stachowiak, M.R., P.M. McCall, T. Thoresen, H.E. Balcioglu, L. Kasiewicz, M.L. Gardel, 
and B. O'Shaughnessy. 2012. Self-organization of myosin II in reconstituted 
actomyosin bundles. Biophysical journal. 103:1265-1274. 
Straight, A.F., A. Cheung, J. Limouze, I. Chen, N.J. Westwood, J.R. Sellers, and T.J. 
Mitchison. 2003. Dissecting temporal and spatial control of cytokinesis with a 
myosin II Inhibitor. Science. 299:1743-1747. 
Svitkina, T.M. 2018. Ultrastructure of the actin cytoskeleton. Curr Opin Cell Biol. 54:1-8. 
Svitkina, T.M., A.B. Verkhovsky, K.M. McQuade, and G.G. Borisy. 1997. Analysis of the 
actin-myosin II system in fish epidermal keratocytes: mechanism of cell body 
translocation. J Cell Biol. 139:397-415. 
Swaminathan, V., and C.M. Waterman. 2016. The molecular clutch model for 
mechanotransduction evolves. Nature cell biology. 18:459-461. 
Szent-Gyorgyi, A. 1943a. The crystallization of myosin and some of its properties and 
reactions. Stud. Inst. Med. Chem. Univ. Szeged. III:76-85. 
Szent-Gyorgyi, A. 1943b. Observations on actomyosin. Stud. Inst. Med. Chem. Univ. 
Szeged. III:86-92. 
Szent-Gyorgyi, A. 1963. Lost in the Twentieth Century. Annu Rev Biochem. 32:1-14. 
Takahashi, K., K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. 
Yamanaka. 2007. Induction of pluripotent stem cells from adult human fibroblasts 
by defined factors. Cell. 131:861-872. 
Taniguchi, K., R. Takeya, S. Suetsugu, O.M. Kan, M. Narusawa, A. Shiose, R. 
Tominaga, and H. Sumimoto. 2009. Mammalian formin fhod3 regulates actin 
assembly and sarcomere organization in striated muscles. The Journal of 
biological chemistry. 284:29873-29881. 
Tojkander, S., G. Gateva, and P. Lappalainen. 2012. Actin stress fibers--assembly, 
dynamics and biological roles. Journal of cell science. 125:1855-1864. 
Tojkander, S., G. Gateva, G. Schevzov, P. Hotulainen, P. Naumanen, C. Martin, P.W. 
Gunning, and P. Lappalainen. 2011. A molecular pathway for myosin II 
recruitment to stress fibers. Current biology : CB. 21:539-550. 
Tullio, A.N., D. Accili, V.J. Ferrans, Z.X. Yu, K. Takeda, A. Grinberg, H. Westphal, Y.A. 
Preston, and R.S. Adelstein. 1997. Nonmuscle myosin II-B is required for normal 
development of the mouse heart. Proceedings of the National Academy of 
Sciences of the United States of America. 94:12407-12412. 
Tuzovic, L., L. Yu, W. Zeng, X. Li, H. Lu, H.M. Lu, K.D. Gonzalez, and W.K. Chung. 
2013. A human de novo mutation in MYH10 phenocopies the loss of function 
mutation in mice. Rare Dis. 1:e26144. 
Uehata, M., T. Ishizaki, H. Satoh, T. Ono, T. Kawahara, T. Morishita, H. Tamakawa, K. 
Yamagami, J. Inui, M. Maekawa, and S. Narumiya. 1997. Calcium sensitization 
of smooth muscle mediated by a Rho-associated protein kinase in hypertension. 
Nature. 389:990-994. 
199 
 
Vallenius, T. 2013. Actin stress fibre subtypes in mesenchymal-migrating cells. Open 
Biol. 3:130001. 
Vasquez, C.G., M. Tworoger, and A.C. Martin. 2014. Dynamic myosin phosphorylation 
regulates contractile pulses and tissue integrity during epithelial morphogenesis. 
The Journal of cell biology. 206:435-450. 
Vassilev, L.T., C. Tovar, S. Chen, D. Knezevic, X. Zhao, H. Sun, D.C. Heimbrook, and 
L. Chen. 2006. Selective small-molecule inhibitor reveals critical mitotic functions 
of human CDK1. Proceedings of the National Academy of Sciences of the United 
States of America. 103:10660-10665. 
Verkhovsky, A.B., and G.G. Borisy. 1993. Non-sarcomeric mode of myosin II 
organization in the fibroblast lamellum. J Cell Biol. 123:637-652. 
Verkhovsky, A.B., T.M. Svitkina, and G.G. Borisy. 1995. Myosin II filament assemblies 
in the active lamella of fibroblasts: their morphogenesis and role in the formation 
of actin filament bundles. J Cell Biol. 131:989-1002. 
Verkhovsky, A.B., T.M. Svitkina, and G.G. Borisy. 1999a. Network contraction model for 
cell translocation and retrograde flow. Biochem Soc Symp. 65:207-222. 
Verkhovsky, A.B., T.M. Svitkina, and G.G. Borisy. 1999b. Network contraction model for 
cell translocation and retrograde flow. Biochem Soc Symp. 65:207-222. 
Vicente-Manzanares, M., X. Ma, R.S. Adelstein, and A.R. Horwitz. 2009a. Non-muscle 
myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell 
Biol. 10:778-790. 
Vicente-Manzanares, M., X. Ma, R.S. Adelstein, and A.R. Horwitz. 2009b. Non-muscle 
myosin II takes centre stage in cell adhesion and migration. Nature reviews. 
Molecular cell biology. 10:778-790. 
Vicente-Manzanares, M., J. Zareno, L. Whitmore, C.K. Choi, and A.F. Horwitz. 2007. 
Regulation of protrusion, adhesion dynamics, and polarity by myosins IIA and IIB 
in migrating cells. J Cell Biol. 176:573-580. 
Wakatsuki, T., B. Schwab, N.C. Thompson, and E.L. Elson. 2001. Effects of 
cytochalasin D and latrunculin B on mechanical properties of cells. Journal of cell 
science. 114:1025-1036. 
Wang, Y.L. 2005. The mechanism of cortical ingression during early cytokinesis: 
thinking beyond the contractile ring hypothesis. Trends in cell biology. 15:581-
588. 
Watkins, H., H. Ashrafian, and C. Redwood. 2011. Inherited cardiomyopathies. The 
New England journal of medicine. 364:1643-1656. 
Wiedenmann, J., S. Ivanchenko, F. Oswald, F. Schmitt, C. Rocker, A. Salih, K.D. 
Spindler, and G.U. Nienhaus. 2004. EosFP, a fluorescent marker protein with 
UV-inducible green-to-red fluorescence conversion. Proceedings of the National 
Academy of Sciences of the United States of America. 101:15905-15910. 
Wilson, C.A., M.A. Tsuchida, G.M. Allen, E.L. Barnhart, K.T. Applegate, P.T. Yam, L. Ji, 
K. Keren, G. Danuser, and J.A. Theriot. 2010. Myosin II contributes to cell-scale 
actin network treadmilling through network disassembly. Nature. 465:373-377. 
Xia, Z.K., Y.C. Yuan, N. Yin, B.L. Yin, Z.P. Tan, and Y.R. Hu. 2012. Nonmuscle myosin 
IIA is associated with poor prognosis of esophageal squamous cancer. Dis 
Esophagus. 25:427-436. 
200 
 
Xu, K., H.P. Babcock, and X. Zhuang. 2012. Dual-objective STORM reveals three-
dimensional filament organization in the actin cytoskeleton. Nature methods. 
9:185-188. 
Yamauchi-Takihara, K., M.J. Sole, J. Liew, D. Ing, and C.C. Liew. 1989. 
Characterization of human cardiac myosin heavy chain genes. Proceedings of 
the National Academy of Sciences of the United States of America. 86:3504-
3508. 
 
